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Abstract 
 
The photoluminescence properties of cyclometallated second and third row 
transition metal complexes make them potential candidates for use in a range of 
applications such as triplet harvesting agents in OLEDS, as photosensitizers, 
and in solar cells.  Also, the strong luminescence of these complexes gives 
them much potential for use in chemosensing applications and as bioimaging 
agents.  This final topic is an area of increasing study as a result of the diverse 
and tuneable excited states of such molecules, and their advantages over 
conventional organic emitters such as reduced photobleaching and long 
luminescence lifetimes allowing time-resolved imaging to be performed. 
 
The synthesis of cyclometallated complexes of the type [Pt(N^C^N)Cl], 
[Ir(N^C)2(L)Cl], and [Ir(N^C^N)(N^X)Cl]
n+ (where N^C^N and N^C are terdentate 
and bidentate cyclometallating aromatic ligands; L = monodentate pyridine 
ligand; X = heterocyclic N or cyclometallated aryl C; n = 0,1) is described and 
their reactions with thiolates are explored with the aim of producing new classes 
of thiol sensors.  Thus, novel monometallic complexes of the type 
[Pt(N^C^N)(thiolate)] and [Ir(N^C^N)(N^C)(thiolate)] are reported as well as a 
novel series of dimers with the general structure [Ir(N^C)2(µ-thiolate)]2 and one 
example of a [Ir(N^C^N)(µ-thiolate)(thiolate)]2 dimer.  The effect of the 
introduction of a thiolate ligand on the excited states of the Pt(N^C^N) 
complexes is also described. 
 
In addition, a series of luminescent compounds based on the dansyl group or 
iridium complexes are reported for use as bioimaging agents and their utility in 
cellular assays has been investigated.  These probes incorporate molecular 
structures inspired by the ability of small molecules to mimic the activity of 
certain redox active proteins and hence have the potential to engage in disulfide 
exchange processes in vivo.  These compounds have been shown to display 
acceptable uptake into cells without excessive cytotoxicity and have been used 
to obtain fluorescence microscopy images of live CHO cells. 
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1 Introduction 
 
The ability of certain compounds to emit light provides a vital tool in chemistry 
since in many cases the characteristics of the emitted radiation are sensitive to 
the molecular environment.  Emissive molecules, therefore, are widely used as 
reporters for many processes.1,2  The diverse photophysical properties of 
transition metals with aromatic chelating ligands such as polypyridyls or their 
cyclometallated analogues have led to their use in many areas involving the 
absorption and emission of light.3,4,5  Such compounds often display strong, 
long-lived emission and thus are well suited to roles in sensing.  More recently, 
in addition to their use in chemosensing applications, these metal complexes 
are becoming more common in cellular studies and bioimaging.6,7 
 
1.1 Luminescence in chemistry 
Luminescence in chemistry is the result of the relaxation of a molecule from 
some electronically excited state back to the ground state by the emission of a 
photon.  The source of energy to form this excited state can be the result of 
various processes, for example the application of an electric current to a 
material leads to electroluminescence or, more commonly, excitation by the 
absorption of a photon of light leads to the processes of fluorescence and 
phosphorescence. 
 
The majority of molecules in their ground state exist with all their electrons 
paired leading to a total spin value S = 0 for the molecule, which is known as a 
singlet ground state, termed S0.  Molecules can also exist in a series of excited 
states where an electron has been promoted to a higher energy molecular 
orbital.  Since two electrons now occupy different orbitals, these may adopt 
„parallel‟ or „opposed‟ spins leading to total spin values of S = 1 or S = 0 for the 
system.  This pairing leads to triplet or singlet excited states which are 
numbered T1, T2, T3 etc. and S1, S2, S3 etc. in order of increasing energy.  In 
general, any given triplet state Tn will be lower in energy than its singlet 
counterpart Sn due to spin correlation.
8 
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The absorption of a photon by the ground state causes the excitation of the 
molecule into an excited state, Sn, from where it relaxes rapidly to the lowest 
singlet excited state, S1, by processes of vibrational relaxation and internal 
conversion (IC) between states of the same multiplicity.  From this state the 
molecule may emit a photon causing relaxation to the ground state in the 
process known as fluorescence, or relax by some other non-radiative pathway.  
It is also possible for a molecule in the S1 excited state to undergo intersystem 
crossing (ISC) to the T1 excited state and subsequent relaxation from this state 
is termed phosphorescence.  Formally transitions of the type Tn←S0 are 
disallowed by the ΔS = 0 selection rule for electronic transitions and are very 
rarely observed in absorption.  Population of the T1 state is therefore almost 
entirely due to ISC.  Equally, the formally forbidden nature of phosphorescence 
leads to much longer luminescence lifetimes, of the order of µs to s, compared 
to fluorescence which generally has lifetimes in the ns range.  In fact, in the 
majority of organic molecules, phosphorescence is not observed due to much 
faster competitive non-radiative decay processes.  All the processes in the 
relaxation of excited states such as non-radiative relaxation, IC, ISC and 
radiative decay have associated rate constants, and it is the balance of these 
rate constants in a particular molecule that determines its photophysical 
properties. 
 
In molecules containing heavy atoms such as second or third row transition 
metals, the high spin-orbit coupling of these atoms leads to a breakdown of the 
ΔS = 0 selection rule, increasing rate constants for the formally spin-forbidden 
processes of ISC and phosphorescence.  The presence of such heavy 
elements can therefore lead to long-lived phosphorescence being observed.  
Figure ‎1.1 shows a Jablonski Diagram which illustrates the described 
processes. 
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Figure ‎1.1 Jablonski Diagram. 
 
Another important factor in luminescence results from the Franck-Condon 
principle.  This states that electronic transitions occur on a much faster 
timescale than molecular reorientation.  This generally results in vibrationally 
excited electronic states upon excitation, after which the molecule relaxes to the 
vibrational ground state of S1 or T1 before emission.  The overall result of this is 
that the emitted radiation is universally red shifted with respect to the absorbed 
frequency, with the gap between the lowest energy absorption band and highest 
emission band being known as the Stokes‟ shift.  It is therefore the case that 
molecules with larger differences between ground state and excited state 
geometries tend to show much larger Stokes‟ shifts than those with very little 
molecular reorganisation. 
 
1.1.1 Luminescence of metal complexes with polypyridyl type ligands 
Aromatic molecules such as 2,2'-bipyridine (bpy) are, in themselves, quite 
unremarkable in their photophysical properties.  In general they display strong 
absorption in the UV region of the spectrum due to π-π* excitation in the 
delocalised aromatic system.  However, by using these compounds as ligands 
for second and third row transition metals, a wealth of varied excited states can 
 5 
 
be unlocked, many with useful emissive properties.  The first such compound to 
be discovered was the octahedral metal complex ruthenium(II) tris-bipyridine 
dichloride [Ru(bpy)3]Cl2 and it and its derivatives have been the subject of 
intensive study.9  In this particular case, significant π backbonding between the 
Ru(II) and the bipyridine ligands10 allows the latter to act as a π acceptor in a 
low energy metal-to-ligand charge transfer (MLCT) excited state.  This, in 
combination with the spin-orbit coupling of ruthenium, results in emission from a 
3MLCT state. 
 
The key to the versatility of this and related metal complexes is the variety in the 
types of excited states that can be achieved by changing the metal centre and 
the ligands around it.  The combination of metal centred orbitals and ligand π 
and π* orbitals can lead to a host of excited states in these complexes including 
metal-centred (MC), metal-to-ligand charge transfer (MLCT), ligand-centred 
(LC) and intraligand charge transfer (ILCT) states.  The high spin-orbit coupling 
of the metal in these complexes may, then, lead to 3MLCT phosphorescence or 
emission from metal-perturbed 3LC or 3ILCT states.  In addition, the mixing of 
metal and ligand orbitals can lead to the formation of states which are 
predominantly ligand-to-ligand charge transfer (LLCT) in character which would 
not normally form due to poor orbital overlap leading to low oscillator strengths 
in the transition.  Figure ‎1.2 shows a representation of the available excited 
states from transitions in a metal complex. 
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Figure ‎1.2 Schematic energy level diagram showing possible excited states in metal 
complexes. 
 
In multimetallic clusters and in square planar complexes, orbital interactions 
between metals can lead to metal–metal-to-ligand charge transfer (MMLCT) or 
other more complex excited states that can be tuned to a specific function. 
 
1.1.2 Complexes of Iridium(III) 
Iridium(III) is isoelectronic with ruthenium(II), but studies into the use of the 
former metal in polypyridyl and related compounds were slower to take off than 
for the latter, in part due to the harsher reaction conditions required to substitute 
the ligands occupying the coordination sphere of the third row, more highly 
charged Ir3+ ion.11 
 
1.1.2.1 Iridium(III) complexes with bipyridine-type ligands 
As a third row transition metal, iridium(III) has lower lying d states than 
ruthenium(II) and thus the Ir(III) centre is more difficult to oxidise leading to 
differences in the observed emissive excited states.  [Ir(bpy)3]
3+ complexes, for 
example, show predominantly LC type emission12 which contrasts with the 
MLCT emission of the pseudo-isoelectronic analogue [Ru(bpy)3]
2+ reflecting the 
lower energy of the d orbitals in Ir(III).  The introduction of negatively charged 
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ligands, for example in complexes such as [Ir(bpy)2Cl2]PF6, leads to a situation 
where dual emission is observed at low temperatures from non-equilibrated 3LC 
and 3MLCT states.13,14  This is the result of an increase in energy of the metal d 
orbitals, such that they reach a level similar to the highest occupied ligand 
based orbitals.  In addition to dual emission, this situation leads to non-radiative 
deactivation through the d-d* excited states.15  Similar compounds with diimine 
ligands such as 2,2'-bipyrimidine, 2,3-bis(2-pyridyl)pyrazine, 2,3-bis(2-
pyridyl)quinoxaline and 2,3-bis(2-pyridyl)benzoquinoxaline (Figure ‎1.3), which 
have more extended π systems, tend to display emissive states with increased 
MLCT character since this state is lower in energy than in the corresponding 
bpy complexes.16 
 
 
Figure ‎1.3 Diimine ligands in complexes of the type [Ir(N^N)2Cl2]
+
 lead to 
3
MLCT emission. 
 
As a result of its kinetic inertness, many early syntheses attempting to introduce 
bpy ligands into the coordination sphere of iridium(III) relied on relatively harsh 
conditions.  In one study, the reaction of IrCl3 with bpy was carried out at high 
temperature (~180 °C) in glycerol.17  The resulting compound contained three 
bipyridine ligands yet had different photophysical properties from a different 
sample of [Ir(bpy)3]
3+ and was erroneously reported as the complex [Ir(bpy-
N,N')2(bpy-N)(H2O)]
3+ (Figure ‎1.4a).  Later studies showed that, in fact, the 
complex was the N-protonated cyclometallated analogue of [Ir(bpy)3]
3+, [Ir(bpy-
N,N')2(Hbpy-C
3,N')]2+ (Figure ‎1.4b).18 
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Figure ‎1.4 a) reported [Ir(bpy-N,N')2(bpy-N)(H2O)]
3+
 structure and b) structure of [Ir(bpy-
N,N')2(Hbpy-C
3
,N')]
2+
 solved by X-ray crystallography. 
 
The emission from this cyclometallated variant was assigned to an LC state with 
increased MLCT character compared to the emission of [Ir(bpy)3]
3+ owing to the 
presence of one Ir-C bond.  In addition, as a result of the protonated pyridine 
fragment, the photophysics of this complex were shown to be pH dependent.17  
The observation of this cyclometallation, however, led to investigations involving 
cyclometallating ligands with structures similar to bpy such as 2-phenylpyridine 
(ppy). 
 
1.1.2.2 Iridium(III) complexes with N^C bidentate cyclometallating ligands 
The reaction of IrCl3 with 2-phenylpyridine yields the bis N^C coordinated dimer 
[Ir(ppy-N,C2)2Cl]2
19 shown in Figure ‎1.5.  The structure of this dimer was 
reported as having the cyclometallating carbons mutually cis due to their 
relatively high trans effect and reported crystal structures have confirmed that, 
in general, related complexes of iridium(III) and rhodium(III) with two bidentate 
N^C cyclometallating ligands do adopt this configuration.20,21,22,23  The relatively 
large trans influence of the carbon in such ligands has also been observed by 
its effect on the vibrational frequency of trans Ir-Cl bonds.24 
 
a) b) 
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Figure ‎1.5 [Ir(ppy-N,C
2
)2Cl]2 
 
This family of bis-bidentate N^C bound dimers are cleaved readily by a variety 
of ligands giving monometallic complexes.  It has been shown that bidentate 
chelating ligands such as bpy and 1,10-phenanthroline (phen) can be used to 
cleave the bis N^C dimer structure yielding cationic complexes such as 
[Ir(ppy)2(bpy)]
+, in which the cis disposition of the cyclometallating carbon atoms 
is retained.25 
 
Cleavage using monoanionic, bidentate β-diketonate ligands such as 
acetylacetonate (acac) likewise gives a series of highly phosphorescent charge 
neutral complexes of the form [Ir(N^C)2(O^O)] with quantum yields in solution of 
up to 0.6 and microsecond lifetimes.26  The emission maxima of these 
compounds can also be readily tuned by variation of the N^C ligand. 
 
Another important class of compounds are homoleptic tris cyclometallated Ir(III) 
complexes using similar N^C bidentate ligands, with Ir(ppy)3 first being reported 
as a by-product in the synthesis of [Ir(ppy)2Cl]2.
27  This type of compound, 
again, can be synthesised with a variety of N^C binding ligands and can exist 
either as fac or mer isomers (as shown in Figure ‎1.6). It is possible, by varying 
the reaction conditions, to selectively synthesise these isomers23,28 which is 
important since they display distinct photophysical properties resulting from their 
structural differences.  While the fac isomer has C3 symmetry, with all Ir-C 
bonds being trans to Ir-N bonds, the mer isomer shows noticeable distortion 
with mutally trans Ir-N bonds being relatively shorter and mutually trans Ir-C 
bonds being lengthened.  This is due to the much higher trans influence of the 
cyclometallating carbon over the pyridine nitrogen.  A larger Stokes‟ Shift in the 
emission of the mer isomer results from more pronounced geometrical changes 
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in the excited state, a reflection of the weaker bonds.  In addition, the mer 
isomer tends to display shorter lifetimes and lower phosphorescence quantum 
yields due to non-radiative decay processes associated with 
photoisomerisation.28 
 
 
Figure ‎1.6 The possible fac and mer configurations of Ir(N^C)3 complexes and the ligands used 
in ref. 28. 
 
With the additional electron density at the metal centre provided by two or three 
strongly σ-donating cyclometallating carbons in bis or tris cyclometallated 
iridium(III) complexes, the highly efficient phosphorescence exhibited by these 
compounds is almost universally from 3MLCT states. 
 
While 3MLCT emission is common in tris-bidentate complexes with two or three 
cyclometallating carbons, the nature of the ligands can alter the orbitals which 
are involved in this state.  In the case of [Ir(ppy)2(acac)] type complexes, the 
ppy ligand is the acceptor in the lowest energy MLCT excited state, but the 
replacement of the acac by a diimine can lead to a change in the emissive 
state.  It has been reported that in the case of [Ir(ppy)2(bpy)]
+, dual emission is 
observed from non-equilibrated 3MLCT states at 77 K, corresponding to charge 
transfer to a ppy ligand or the bpy as the energies of the two ligands are similar 
in this case.25  In related complexes containing diimine ligands with more 
extended π systems, this ligand‟s π* orbital is sufficiently lower than the 
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corresponding ppy orbitals leading to phosphorescence from a d→π*(diimine) 
3MLCT state. 
 
The highly tuneable photophysical properties of these N^C cyclometallated Ir(III) 
complexes and the observed high quantum efficiencies have led to wide 
ranging potential of these compounds in areas such as photocatalysis,27 singlet 
oxygen sensitizers,29 oxygen sensing30 and, in particular, triplet harvesting 
agents in OLEDS.26,31,32,33,34 
 
1.1.2.3 Iridium(III) complexes with terdentate ligands 
Developments in the chemistry of iridium(III) complexes with terdentate 
polypyridyl ligands began significantly later than the corresponding bidentate 
complexes.  The terdentate ligand 2,2':6',2''-terpyridine (tpy) was first 
successfully incorporated into the homoleptic complex [Ir(tpy)2]
3+ in 1990 by 
Demas et al. using harsh conditions and with only a poor yield.35  An improved 
stepwise synthesis via Ir(tpy)Cl3 was reported several years later which also 
allowed a series of similar heteroleptic complexes to be made36 (Figure ‎1.7).  
These complexes tend to show phosphorescent emission from 3LC excited 
states with lifetimes of a few microseconds with relatively low oxygen 
quenching.  These properties led to the exploration of such compounds as 
potential sensors with elaboration at the 4' position on the central pyridine 
leading to reports of pH sensitive emission37,38 and chloride ion sensing.39 
 
 
Figure ‎1.7 Homoleptic and heteroleptic complexes of iridium(III) with terpyridyl ligands. 
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In addition to the use of terpyridine ligands, the effects of cyclometallation in 
these bis-terdentate systems have also been of interest.  Ligands such as 6-
phenyl-2,2'-bipyridine (phbpyH), 2,6-diphenylpyridine (dppyH2) and 1,3-di(2-
pyridyl)benzene (dpybH) have the potential to bind as anionic analogues of tpy 
with N^N^C, C^N^C and N^C^N binding modes respectively (Figure ‎1.8). 
 
 
Figure ‎1.8 The terdentate bicyclometallating ligands phbpyH, dppyH2 and dpybH. 
 
The synthesis of transition metal complexes with the N^N^C binding terpyridine 
analogue phbpy was first reported for palladium and platinum.40  Similar use 
was soon reported with ruthenium(II) in a heteroleptic complex with 4'-tolyl-
2,2':6'2''-terpyridine (ttpy), [Ru(phbpy)(ttpy)]+, which gave significant 
enhancement in emissive properties compared to [Ru(tpy)2]
2+.41  The use of the 
N^C^N binding analogue dpyb was also reported with ruthenium(II) around the 
same time.42 
 
The first report of cyclometallated analogues of tpy in iridium complexes made 
use of the ligand 2,6-bis(7'-methyl-4'-phenyl-2'-quinolyl)pyridine where a bis 
terdentate complex can be formed either with both ligands bound in an N^N^C 
mode or with one ligand instead bound in an N^N^N coordination mode43 (see 
Figure ‎1.9). 
 
 
Figure ‎1.9 N^N^N and N^N^C binding modes with a bis-quinolylpyridine ligand giving rise to 
[Ir(N^N^N)(N^N^C)]
2+
 and [Ir(N^N^C)2]
+
 complexes. 
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The use of dianionic tpy analogues with C^N^C bound ligands is also reported44 
in heteroleptic complexes of the type [Ir(C^N^C)(N^N^N)]+ which show 
microsecond lifetime red emission in room temperature solutions.44,45 
 
During investigations into potential N^C^N bound ligands, it was discovered that 
the simplest ligand of this type, dpyb, does not adopt the desired configuration.  
Unlike with ruthenium(II), it was discovered that the preferred site of metallation 
of iridium(III) is at the C4 position of the central benzene ring rather than the 
desired C2 position as shown in Figure ‎1.10.  This problem was initially 
overcome through the use of the dimethyl substituted ligand 4,6-di(2-pyridyl)-
meta-xylene (dpyxH), where the C4 position is blocked, in the synthesis of the 
complex [Ir(dpyx)(dppy)].46  This complex is particularly interesting in that it is a 
bis-terdentate analogue of the highly phosphorescent complex Ir(ppy)3 with 
three cyclometallating carbon atoms. 
 
 
Figure ‎1.10 Competitive binding displayed by iridium(III) with dpyb. 
 
The number of cyclometallating carbons present in these bis-terdentate 
complexes with iridium(III) appears to govern the observed emissive excited 
states.  While [Ir(tpy)2]
3+ shows long lived 3LC emission in room temperature 
solutions, [Ir(dpyx)(ttpy)]2+ is a poor emitter47.  This is due to poor orbital overlap 
in the lowest excited state which is in this case a dpyx→ttpy ligand-to-ligand 
charge transfer.  The incorporation of a second cyclometallating carbon for 
example in [Ir(dpyx)(phbpy)]+, however, raises the energy of the metal centred 
orbitals leading to increased metal character in the excited state and improved 
emission48.  The metal centred orbitals are further increased by the addition of a 
third carbon in the ligand system leading to strong 3MLCT phosphorescence.46  
The effect of increasing cyclometallation in these complexes is illustrated in 
Figure ‎1.11. 
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Figure ‎1.11 Simplified schematic energy level diagram showing the influence of 
cyclometallation on the frontier orbitals in bis-terdentate Ir(III) complexes, leading to excited 
states of different character.
49
  Reprinted from J. A. G. Williams et al., Dalton Trans., 2008, 
2081, Copyright 2008, with permission from RSC Publishing. 
 
A particular advantage of bis-terdentate complexes over their tris-bidentate 
counterparts is in the formation of multimetallic assemblies.  The latter, having 
D3 symmetry exist as racemic mixtures, and thus when two complexes are 
linked diastereoisomers may form which have subtly different photophysical 
properties.  This problem is not suffered by bis-terdentate complexes, and in 
addition, they allow linear assemblies to be built which display well defined 
directional electron transfer.  These structural advantages have led to a 
predominant focus upon these compounds for use in multimetallic assemblies, 
electron transfer processes and photoinduced charge separation.48,50,51 
 
In summary, the complexes of iridium(III) with bidentate and terdentate 
cyclometallating ligands provide a wealth of options in terms of the tuning of 
excited states in both cationic and neutral complexes, as well as a structural 
diversity making them ideal for use in monometallic roles or multimetallic 
assemblies. 
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1.1.3 Complexes of Platinum(II) 
The first reported compound of platinum(II) with the cyclometallating ligand 2-
phenylpyridine was the simple complex cis-bis(2-phenylpyridine)platinum(II),52 
synthesised by the treatment of trans-PtCl2(SEt2)2 with ortholithiated ppyH.  The 
cis product was the result of sequential binding of the ppy ligand, with the 
pyridine N of the second ligand being directed trans to the first cyclometallated 
carbon followed by subsequent ring closure to form the bis-cyclometallated 
species.  This complex displayed a solvatochromic absorption band in the 
visible region assigned to an MLCT transition and, while it is non-emissive in 
solution, the solid displays strong emission around 600 nm which was reported 
to be the result of a dimeric species in the solid state.53 
 
Similar compounds with ppy type ligands were shown to also display emission 
from 3MLCT states in low temperature glasses and in the solid state,54 however 
the majority of compounds of this type are essentially non-emissive in room 
temperature solutions. 
 
1.1.3.1 Platinum with terdentate cyclometallating ligands 
Constable et al. first demonstrated the use of an N^N^C bound terdentate 
ligand with platinum(II)55,56 (Figure ‎1.12) and compounds using this type of 
ligand were demonstrated to show emission in both low temperature glasses 
and in solution at room temperature.57  Similarly to complexes with ppy, the 
planar nature of these Pt(N^N^C) complexes causes the photophysical 
properties to be strongly influenced by Pt-Pt interactions at low temperature, 
with emission from 3MMLCT states common in these systems.  In solution most 
complexes of this type show 3MLCT emission, however with the use of a 
bridging bis(diphenylphosphino)methane (dppm) ligand, 3MMLCT emission can 
also be observed in solution. 
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Figure ‎1.12 Some platinum(II) complexes with N^N^C ligands. 
 
The use of terdentate C^N^C binding motifs has also been reported58,59 and 
again, the emissive properties of these compounds are affected by stacking 
interactions in the solid state.  However unlike the interactions in Pt(N^N^C) 
complexes, the C^N^C ligand leads to head-to-tail π stacking in the solid state 
with minimal Pt-Pt interactions.60  This leads to the concentration dependent 
formation of ππ* excimer formation in low temperature glasses.  These 
compounds, like many with ppy ligands, prove to be non-emissive under 
ambient conditions. 
 
In contrast to many other cyclometallated complexes of platinum(II), the 
complex with an N^C^N coordinating ligand [Pt(dpyb)Cl] (Figure ‎1.13), first 
reported by Cardenas,61 is highly emissive in room temperature solutions 
(Φ = 0.6 τ = 7.2 µs in degassed DCM).62  The emission wavelength of similar 
compounds can also be widely tuned by substituent effects on the dpyb 
ligand.63  The emission of these compounds is of 3π-π* character, although a 
significant contribution from a d-π* component is suggested by DFT calculations 
which is consistent with high rates of triplet emission induced by the spin-orbit 
coupling of the metal.64 
 
 
Figure ‎1.13 [Pt(dpyb)Cl] 
 
The high efficiency of phosphorescence in these complexes is in part attributed 
to a shorter Pt-C bond in comparison to complexes with N^N^C ligands leading 
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to an increase in energy of MC excited states.  This in turn leads to a decrease 
in non radiative decay through these metal-centred states.  In addition, the 
rigidity of the terdentate ligand reduces excited state relaxation through 
distortion as is observed in analogous compounds with bidentate ligands such 
as [Pt(ppy)(ppyH)Cl].54 
 
The varied properties of cyclometallated platinum complexes, particularly the 
highly emissive Pt(N^C^N) systems, has led to such compounds being 
investigated for use as phosphorescent dopants in OLEDS,65 emissive liquid 
crystals,66 and bioimaging agents.67 
 
1.2 Disulfide bond formation in protein biosynthesis 
The endoplasmic reticulum (ER) is an organelle that resides around the nucleus 
in eukaryotic cells.  It is in the ER (specifically, the rough ER) that the translation 
and folding of trans-membrane and secretory proteins is performed.  Many of 
these proteins rely on disulfide bonds for their structural integrity or function, 
unlike those destined for roles in the cytosol which generally do not.  The 
electrochemical potential of the cytosol in most cells will disfavour the stability of 
disulfide bonds as it is more reducing than the conditions in the extra-cellular 
space.  The ER, therefore, provides safe passage for proteins destined for 
secretion or trans-membrane roles which rely on these disulfide bonds, and as 
part of this function it maintains a more oxidising environment than the 
surrounding cytosol.  After biosynthesis in the ER, proteins are transported in 
vesicles to their necessary destinations.  The structure of a general eukaryotic 
cell is shown in Figure ‎1.14. 
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Figure ‎1.14 The general structure of a eukaryotic cell.
68
 
 
Transcription of DNA in the nucleus followed by translation in the ER gives an 
unfolded protein.  Any thiols present on cysteine residues will be in their 
reduced form when the protein is translated.  If the protein is required to form 
disulfide bonds between these thiols to achieve its functional structure then an 
oxidative pathway must be present.  Under aerobic conditions, many thiols will 
spontaneously form disulfide bonds depending on their precise oxidation 
potential, however, indiscriminate disulfide bond formation in protein folding can 
lead to aggregates of many separate proteins and non-native structures which 
do not show the required function.  As is the case in many biological systems, a 
large number of enzymes and chaperones are present in the ER to aid correct 
protein folding.  The identity and action of some of the key enzymes in protein 
folding in the ER have been discovered and the current understanding of these 
processes is discussed. 
 
1.2.1 Protein Disulfide Isomerase 
During investigations into the folding of reduced bovine pancreatic ribonuclease 
(RNase) upon reoxidation of the sulfhydryl groups to disulfide bonds in vitro, it 
was found that the protein will spontaneously adopt its native configuration.69,70  
In order to establish whether systems were present in vivo to accelerate re-
oxidation, the reactivation of RNase activity was studied in the presence of 
homogenised rat liver cells.71  It was discovered that certain microsomal 
fractions did indeed greatly accelerate the regeneration of the native RNase 
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from its reduced form.  Further study indicated that the system was not only 
involved in the oxidation of sulfhydryl groups but also in the isomerisation of 
non-native disulfide bonds.72 
 
This, in essence, was the first discovery of protein disulfide isomerase (PDI), 
which was successfully purified from bovine liver and partly characterised in 
1966.73  Refinements to the purification and a more detailed molecular 
characterisation classified PDI as a 57 kDa protein which resides in the 
endoplasmic reticulum.74 
 
1.2.1.1 Structure and activity of PDI 
Analysis of complementary DNA cloned from rat liver indicated a protein 
structure with domains homologous to that of the single domain protein 
thioredoxin (Trx), a known cofactor in redox reactions in prokaryotes such as 
Escherichia coli.75  Comparison between PDI amino acid sequences from 
bovine, rat and human sources revealed two regions homologous to Trx in all 
three, with rat and bovine PDI being identical within these regions76 (Figure 
‎1.15). 
 
 
Figure ‎1.15 (a) Schematic domain Structure of PDI.  (b) Homology between PDI and Trx.
76
  
Reprinted from R. B. Freedman et al., Biochem. Soc. Trans., 1987, 16, 96, Copyright 1987, with 
permission from Portland Press Ltd. 
 
From this information it was deduced that PDI has two active sites with the 
amino acid sequence WCGHCK, differing only from Trx in the substitution of a 
histidine residue for proline.  The gene for encoding PDI in Saccharomyces 
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cerevisiae (yeast) was also identified and predicted a protein with the same 
homologous regions and active sites with 30% overall similarity to mammalian 
PDI.77  In this study it was also found by gene disruption experiments that S. 
cerevisiae cells are inviable without PDI production. 
 
Bearing in mind the function of PDI as an oxidase for sulfhydryl groups and an 
isomerase for non-native disulfide bonds, it is evident that the two cysteine 
residues are of importance.  Various studies of mutant PDIs where one or both 
cysteine residues was substituted for serine have shown that the N- and C-
terminal cysteines are inequivalent in properties and function.78  Removal of the 
N-terminal residue causes a significant decrease in the rate of reactivation in 
reduced, denatured RNase while an inactivated C-terminal mutant shows no 
appreciable loss of activity.  This mutation did appear, however, to reduce the 
steady-state binding constant Km between enzyme and substrate. 
 
Further analysis of these mutants confirmed that only the N-terminal cysteine is 
necessary for catalysis of isomerisation while both cysteine residues are 
needed for activity in the oxidation of reduced, denatured RNase.79  This 
investigation also noted the accumulation of covalent PDI-RNase complex for 
the Cys-Gly-His-Ser active site mutant which does not occur with the wild-type 
PDI.  It was suggested that, as well as allowing catalytic oxidation, the presence 
of two cysteine residues allows the enzyme an escape in the event of a 
geometrical barrier to rapid formation of the native structure (Scheme ‎1.1). 
 
 
Scheme ‎1.1 Action of PDI in isomerisation of disulfide bonds showing escape from 
geometrically trapped arrangement.
79
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Microbiological studies have also revealed that in S. cerevisiae with 
chromosomal deletion of the pdi1 gene, the inviable cells can be complemented 
with a wild-type rat gene.  This is also possible with a CGHS mutant gene 
coding, but cells with a mutant SGHC coding remain inviable.80  This indicates 
that the primary function of PDI in yeast is as an isomerase since the lack of 
oxidase activity of the CGHS mutant PDI does not affect viability. 
 
There has been some disagreement over these results since in studies of PDI 
variants and individual PDI domains it was found that a significant reduction in 
isomerase activity still allows viability in pdi1Δ* S. cerevisiae, provided the 
variant has high oxidase activity.81,82,83  This may suggest that isomerisation to 
the native structure could proceed by reduction and re-oxidation of disulfide 
bonds in systems with low isomerase activity.  It has been shown, however, that 
isomerase activity in homogeneous conditions can be fully retained in variants 
without redox capabilities.84 
 
In any case it is certain that wild type PDI performs both isomerase and oxidase 
functions, even though its exact roles and those of its homologues in redox 
cycles and isomerisation in vivo are not fully understood. 
 
The structure of PDI proposed from initial determination of the amino acid 
sequence76 was of two homologous domains, a and a', separated by two 
segments (b and b') which were recognised as being internal repeats.  The 
limits of these domains (see Figure ‎1.15) and their structures have since been 
studied in more depth.85,86,87  The full structure consists of 5 domains 
designated a, b, b', a' and c with a C-terminal endoplasmic reticulum retention 
signal.88  The first four domains have been found to have Trx-like folds although 
b and b' are without an active site.  A fragment containing the first 120 amino 
acids (the a domain) has been directly characterised by multidimensional 
heteronuclear NMR85 and is shown in Figure ‎1.16. 
                                            
*
 pdi1Δ indicates the deletion of the pdi1 gene which is responsible for coding the protein PDI. 
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Figure ‎1.16 PDI a domain.
85
  Reprinted from J. Kemmink et al., Biochemistry, 1996, 35, 7684, 
Copyright 1996, with permission from ACS Publications. 
 
The full domain structure of PDI is shown in Figure ‎1.17.  The numbering 
system shown is for rat PDI.  Domain sizes vary slightly between different 
mammals but all retain the C-terminal Lys-Asp-Glu-Leu (KDEL) ER retention 
signal while S. cerevisiae PDI has the yeast ER retention signal His-Asp-Glu-
Leu (HDEL). 
 
 
Figure ‎1.17 Numbered domain sequence for rat PDI.
89
  Reprinted from E. A. Kersteen et al., 
Antioxid. Redox Signalling, 2003, 5, 413, Copyright 2003, with permission from Mary Ann 
Liebert, Inc. 
 
It should also be noted that as well as individual activity as an 
isomerase/oxidase, PDI has been identified as a subunit of the multimeric 
enzyme assemblies prolyl-4-hydroxylase90 and microsomal triglyceride transfer 
protein.91  Interestingly, there is also evidence that PDI chaperones the folding 
of proteins without disulfide bonds while preventing aggregation.92 
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1.2.1.2 PDI mimics 
As discussed previously, PDI is a protein with five domains, two of which 
contain an active site homologous to that of the well classified93,94 Escherichia 
coli thioredoxin (Trx), a 12 kDa polypeptide (Figure ‎1.18).  Despite the similarity 
in structure, Trx is not able to replicate the function of PDI in yeast cells as only 
a fraction have a reduced, deprotonated thiolate group necessary for activity 
under the pH and electrochemical conditions of the ER.95  Modified Trx with a 
lower thiol pKa on the other hand will show PDI activity
96 indicating that small 
analogues can mimic the behaviour of PDI. 
 
Figure ‎1.18 Thioredoxin structure.
96
  Reprinted from P. T. Chivers et al., EMBO J., 1996, 15, 
2659, Copyright 1996, with permission from Nature Publishing Group. 
 
It was found that as well as homologues with a CXXC active site, the tripeptide 
Cys-Gly-Cys-NH2 and a mutant Trx with the P34 residue absent giving it a CXC 
active site will mimic PDI activity.97 
 
It has now been shown that as well as small proteins and polypeptides, even 
small molecules can also mimic PDI activity.  The molecule (±)-trans-1,2-bis(2-
mercapto-acetamido)cyclohexane (BMC) (Figure ‎1.19), which has been studied 
for use as a technetium ligand98 and as a reducing agent,99 will catalyse the 
reactivation of scrambled RNase A in vitro.95  This study also showed that BMC 
added to the growth medium of S. cerevisiae cells increased secretion of 
Schizosaccharomyces pombe acid phosphatase, a side effect normally 
associated with PDI overproduction indicating in vivo PDI activity. 
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Figure ‎1.19 trans-1,2-bis(2-mercaptoacetamido)cyclohexane (BMC). 
 
Although this small molecule does mimic PDI, its activity is only a fraction of that 
of the wild-type protein.  This was attributed to lack of peptide binding sites 
possessed by PDI to form enzyme-substrate complexes, non-ideal thiol pKa and 
E0 and also to loss of BMC through formation of mixed disulfides with the redox 
buffer.95 
 
Similar small-molecule approaches have been used in studies regarding the 
acceleration of reduced protein refolding in vitro.  The usual standard for the re-
formation of disulfide bonds in the production of native proteins in vitro is a 
mixture of oxidised and reduced glutathione.100  Systems similar to the 
glutathione buffer have been used to enhance the rate of folding and 
isomerisation.  An aromatic thiol/disulfide buffer gives a 5-fold rate 
enhancement over glutathione.101  Other strategies, more similar to the dithiol 
nature of BMC, have produced dithiol moieties immobilised on various 
supports.102  The effectiveness of the system is dependent upon the support 
used but, of those studied, the most effective gave a 17-fold increase in the 
yield of native protein.  The major advantage of this approach is the drastic 
simplification of purification once the native proteins have been produced. 
 
Since, on this evidence, small molecules can be made to mimic PDI activity, an 
investigation into similar small molecules containing fluorescent or 
phosphorescent tags would prove highly advantageous in the development of 
knowledge concerning the action and localisation of PDI in vitro and in vivo. 
 
1.2.2 Endoplasmic Reticulum Oxidoreductase 
As previously discussed, PDI is intimately involved in oxidative protein folding in 
the endoplasmic reticulum.  PDI in its oxidised state can form disulfide bonds in 
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newly synthesised proteins by dithiol-disulfide exchange reactions.  Any non-
native bonds produced can then be isomerised by PDI in its reduced, 
deprotonated form.  In this state, however, PDI can no longer provide any 
oxidase activity.  There must, therefore, be a system in place in vivo to maintain 
the correct ER environment which will give the right balance of PDI in its 
disulfide and dithiol forms. 
 
Genetic studies in Saccharomyces cerevisiae revealed the existence of a 
protein that is essential to oxidative folding in the ER.103,104  It was concluded 
that this protein, named Ero1p in yeast, was involved in oxidative pathways for 
the maintenance of active PDI.  During these studies, comparison of Ero1p to 
sequence databases indicated the existence of homologues in mammals.  Two 
homologues have since been identified in human cells and have been named 
Ero1α105 and Ero1β.106 
 
1.2.2.1 The role of ERO proteins in the action of PDI 
Further investigations have revealed more details of the oxidative pathways 
involved in protein folding.  The dependence of Ero1p upon the cofactor flavin 
adenine dinucleotide (FAD) for oxidase activity has been demonstrated107 as 
well as the importance of the reduced and oxidised glutathione levels in vivo, 
both within the ER and in the surrounding cytosol.108,109  It has also been shown 
that Ero1p transfers electrons from the reduced PDI directly to molecular 
oxygen.110  The likely mechanism for oxidative protein folding based on these 
findings is shown in Scheme ‎1.2.  Interestingly, despite the presence of definite 
oxidative pathways for PDI involving Ero1 proteins in both yeast and 
mammalian cells, it has been noted that the while PDI at steady state in yeast is 
mostly oxidised,111 it appears to be mostly in its reduced form in mammals.112 
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Scheme ‎1.2 A model for the transfer of oxidative equivalents from O2 or an e
-
 acceptor to 
folding proteins in the ER of yeast.  Ero1p activity is dependent on weakly associated free FAD 
as well as bound FAD.  Apo Ero1p refers to a state where weakly associated FAD is absent.
110
  
Reprinted from B. P. Tu et al., Mol. Cell, 2002, 10, 983, Copyright 2002, with permission from 
Cell Press 
 
Another factor relating to protein folding is that of „quality control‟.  An excess of 
unfolded protein in the ER induces increased transcription of various genes.  In 
general the genes activated by this Unfolded Protein Response (UPR) are ER 
specific proteins.113,114  Ero1p in yeast is one of the proteins up-regulated by the 
UPR104 but in mammalian cells only Ero1β expression is increased by this 
response.106  Despite the fact that Ero1α is homologous, up-regulation is 
stimulated by hypoxia115 not UPR indicating that although they are related, 
Ero1α and Ero1β have separate specialised functions.  This is supported by 
reports that Ero1β exhibits tissue specific expression.116  It is also becoming 
apparent that Ero proteins and Ero-Ero dimers may be involved in processes 
unrelated to PDI since in certain tissues Ero1β expression is inversely 
correlated with that of PDI.116 
 
1.2.2.2 Structural features of ERO proteins 
Unsurprisingly, Ero1 proteins contain several cysteine residues, some of which 
form redox active or structural disulfide bonds.  The functions of conserved 
cysteine-containing motifs have been investigated117,118 and the absolute 
structure of Ero1p has been determined by X-ray crystallography119 (Figure 
‎1.20). 
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Figure ‎1.20 Structure of Ero1p showing cysteine residues and FAD positions.
119
  Reprinted 
from E. Gross et al., Cell, 2004, 117, 601, Copyright 2004, with permission from Cell Press. 
 
The Ero1p structure contains two relevant conserved motifs with the structures 
CXXXXC and CXXCXXC.  Amino acid substitution studies indicate that the 
C100XXXXC105 site is needed in the binding of Ero1p to PDI and the necessary 
dithiol-disulfide exchange.  Removal of C352 or C355 (the two cysteine residues 
closer to the C-terminus in CXXCXXC) also impairs Ero1p activity indicating 
that these are also involved in the process, most likely their role being in 
reoxidising the CXXXXC dithiol.118  This is consistent with the determined 
structure as the N-terminal C349 of this motif is involved in a structural disulfide 
bond.  It is also apparent from the X-ray structure that the CXXXXC motif 
resides on a flexible chain section which facilitates shuttling between an 
exposed position for interaction with PDI and the CXXCXXC active site, 
adjacent to the FAD cofactor. 
 
While it is likely that there are a many more enzymes and chaperones involved 
in oxidative protein folding, both PDI and the ERO proteins are clearly key 
species in this process.  The ability to further target these enzymes for study 
would therefore provide more insight into the function of the endoplasmic 
reticulum as a factory for secretory and trans-membrane proteins. 
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1.3 Detection of biological thiols 
The detection of biological thiols has been extensively researched, initially in the 
context of detecting levels of free amino acids such as cysteine and 
homocysteine.120  Elevated or depressed concentrations of these substances in 
plasma can be indicators of various diseases such as cardiovascular disease121 
and Alzheimer‟s disease.122  Deficiencies in these amino acids can also be 
responsible for health problems including slowed growth, muscle and fat loss, 
lethargy and many others.123  Many of these early methods, however, rely on 
derivatisation and separation prior to analysis and are useful only in the 
determination of concentration with respect to free cysteine, homocysteine and 
glutathione. 
 
Approaches of this nature, while suited to roles in medical analysis and 
diagnosis, are less useful for probing the structure and action of larger biological 
species such as polypeptides and proteins. 
 
1.3.1 Organic fluorophores as sulfhydryl labels 
There have been two general approaches to the detection of thiol-containing 
molecules in biological systems using organic fluorophores.  These are direct, 
normally irreversible reactions of a thiol group with a suitable label or the use of 
a “chemosensing ensemble”124 where non-covalent interactions between a 
receptor and the analyte and fluorophore induce changes in fluorescence. 
 
The direct labelling approach has been successfully employed in the selective 
detection of the amino acids cysteine and homocysteine.  One investigation125 
developed a labelling system based on the selective reaction of N-terminal 
cysteine residues with aldehydes to form thiazolidines126 (Scheme ‎1.3). 
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Scheme ‎1.3 Reaction of N-terminal cysteine with an aldehyde. 
 
This reactivity is also displayed by free cysteine and homocysteine, forming 5 
and 6 membered rings respectively, since the required functionality is a thiol 
group and a neighbouring primary amine.  The necessity for both these groups 
allowed the development of a colorimetric sensor with specificity for cysteine 
and homocysteine over other biological thiols such as glutathione or non-
terminal cysteine residues in proteins.125  The reactivity of the aldehyde group 
with cysteine has also been used to label proteins synthesised with additional 
N-terminal cysteine residues.126,127 
 
Another novel sensor system based on squaraine derivatives was found to 
show selectivity for thiol groups when tested with various amino acids.128  The 
quenching of luminescence in the sensor has been proposed to be a result of 
the reaction shown in Scheme ‎1.4. 
 
 
Scheme ‎1.4 Proposed reaction between squaraine derivatives and biological thiols causing 
bleaching of the sensor and quenching of fluorescence.
128
 
 
As well as detection of small biological molecules, direct labelling has also been 
used in the study of proteins, often in conjunction with protein modification.  
Common functionalities for labelling the thiol side chains of cysteine residues 
are maleimides129 and haloacetamides.130  A good example of the use of these 
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labels was in a study of adenosine-5'-triphosphate (ATP) hydrolysis by 
actomyosin subfragment 1 ATPase.131  Here, to measure the release of 
phosphate upon ATP hydrolysis, an A197C mutant of the Escherichia coli 
phosphate binding protein was labelled via the unnatural cysteine with a 
fluorescent maleimide.  The labelled mutant showed a ~50 nm shift in emission 
maxima with a 5-fold increase in intensity upon the binding of phosphate 
allowing the kinetics of ATP hydrolysis to be studied in depth. 
 
 
Scheme ‎1.5 A chemosensing ensemble.  Displacement of the fluorophore by the analyte 
causes a change in its photochemical response.
124
  Reprinted from S. L. Whiskur et al., Acc. 
Chem. Res., 2001, 34, 963, Copyright 2001, with permission from ACS Publishing. 
 
The alternate “chemosensing ensemble” approach has been shown to be 
successful in the detection of biological molecules including citrate, tartrate and 
also inorganic species such as nitrate.124  There has also been some success in 
selective detection of histidine over other amino acids.132  The general scheme 
for the action of a chemosensing ensemble is shown in Scheme ‎1.5.  One such 
sensor developed using this approach which has the ability to selectively detect 
cysteine, homocysteine and peptides with thiol groups using Cu2+ has been 
demonstrated.133  In this ensemble Cu2+ was used as the receptor since thiol 
groups have a strong affinity for this ion.  The fluorophore used was the 
anthracene derivative shown in Figure ‎1.21. 
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Figure ‎1.21 Fluorescent indicator for Cu
2+
. 
 
The addition of Cu2+ to the indicator causes quenching of fluorescence from the 
anthracene moiety by this ion as it is held in proximity by the complexation of 
the carboxylate groups.  While the addition of most amino acids to a solution of 
the receptor and indicator had very little effect, cysteine, homocysteine and 
glutathione resulted in almost complete recovery of fluorescence. 
 
As well as organic emitters, there has also been a report of a novel 
chemosensing ensemble approach using luminescence in metal complexes.134  
A trinuclear heterobimetallic complex of Ru and Pt was synthesised with 
bridging cyano groups between the metals.  Upon the addition of thiol-
containing peptides, the affinity of platinum for these side chains causes the 
release of the mononuclear ruthenium fragment producing a marked change in 
luminescence (Scheme ‎1.6). 
 
 
Scheme ‎1.6 Action of trimetallic Ru/Pt complex in thiol detection.
134
 
 
The use of metal complexes has become more common in biological sensing, 
however most are externally functionalised complexes for use in bioconjugation.  
This approach is discussed in the following section. 
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1.3.2 Luminescent metal complexes for bioconjugation 
Initial research into transition metal complexes for use as thiol labelling agents 
was mainly centered on ruthenium135 and rhenium.136,137  Complexes of these 
metals with polypyridyl or diimine ligands such as phenanthroline, display 
relatively long-lived 3MLCT emission138,139,140 and so were deemed useful in 
fluorescent labelling.  In general maleimide,137 or haloacetamide135,136 units 
were attached to one of the ligands as a sulfhydryl specific linker. 
 
 
Figure ‎1.22 Luminescent complexes with a) maleimide linker
137
 and b) haloacetamide
135
 
 
Although osmium complexes with these ligands generally display lower 
quantum yields than Re and Ru analogues,141 these have also been explored 
as possible bioconjugates.  Initial studies reported an osmium complex with 5-
amino-1,10-phenanthroline which could be converted to the isothiocyanate 
derivative for attachment to amine side chains of peptides.142  Unsurprisingly, 
similar osmium complexes have now been used for labelling via thiol containing 
side chains using the well established iodoacetamide linker.143 
 
Iridium complexes with polypyridyl and cyclometallating ligands have also 
received significant attention due to their useful photochemical 
properties.144,145,146,147  The first reported iridium bioconjugate was a complex 
with two cyclometallating phenylpyridines and a functionalised phenanthroline 
as ligands148 (Figure ‎1.23). 
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Figure ‎1.23 Iridium complex for conjugation to amine or thiol side chains. 
 
A set of iridium bis-terpyridine complexes has also been synthesised.  In this 
study the terpy ligands were functionalised, one with an isothiocyanatophenyl 
group and the other with various groups to tune the photochemical 
properties.149  Further work has resulted in the publication of a series of thirty 
iridium complexes with bidentate ligands of the form [Ir(N^C)2(N^N)]PF6 where 
the N^N ligand is functionalised for bioconjugation150 (Figure ‎1.24).  This 
included ten complexes specifically targeted at cysteine residues. 
 
 
Figure ‎1.24 Series of Iridium bioconjugating complexes.
150
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The majority of thiol targeted labels discussed above have been proven to be 
effective in labelling human serum albumin (HSA) and also, in one case,135 
human immunoglobulin G (IgG) via their free cysteine residues. 
 
More recently, functionalised iridium complexes have been shown to display 
selective reactivity with cysteine and homocysteine with a concurrent change in 
emission maximum.151,152  This uses an analogous approach to that discussed 
above in Scheme ‎1.3, where the aldehyde functional group of iridium complexes 
with 4-(2-pyridyl)benzaldehyde (pybaH) reacts with the thiol and amine 
functional groups of cysteine and homocysteine to form a 5 or 6 membered ring 
respectively (Figure ‎1.25). 
 
 
Figure ‎1.25 Functionalised iridium complexes [Ir(pba)2(bpy)]
+
 and [Ir(pba)2(acac)] which show 
selectivity for cysteine and homocysteine. 
 
These compounds have been successfully employed as ratiometric sensors for 
these amino acids in vivo.152 
 
So far, all labelling strategies discussed, with the exception of a chemosensing 
ensemble, have relied upon covalent binding to sulfur.  As mentioned 
previously, methods of this nature are unsuitable for the study of dynamic 
processes involving cysteine residues in biological redox cycles.  In order to 
produce effective probes for these processes, a system must be found which 
shows fully reversible binding to cysteine thiol groups with a concomitant 
change in photochemistry while also being soluble in aqueous media.  Direct 
coordination of an analyte to transition metals as a ligand is in many cases 
reversible and thus seems an effective approach to explore. 
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1.3.3 Metal coordination in sensory systems 
There are several general methods for using coordination of an analyte to 
metals in sensing applications.  This technique is in many ways related to the 
well established detection of transition metal ions153 through ligation or chelation 
by fluorescent organic species, except the roles of ligand and metal are 
reversed.  Here, a metal with some fixed ligand system is perturbed by the 
binding of a new ligand (the analyte) and a change in the photochemical 
properties of the sensor occurs.  Also, while the use of transition metal and 
lanthanide complexes in general has become common in sensing 
applications154,155, the approach using direct analyte-metal interactions is 
relatively recent. 
 
There has been very little use of this technique in the selective detection of 
cysteine residues but there has been a significant body of work towards sensors 
of anions, small molecules such as water, and ammonia as well as other gases.  
The methods used in these sensors are ideal for adaptation to cysteine sensors 
since the systems are designed to show fast, fully reversible binding to the 
analyte. 
 
There are various approaches to molecular sensing via direct metal 
coordination that have been explored.  Firstly, coordination of the analyte can 
take place by substitution of a weakly bound ligand or coordination to a vacant 
site.  Secondly, the metal can either be simply a binding receptor attached to a 
separate luminophore or can alternatively perform both of these roles. 
 
Where the metal is used as both the receptor and luminophore, it is easy to 
appreciate how a change in photochemical properties occurs.  Direct 
perturbation of the metal orbitals by the analyte causes a shift in energy of the 
emissive state or may even change the nature of the lowest energy state.  The 
modular approach to this method with a separate luminophore can require more 
consideration.  Often in these systems the metal acts as an electron transfer 
quencher for the luminophore which can be modulated by anayte binding, either 
by altering the electron transfer ability of the metal or the separation between 
the metal and luminophore. 
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A common approach to sensing via a vacant coordination site is the use of 
porphyrin or other related planar ring systems (Figure ‎1.26) and is analogous to 
the function of haemoglobin in the body which shows reversible binding to O2.  
This type of complex has been demonstrated for use in the detection of 
nucleobases156 and has also been used extensively in the production of O2 
sensors.157,158,159  The incorporation of binding pockets around the vacant 
coordination site has also been used to produce selective sensors for a wide 
range of analytes.160 
 
N
N
N
N
M
Analyte
R
R
R
R  
Figure ‎1.26 A porphyrin based sensor. 
 
A similar approach has been used in anion sensing except using the chelating 
ligand cyclen with a pendant organic fluorophore.161  This sensor (Figure ‎1.27) 
was found to detect pyrophosphate and citrate anions in neutral aqueous 
solution, as well as the biological anions ATP and ADP.  The success of this 
sensor in aqueous solution is important since many fluorescent species are 
subject to quenching by H2O. 
 
 
Figure ‎1.27 Anion sensor based on displacement of the organic fluorophore. 
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In sensors where the metal provides both photochemical activity and the 
binding site by substitution of a weakly bound ligand, reversibility of the process 
is often problematic since there is no thermodynamic drive for the replacement 
of the analyte by the weak ligand.  It has been discovered that a system in 
which the displaceable ligand is covalently attached to a fixed ligand, keeping it 
in the vicinity of the metal, can enhance the reversibility of an analyte response.  
This was demonstrated in the sensing of CO162 and has been referred to as the 
„hemilabile ligand‟ approach.  A system with more relevance to cysteine sensing 
has also been reported using this approach.  A luminescent ruthenium bipyridyl 
complex with a hemilabile ligand has shown affinity for sulfur donors such as 
DMSO, thiols and sulfides163 (Scheme ‎1.7).  This complex has limitations 
however: the luminescence is only observed in low temperature glasses and it 
is also sensitive to binding of H2O, making it unsuitable for use in aqueous 
media. 
 
 
Scheme ‎1.7 Reversible binding of S donors to ruthenium. 
 
It has also been discovered that cyclometallated complexes of platinum with 
diamine pincer ligands provide very useful colorimetric sensors for sulfur dioxide 
gas.164  This Pt(N^C^N) motif has been now incorporated into dendritic and 
quartz microbalance systems for the detection of sulfur dioxide at very low 
levels.165  The action of this platinum unit is shown in Scheme ‎1.8.  It is worth 
noting, however, that upon changing the amine substituents from methyl to ethyl 
the binding of sulfur dioxide no longer occurs, most likely due to steric 
considerations. 
 
 38 
 
 
Scheme ‎1.8 Reversible binding of SO2 to platinum. 
 
As a final note, although not studied in the context of sensing, it has been found 
that platinum complexes with a bidentate diimine and the 1,4,7-
trithiacyclononane ligand display a square pyramidal structure with a very long 
apical Pt-S interaction as shown in Figure ‎1.28.166  It has been discovered that, 
by variation of the σ-donor and π-acceptor strength of the diimine ligands, the 
apical Pt-S interaction can, to some extent, be modified.166,167  This provides 
further indication that interaction between thiol groups and the vacant site of 
square planar platinum compounds can be controlled. 
 
 
Figure ‎1.28 Platinum complex with apical Pt-S interaction 
 
1.4 The role of luminescence in cellular studies 
Microscopy is well established in studies of the cellular environment and as a 
non-invasive technique is vital in exploring the behaviour of cells without 
disturbing their function.  The introduction of fluorescent cellular probes and the 
associated use of fluorescence microscopy can provide the opportunity to study 
in more detail specific sub-cellular structures by using probes which display 
specific cellular localisation.  It is also possible, through the design of 
fluorescent probes that are responsive to their environment, to investigate the 
biological processes at work within the cell. 
 
1.4.1 Fluorescence microscopy 
In fluorescence microscopy a light source, in combination with an appropriate 
filter, is used to irradiate the sample through the objective lens of the 
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microscope.  Emitted light from the sample passes back through the objective 
and on to a detector, in many cases a digital camera.  A dichroic mirror is used 
to reflect the excitation beam towards the sample while allowing the emitted 
light to pass through to the detector.  Using this set-up, known strictly as 
epifluorescence microscopy, most of the excitation beam passes through the 
sample and only a small proportion reflected by the sample passes through 
towards the detector with the emitted light.  The addition of an emission filter 
leads to a very good signal-to-noise ratio using this method.  A schematic 
diagram of an epifluorescence microscope is shown in Figure ‎1.29. 
 
Figure ‎1.29 Schematic representation of a fluorescence microscope.
168
 
 
In addition to standard epifluorescence microscopy, the use of confocal 
fluorescence microscopy is becoming more common where focused „point 
illumination‟ is used to excite only part of the sample in the focal plane.  By 
scanning over the sample in the xy plane as well as adjusting the depth of 
focus, a 3D image of the sample can be acquired with high spatial resolution. 
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1.4.1.1 Desired properties of probes for fluorescence microscopy 
There are several requirements for luminescent probes for use in bioimaging in 
addition to the obvious need for an acceptable intensity of emission.  These 
include low cytotoxicity, good cell uptake properties, high chemical stability and 
photostability as well as good localisation properties. 
 
There are also several considerations specific to the photophysical properties of 
the probe that can lead to limitations in its use.  Ultraviolet light shows poor 
tissue penetration and UV irradiation can lead to cell damage; therefore it is 
preferred for a luminophore to display absorption bands in the visible region of 
the spectrum.  Compounds with small Stokes‟ shifts will tend to be affected by 
self-quenching where emitted light is reabsorbed by the sample.  A larger 
Stokes‟ shift also allows much easier separation of the excitation beam and the 
luminescence of the sample. 
 
1.4.1.2 Organic and biological probes for bioimaging 
The vast majority of probes currently in use are based on organic 
fluorophores.169  Also, more recently, developments in cloning techniques and 
genetic engineering have led to an increased use of fluorescent proteins, in 
particular green fluorescent protein (GFP) from jellyfish as the fluorescent unit in 
a variety of studies.170  In general, these systems display only small Stokes‟ 
shifts and are often prone to photobleaching. 
 
1.4.1.3 Inorganic species as cellular probes 
Nanoparticles of semiconducting materials, or „Quantum Dots‟, show high 
quantum yields as well as longer lifetimes than organic emitters and have also 
been used for biological imaging studies.171  While these are advantageous in 
that they do not suffer from photobleaching or excited state reactivity, the 
materials used tend to show very high cytotoxicity.  This can be mitigated by 
coating the dots with organic layers, however this can lead to expensive 
synthetic procedures. 
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The lanthanide series has also received attention as luminophores as they 
display very long-lived emission at specific energies, however these ions also 
display high cytotoxicity and must be used in complexes of very high stability, in 
many cases using macrocyclic ligands.172,173,174  The direct excitation of 
lanthanides is also problematic due to the forbidden nature of f-f transitions 
leading to the need for further functionalisation of the ligands with antennae 
units.174 
 
1.4.1.4 Transition metal complexes in bioimaging 
Recently, phosphorescent transition metal complexes have become more 
common in cellular imaging applications.6,7  As discussed earlier, complexes of 
second and third row transition metals with cyclometallating ligands can display 
a wide range of excited states which can be easily tuned to a particular function.  
The versatile properties of such compounds have led to their use as imaging 
agents for live cells with a common approach being the functionalisation of 
emissive complexes with biological molecules.  Examples of this include the 
attachment of biotin to complexes of rhenium175 and iridium176 and 
functionalisation of ruthenium complexes with estradiol.177  The conjugation to 
biotin provides a wide range of uses for these emitters since the affinity of biotin 
for the protein avidin is already the basis for a wide variety of biochemical 
assays.178,179,180  Equally, conjugation to hormones such as estradiol provides 
the opportunity to study the binding of these biomolecules to protein receptors. 
 
Since the localisation of cellular probes is so important in determining their 
applications, this is a particular area that has received much interest.  It has 
been found that the structural variety in luminescent transition metal complexes 
can lead to noticeably different intracellular localisation. 
 
Compounds of ruthenium(II),181 iridium(III)176,182 and rhodium(III)183 with 
polypyridyl and cyclometallating ligands have been shown to localise in the 
cytoplasm.  Additionally, Coogan et al. have shown that rhenium(I) complexes 
containing long chain ester functional groups tend to localise in membranes 
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within the cytoplasm.184  Figure ‎1.30 shows a selection of these compounds 
observed as showing cytoplasmic localisation. 
 
 
Figure ‎1.30 Some luminescent complexes of Ru(II), Ir(III) and Rh(III) which localise in the 
cytosol. 
 
In addition, while some platinum(II) complexes with an N^N^C ligand have also 
been shown to localise in the cell cytoplasm185,186 similar compounds with an 
N^C^N coordinating ligand instead show localisation in the nucleoli.67  The 
localisation properties of complexes can also be altered by functionalization of 
the ligands.  For example the incorporation of a triphenylphosphonium-
functionalised unit into a platinum N^N^C complex results in staining of the 
nucleoli187 rather than the cytoplasm.  These two compounds are shown in 
Figure ‎1.31. 
 
 
Figure ‎1.31 Complex a) shows cytoplasmic localisation
186
 while the functionalised analogue b) 
stains the nucleoli.
187
 
 
The varied cellular localisation properties of these complexes, coupled with their 
tuneable emission makes the exploration of such complexes as bioimaging 
agents of particular interest.  It certainly seems likely that the recent interest is 
justified and likely to continue for some time. 
 
a) b) 
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A potential problem, however, in the use of these phosphorescent complexes is 
that many commonly suffer from quenching in aerated solution via 1O2 
sensitization mechanisms.  In addition to the loss of quantum yield, this creates 
problems with phototoxicity in their use in cellular studies due to the production 
of singlet oxygen in vivo.  Complexes that show high levels of oxygen 
quenching therefore may not be ideal for use as intracellular probes. 
 
1.4.2 Lifetime based fluorescence microscopy techniques 
Intensity based measurements are inherently affected by, for example, 
wavelength dependence in the output of a light source or the response of a 
detector as well as being dependent on the local concentration of the emissive 
species.  Luminescence lifetimes, on the other hand, can be measured 
absolutely, independent of concentration, and are often sensitive to the local 
environment.  This has led to the development of fluorescence lifetime imaging 
microscopy (FLIM) which allows the measurement of environment effects such 
as pH and O2 concentrations as well as processes such as Förster resonance 
energy transfer (FRET) in vivo.188  In addition, polarisation-resolved FLIM can 
be used to measure the rotational mobility of a fluorophore indicating the 
viscosity of its surroundings.189  FLIM has mainly been used in the analysis of 
organic emitters and other fluorescent species with short, nanosecond 
lifetimes190,191 and thus requires fast gated excitation and measurement 
techniques. 
 
The use of bioimaging agents which show much longer lifetimes in vivo, such as 
lanthanide complexes and transition metal complexes with low levels of oxygen 
quenching, low cytotoxicity and high photochemical stability, has allowed the 
development of time-resolved emission imaging microscopy (TREM).192  This 
technique employs the use of a pulsed laser as the excitation source while a 
time-gated CCD camera is used as the detector.  It has been shown that TREM 
is especially useful in removing interference from short-lived background 
autofluorescence.67  Autofluorescence occurs in all cells as a result of 
endogenous fluorescent molecules such as the amino acids tyrosine and 
tryptophan as well as various fluorescent proteins.  This can lead to high signal-
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to-noise ratios in fluorescence microscopy methods and can cause particular 
interference in FLIM measurements due to the similarity in lifetimes between 
fluorescent probes and this background autofluorescence.  The advantage of 
TREM as a technique for overcoming this interference is illustrated in Figure 
‎1.32. 
 
 
Figure ‎1.32 Illustration of time gating to eliminate short-lived background fluorescence.  
Reprinted from S. W. Botchway et al., Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 16071, 
Copyright 2008, with permission from the National Academy of Sciences. 
 
The availability of this technique provides an additional advantage in the 
development of bioimaging agents based on transition metal emitters which will 
have the appropriate long-lived phosphorescent emission. 
 
1.4.3 Flow cytometry 
Another important tool in the study of emissive bioimaging agents is flow 
cytometry which can be used as a method of counting fluorescently or 
phosphorescently labelled cells.  This technique involves the injection of cells 
into a hydrodynamically focused stream of carrier fluid which forces the cells 
into „single file‟ within the stream.  The cells are analysed one at a time by 
directing a beam of light at the stream and both reflected and emitted light are 
analysed by a series of detectors.  Detectors in line with the incident beam and 
at 90° to it measure the forward and side scattering of all cells which gives 
information on their size and composition, while fluorescence detectors count 
cells which have been successfully labelled with an emissive compound.  This 
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gives a rapid method for counting the proportion of labelled cells in a sample.  
Figure ‎1.33 shows a schematic representation of the operation of a flow 
cytometer. 
 
 
Figure ‎1.33 Schematic of the function of a flow cytometer. 
 
Some flow cytometers are also able to perform fluorescence-activated cell 
sorting where a vibrating mechanism causes the flow to break into droplets.  
These will generally each contain a maximum of one cell per droplet.  The 
stream in this type of machine also passes through an electrical charging ring 
which can apply a charge to individual droplets.  After measurement, the stream 
passes through an electrostatic deflector and using this set-up, a droplet 
conforming to some measured criteria, e.g. successful fluorescent labelling, can 
be diverted from the main stream into a collection vessel. 
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1.5 Concluding remarks 
A brief overview has been given of the role of second and third row transition 
metals in photochemical and photophysical applications, with particular 
reference to complexes containing cyclometallating ligands.  The utility and 
tenability of such complexes has been discussed 
 
The role of particular proteins which mediate cellular processes involving thiols 
has also been explored, as well as developments in the detection of sulfur 
containing molecules.  It is evident that much of the oxidoreductase machinery 
in the endoplasmic reticulum is controlled by dithiol-disulfide exchange 
reactions.  Although there is a significant body of research into fluorescent 
probes for cysteine residues, the vast majority of those currently available are 
unsuitable for studying these dynamic processes.  The direct labelling of 
cysteine residues through covalent linkages will seriously disrupt, if not remove, 
any processes performed by the labelled site.  If, on the other hand, a set of 
fluorescent labels could be produced with transient associations to cysteine 
residues this would provide a very useful tool in monitoring disulfide bond 
formation and reduction in situ while minimising interference with the processes 
involved. 
 
Furthermore, the application of techniques such as fluorescence microscopy 
and flow cytometry in the study of cellular environments has been discussed, 
with emphasis on the growing role of luminescent metal complexes in this field. 
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1.6 Aims 
The primary aim of this project is to synthesise fluorescent compounds which 
are functionalised in such a way as to show potential activity as PDI mimics.  If 
successful, this will provide a series of novel compounds which could be used 
to elucidate the mechanisms of oxidative protein folding and disulfide 
isomerisation processes in vivo through the use of fluorescence microscopy.  
As a result of functionalisation it is hoped that such compounds will display 
particular intracellular localisation properties, ideally being taken into cellular 
compartments particularly associated with disulfide oxidation and isomerisation, 
for example the endoplasmic reticulum. 
 
In addition, the substitution chemistry of sulfur with cyclometallated complexes 
of platinum(II) and iridium(III) will be explored.  It is hoped that this will provide 
potential for luminescent sensors that show affinity for sulfur and, especially, 
reversible binding to sulfur containing species, allowing the study of dynamic 
processes involving thiol/disulfide interchange without inhibiting them. 
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Chapter 2 
 
Cyclometallated 
platinum complexes 
with thiolate ligands 
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2 Cyclometallated platinum complexes with thiolate 
ligands 
 
As discussed in the introduction, complexes of platinum have received much 
attention as luminescent reporters for a variety of applications due to their 
varied excited state properties.  In particular, complexes related to 1,3-di(2-
pyridyl)benzene platinum(II) chloride are highly emissive, with long 
phosphorescence lifetimes.  In addition, complexes of platinum(II) are of 
particular interest due to their tendency to display square-planar geometries, 
allowing axial interactions with the metal centre leading to excited state 
modification through metal-metal or transient ligand-metal interactions.  The 
utility of such compounds will therefore be explored in the hope of producing 
novel luminescent sensors for sulfur-containing analytes. 
 
2.1 Complexes of platinum designed for axial thiol interactions 
The initial approach explored in this section is modelled on the SO2 sensors 
reported by Van Koten.165  The ability of the amine pincer ligand complex 
(Figure ‎2.1a) to form an axial interaction with SO2 suggests that interaction with 
thiols may also be possible.  This complex, however, does not display any 
luminescence in fluid solutions.  It was hoped that replacing one aliphatic amine 
with a pyridyl substituent will activate radiative decay from charge-transfer or 
ligand-centred excited states involving the new phenylpyridine moiety whilst 
maintaining the ability to reversibly bind to sulfur (Figure ‎2.1).  It is certainly the 
case that many platinum complexes with the phenylpyridine ligand display 
bright luminescence in fluid solutions.193,194 
 
 
Figure ‎2.1 a) Known SO2 sensor b) Proposed general structure for new sensors. 
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2.1.1 N^C^N binding ligands with inequivalent nitrogen donors 
In the design of a potential terdentate ligand which can bind in an N^C^N mode 
containing both a phenylpyridine fragment and an amine, possibly the simplest 
structure would be 3-(2-pyridyl)benzylamine (pybzaH), shown in Figure ‎2.2. 
 
 
Figure ‎2.2 3-(2-pyridyl)benzylamine (pybzaH). 
 
The synthesis of this ligand was carried out using the Stille reaction which 
provides a convenient method for C-C bond-forming reactions between aryl 
rings.  This reaction is one of a range of palladium-catalysed cross-coupling 
reactions which are commonly used to link aryl or vinyl halides to a variety of 
functionalised molecules including aryl-boronic acids (Suzuki coupling), alkenes 
(Heck reaction) and alkynes (Sonogashira coupling).  In the case of the Stille 
reaction, an aryl stannane is used and the mechanism for this reaction is shown 
in Scheme ‎2.1. 
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Scheme ‎2.1  Mechanism of the Stille reaction.  When a Pd(II) catalyst is used, an equivalent 
molar amount of the homo-coupled stannane is produced in the reduction of the catalyst to 
Pd(0). 
 
Scheme ‎2.2 shows the synthesis of pybzaH by a Stille reaction between 3-
bromobenzonitrile and 2-(tri-n-butylstannyl)pyridine followed by reduction of the 
nitrile to the primary amine using borane in THF. 
 
 
Scheme ‎2.2 Stille cross-coupling reaction between 3-bromobenzonitrile and 2-(tri-n-
butylstannyl)pyridine followed by reduction with borane in THF. 
 
With a quantity of this ligand available, various modified analogues could also 
be synthesised by reactions with the amine group.  Firstly, the synthesis of a 
tertiary amine would be a useful structure to complement pybzaH, and would 
also avoid potential problems with the reactivity of the primary amine upon 
complexation with platinum.  As noted in Section ‎1.3.3, the utility of 
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cyclometallated amine pincer complexes as SO2 sensors is impaired by 
nitrogen substituents larger than a methyl group so the potential ligand N,N-
dimethyl-3-(2-pyridyl)benzylamine (dmpybzaH) was regarded as the most 
suitable structure.  While primary amines will readily react with methyl iodide to 
give methyl substituted amines, this reaction generally leads to quaternary 
amine salts.  Instead, the Eschweiler-Clarke reaction was used which provides 
a simple route to methyl-substituted tertiary amines by successive reductive 
amination steps.195  This method conveniently yielded the desired dmpybzaH 
ligand as shown in Scheme ‎2.3. 
 
 
Scheme ‎2.3 Reductive amination using formaldehyde and formic acid to give dmpybzaH 
(Eschweiler-Clarke reaction). 
 
It was also considered to be of interest to explore other „mixed nitrogen donor‟ 
N^C^N ligands and so, in addition to the pyridine-amine ligands, other potential 
ligands were synthesised.  The reaction of pybzaH with benzaldehyde provided 
a simple method for the synthesis of a potential N^C^N ligand with one pyridine 
donor and a substituted imine as shown in Scheme ‎2.4. 
 
 
Scheme ‎2.4 Synthesis of N-(3-(2-pyridyl)benzyl)benzylimine (pybzbiH). 
 
A novel piperidine containing structure was also synthesised using a tandem 
SN2-Michael addition analogous to a procedure reported by Bunce et al. for the 
synthesis of N or S containing heterocycles.196  This required the preparation of 
an an iodo-enone compound via a Wittig-type reaction and a halide exchange.  
The reaction of this compound with pybzaH gave the new potential ligand ethyl 
1-(3-(2-pyridyl)benzyl)piperidin-2-yl acetate (pybzpipH) as shown in Scheme 
‎2.5.  This ligand is particularly of interest due to the ester pendant on the 
 53 
 
piperidine ring; if this ester were to be hydrolysed to the carboxylic acid this 
could provide a ligand with the potential to chelate the platinum centre in an 
N^C^N^O binding mode (Figure ‎2.3). 
 
 
Scheme ‎2.5 Preparation of iodo-enoate and tandem SN2-Michael addition to give pybzpipH. 
 
 
Figure ‎2.3 Potential N^C^N^O binding of hydrolysed pybzpip. 
 
2.1.2 Attempted complexation of N^C^N ligands with platinum 
N^C^N bound complexes with platinum(II) are commonly synthesised by 
heating K2PtCl4 with the appropriate ligand in degassed acetic acid as reported 
for the original synthesis of [Pt(dpyb)Cl].61 For certain ligands, the reaction has 
been carried out in mixtures of acetonitrile and water, in some cases without the 
need for oxygen-free conditions.62,197 
 
The complexation of the four ligands was attempted using these two methods, 
however all reactions attempted resulted in complicated mixtures.  While it did 
appear from the consumption of the red PtCl4
2- and the precipitation of 
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yellow/brown solids that some complexation was occurring, the clean reaction 
to a single product observed in the synthesis of other Pt(N^C^N) complexes did 
not occur.  Further evidence for the partial success of the reactions was 
observed in the 1H NMR spectra of the products where some signals at high δ, 
corresponding to the pyridine H6 signal, displayed satellite peaks arising from 3J 
coupling to 195Pt which has nuclear spin = ½ and comprises ~33% naturally 
occurring platinum.  Extraction or washing of the crude products with solvents 
such as ethanol or DCM in some cases yielded products of slightly increased 
purity, however no pure complexes could be obtained by these methods.  In 
addition, the purification of such complexes by column chromatography is 
generally unsuitable as many are poorly soluble and suffer from instability with 
respect to oxidation when in solution.  Also, dissociation of chloride in solution 
leads to immobilisation of the resulting cationic species on the chromatography 
support. 
 
The best sample obtained was from the reaction of the dimethylamino ligand 
(dmpybzaH) with K2PtCl4 in 3:1 MeCN:H2O at reflux, followed by extraction of 
the crude product with ethanol after washing with water.  In the first attempt this 
gave only a trace of sparingly soluble yellow solid which showed a 1H NMR 
spectrum consistent with the desired complex [Pt(dmpybza)Cl].  The spectrum 
clearly shows 195Pt satellites on one low field aromatic doublet, H6 on the 
pyridine, and two aliphatic signals, the CH2 and methyl groups (Figure ‎2.4).  
This is consistent with the ligand in an N^C^N bound pincer configuration. 
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Figure ‎2.4 300 MHz 
1
H NMR spectrum of [Pt(dmpybza)Cl] in d6-acetone.  Arrows indicate 
signals with 
195
Pt satellites. 
 
The NMR also showed traces of at least one other Pt complex indicated by 
another H6-py signal at δ ~ 9.6 (not shown in Figure ‎2.4).  There was also a 
significant amount of this complex remaining in the residual solid after 
extraction.  Attempts to repeat the complexation on a larger scale gave a very 
impure sample. 
 
The complexation of pybzaH was also attempted using a method analogous to 
that used in the synthesis of the dimer bis(2-phenylpyridine-N,C)(µ-
dichloride)diplatinum198 as shown in Scheme ‎2.6.  It was hoped that the use of 
this method would encourage the formation of a platinum dimer with the 
phenylpyridine fragment of dmpybzaH followed by either spontaneous cleavage 
by the pendant amine or cleavage by a subsequent reaction.  This procedure, 
however, also failed to yield a pure complex for study. 
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Scheme ‎2.6 Reaction of ppy with K2PtCl4 in 2-ethoxyethanol gives the dichloro-bridged 
dimer.
198
 
 
It was evident from these results that complexation of these ligands is less 
specific than that of 1,3-di(2-pyridyl)benzene and its derivatives.62  This may be 
a result of weaker coordination of the platinum between the two nitrogen donors 
prior to cleavage of the C–H bond.  Aromatic nitrogen donors have significant  
acceptor abilities which leads to stronger bonding interactions with ligands such 
as pyridine compared to aliphatic amines.  Therefore, while there is sufficient 
interaction to induce C-H activation in dpybH, this may not be the case with 
these new ligands.  It is also possible that alternate complexes are formed in 
the reactions since with these ligands there are three sites where 
cyclometallation can occur which give distinct complexes, thus leading to the 
observed mixtures (Figure ‎2.5). 
 
 
Figure ‎2.5 Possible binding modes in mixed nitrogen N^C^N ligands. 
 
Since complexation of the new N^C^N ligands could not be achieved by direct 
reaction with K2PtCl4, an approach similar to that used by Soro et al
199 in 
overcoming competitive binding modes of palladium with dpybH was attempted.  
In this report, reaction of the N^C^N ligand was first carried out with mercury(II) 
acetate in the presence of LiCl giving a [Hg(dpyb)Cl] complex with metallation 
only observed at the 2 position of the benzene.  This was then transmetallated 
using Pd(OAc)2 to give the required palladium complex. 
 
It was hoped that the reaction of Hg(OAc)2 with the new N^C^N ligands would 
also give selective metallation at the desired 2 position and the resulting 
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complex could be transmetallated with Pt(PPh3)4.  Unfortunately, here, as was 
the case with the direct reaction of the novel N^C^N ligands with platinum, no 
mercury complexes were successfully isolated and so the transmetallation with 
platinum could not be attempted. 
 
 
Scheme ‎2.7 Attempted synthesis of a mercury complex followed by transmetallation with 
Pt(PPh3)4. 
 
It appears that, while these „mixed nitrogen‟ N^C^N ligands could be of 
particular interest in the design of new platinum N^C^N complexes, there are 
particular problems associated with their use.  It seems the case that poorer 
binding prior to cyclometallation and the asymmetric nature of the ligands leads 
to significant problems in the isolation of platinum complexes with these ligands.  
This is unfortunate, since the properties of such complexes would likely be 
distinct from both Pt(N^C) complexes and Pt(N^C^N) complexes with fully 
aromatic ligands. 
 
2.2 Platinum N^C^N complexes with thiolate ligands 
In addition to the attempted synthesis of novel Pt(N^C^N) complexes with mixed 
nitrogen donors, the effects of the introduction of thiolate ligands into the 
coordination sphere of platinum were explored.  As discussed previously, the 
complex [Pt(dpyb)Cl] is highly phosphorescent and it was hoped that the 
substitution of the relatively labile chloride ligand with thiols or thiolates in this 
and related complexes would lead to new excited-state properties. 
 
2.2.1 Synthesis of complexes 
Two starting complexes were synthesised using the ligands 1,3-di(2-
pyridyl)benzene (dpybH) and methyl-3,5-di(2-pyridyl)benzoate (mdpybzH) to 
give the complexes [Pt(dpyb)Cl] and [Pt(mdpybz)Cl] using reported methods62 
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(Scheme ‎2.8).  For simplicity, the coordinated ligands dpyb and mdpybz will be 
referred to as L1 and L2 respectively. 
 
 
Scheme ‎2.8 Synthesis of [PtL
1
Cl] and [PtL
2
Cl]. 
 
With these two complexes in hand, substitution reactions were carried out with 
the thiols sodium methanethiolate (mtNa), thiophenol (tpH), 4-methylthiophenol 
(mtpH), 4-methoxythiophenol (motpH) and 4-nitrothiophenol (ntpH). 
 
Initially, substitutions with the aryl thiols were attempted without the use of base 
in both degassed and aerated methanol solutions at room temperature.  While 
this led to some substitution of chloride by thiolate, in most cases no more than 
30% conversion was achieved using these methods.  Instead, it was discovered 
that reaction of the complexes with a degassed solution of thiolate prepared by 
treatment of the thiol with potassium tert-butoxide led to precipitation of the 
desired complexes at room temperature.  The resulting yellow, orange or red 
compounds were purified by successive washings with H2O, methanol and 
diethyl ether giving the complexes [PtLn(tp)], [PtLn(mtp)], [PtLn(motp)] and 
[PtLn(ntp)]. 
 
The complexes [PtL1(mt)] and [PtL2(mt)] were prepared by the treatment of the 
corresponding chloride complexes with aqueous sodium methanethiolate 
suspended in methanol, also at room temperature.  The synthesis of these 
thiolate containing complexes is summarised in Scheme ‎2.9. 
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Scheme ‎2.9 Synthesis of [PtL
n
(thiolate)] complexes. 
 
2.2.1.1 Characterisation of the complexes 
The newly synthesised complexes showed 1H NMR spectra similar to those of 
their parent chloride complexes with the addition of peaks expected from the 
aromatic thiolates or from the methyl group in [PtLn(mt)].  When the 
characterisation of these complexes was attempted by electrospray mass 
spectrometry, however, no peaks relating to the expected molecular ion were 
observed.  Instead, a number of dimetallic clusters were indicated by isotopic 
patterns in the spectra, with the species [(Pt(N^C^N))2(SAr)]
+ and 
[(Pt(N^C^N))2(S)(SAr)]
+ being the most commonly observed in the case of the 
complexes containing aromatic thiolates.  Presumably these species involve 
bridging sulfur atoms between platinum centres, since the tendency of sulfur to 
bridge between metals is known.  In fact, in related complexes with terpyridine 
ligands, a solid state structure of {[Pt(tpy)]3S} has been reported by X-ray 
crystallography.200  The ES mass spectra of the complexes with an mt ligand 
instead tended to show trimetallic clusters of the form [3M]+, [3M-Me]+, [3M-
2Me]+ and [3M-3Me]+.  The likely structure of these, again, features bridging 
sulfur atoms, with or without methyl substituents, possibly a ring-type structure 
such as that shown in Figure ‎2.6. 
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Figure ‎2.6 Possible gas phase structure observed in ES MS.  Similar ions were also observed 
with 1, 2 or 3 methyl substituents on the sulfurs. 
 
In contrast, electron ionisation mass spectrometry showed the expected 
molecular ion peaks and molecular ion fragments such as [M-thiolate]+.  In 
addition, commonly observed features of EI MS were observed such as the 
tropylium ion, [C7H7]
+, in complexes with the tolyl thiolate. 
 
2.2.1.2 Stability of the complexes 
While it appears that all the complexes are stable indefinitely in the solid state, 
data from NMR spectra suggest that the complexes tend to decompose over 
time when left in solution.  This is most noticeable in complexes with the motp 
ligand and, in general, the complexes containing L1 are less stable than their 
counterparts with L2.  This is evident from the appearance of signals in the 1H 
NMR spectrum which apparently correspond to new species containing the 
Pt(N^C^N) fragment.  It is likely, therefore, that the thiolate ligands are prone to 
dissociation, being replaced by a solvent molecule, possibly with concurrent 
oxidation to disulfides in air making re-coordination of this ligand impossible.  
This is supported by the observation that [PtLn(motp)] are the least stable 
complexes since these will be the most electron-rich thiolates and thus most 
prone to dissociation. 
 
2.2.2 Photophysical and electrochemical properties of [PtLn(thiolate)] 
complexes 
It was immediately obvious upon synthesis that the introduction of the thiolate 
ligand led to a significant change in the absorption properties of the Pt(N^C^N) 
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complexes from their colour.  While the starting chloride complexes are pale 
yellow in colour, the precipitated products showed strong colouring from yellow 
to red depending upon the thiolate. 
 
The photochemical and electrochemical properties of these ten new complexes 
were therefore studied in order to determine what changes in the observed 
excited states had occurred by the introduction of these new ligands. 
 
2.2.2.1 Absorption spectra 
The absorption spectra were measured at room temperature in 
dichloromethane solution and all show strong absorption bands in the far UV 
region similar to those observed in the chloride complexes arising from π-π* 
transitions in the aromatic ligand systems.62  In the near UV and visible region 
the complexes display moderately intense absorption up to around 500 nm.  
Absorbance data for the complexes are summarised in Table ‎2.1 and 
absorption spectra from 350 nm to 700 nm for the two series, [PtL1(thiolate)] 
and [PtL2(thiolate)] are shown in Figures 2.7 and 2.8. 
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Complex Absorption max / nm 
 / dm3mol–1cm–1)(a) 
[PtL1(mt)] 332 (7490), 365 (5660), 377 (5980), 465 sh (2210) 
[PtL1(tp)] 363 (6420), 376 (6510), 452 sh (2040) 
[PtL1(mtp)] 363 (5700), 377 (5990), 460 sh (1820) 
[PtL1(motp)] 365 (7490), 377 (7580), 463 sh (2450) 
[PtL1(ntp)] 305 (15500), 335 (8950), 376 sh (11000), 415 
(17100), 455 sh (13600) 
[PtL2(mt)] 307 (19800), 330 sh (11600), 369 (6690), 468 (3250) 
[PtL2(tp)] 330 sh (12200), 360 (7350), 373 (7780), 465 (2890) 
[PtL2(mtp)] 332 sh (11100), 362 (7380), 375 (7820), 469 (2720) 
[PtL2(motp)] 332 sh (11600), 362 (7490), 376 (7660), 472 (3150)  
[PtL2(ntp)] 305 (17000), 333 sh (8030), 378 (11500), 415 
(17800), 455 sh (13800)  
Table ‎2.1 Absorption maxima at  > 300 nm for [Pt(N^C^N)(thiolate)] complexes in CH2Cl2 at 
room temperature. (a) all bands in the observed range obey the Beer-Lambert law up to 
ca. 7 × 10
-4
 mol dm
-3
. 
 
 
Figure ‎2.7 Absorption spectra of [PtL
1
(thiolate)] complexes in CH2Cl2 at room temperature. 
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Figure ‎2.8 Absorption spectra of [PtL
2
(thiolate)] complexes in CH2Cl2 at room temperature. 
 
The lower energy band structure in the [PtLn(thiolate)] complexes is similar 
throughout the series with the noticeable exception of [PtL1(ntp)] and [PtL2(ntp)].  
In all complexes, excluding those containing the ntp ligand, in addition to the 
band at ~375 nm corresponding to the parent complex, these complexes 
display a broad absorption whose position is dependent on the thiolate ligand.  
For the aromatic thiolates with either L1 or L2 this band is red shifted in the order 
tp <mtp <motp within the series, while the complexes of L1 appear blue shifted 
in comparison to their L2 counterparts.  As a result of these shifts this lowest 
energy band displayed by, for example [PtL2(motp)], is distinct from the higher 
energy band at ~375 nm while in more blue-shifted examples such as [PtL1(tp)] 
overlap of this band with those at higher energy make it appear as more of a 
shoulder.  The non-aromatic thiol complexes [PtL1(mt)] and [PtL2(mt)] show very 
similar profiles to the corresponding [PtL1(tp)] and [PtL2(tp)] complexes. 
 
In the case of the complexes with the ntp ligand, the low energy band structure 
is dominated by an intense absorption ( ~ 17000 dm3mol-1cm-1) at 415 nm in 
both complexes.  This band displays shoulders at both the higher and lower 
energy which correspond to the two lowest energy bands observed in the other 
complexes.  This strong feature is undoubtedly related to π-π* absorption in the 
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thiolate ligand appearing at low energy due to conjugation with the nitro-
substituent, while the shoulders are likely to be related to the more general 
band structure present throughout the series. 
 
 
2.2.2.2 Absorption solvatochromism in the complexes 
The effect of solvent polarity on the absorption of the complexes was also 
investigated.  In addition to the above spectra recorded in dichloromethane, 
spectra were also run in acetonitrile, tetrahydrofuran and toluene.  Absorption 
spectra for a selection of the complexes in these solvents are shown in Figure 
‎2.9.  In the UV region, the bands show very little solvatachromic shift, as 
expected for transitions of π-π* character.  Equally, in the complexes [PtL1(ntp)] 
and [PtL2(ntp)], the intense band at 415 nm also shows very little change with 
the solvent polarity.  The bands between 350 nm and 400 nm show a small 
negative solvatochromic shift, however the most striking change is a large 
negative solvatochromic shift in the lowest energy band/shoulder.  In most 
cases, this band shows a blue shift of up to 50 nm between the non-polar 
toluene and more polar acetonitrile.  This indicates a relatively large change in 
dipole moment between the ground state and the lowest energy excited state, 
indicative of some type of charge-transfer state. 
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Figure ‎2.9 Normalised absorption spectra of a) [PtL
1
(motp)], b) [PtL
1
(ntp)], c) [PtL
2
(tp)] and 
d) [PtL
2
(mt)] in various solvents at room temperature. 
 
2.2.2.3 Electrochemical properties 
The redox potentials for the new complexes in dichloromethane solution were 
measured using cyclic voltammetry (CV) with Bu4NPF6 as the supporting 
electrolyte.  The resulting data are recorded in Table ‎2.2. 
 
The first reduction wave of the complexes occurs at around – 1.4 V and in most 
cases is partially reversible at high scan rates.  When using scan rates of less 
than 100 mVs-1, the return wave becomes poorly defined.  The first oxidation 
wave, however, while being well defined is irreversible for all complexes and 
varies noticeably depending upon the structure of the thiolate ligand.  The most 
readily oxidised complexes are [PtL1(mt)] and [PtL2(mt)], both with           
Ep
ox ~ –0.35 V.  The values for the remaining aryl thiolate complexes appear in 
the region –0.3 V to +0.3 V, with the ease of oxidation relating qualitatively to 
the electron donating ability of the para-substituent of the thiolate ligand, e.g. 
OMe > Me > H > NO2. 
 
a) b) 
c) d) 
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Complex Ep
ox / V(a) E1/2
red / V (a) 
( / mV) 
Ep
ox – E1/2
red 
 
[PtL1(mt)] –0.36 –1.36 1.72 
[PtL1(tp)] –0.03 –1.39 (240) 1.36 
[PtL1(mtp)] –0.10 –1.36 (220) 1.26 
[PtL1(motp)] –0.12 (b)  
[PtL1(ntp)] +0.26 –1.36 
–1.73 (160) 
1.62 
[PtL2(mt)] –0.35 (b)  
[PtL2(tp)] –0.07 –1.44 (290) 1.37 
[PtL2(mtp)] –0.11 –1.38 (280) 1.27 
[PtL2(motp)] –0.22 –1.43 (250) 1.21 
[PtL2(ntp)] +0.13 –1.45 (200) 
–1.87 (90) 
1.58 
Table ‎2.2 Electrochemical data for [PtL
n
(thiolate)] complexes, recorded in CH2Cl2 at room 
temperature using Bu4NPF6 (0.1 M) as the supporting electrolyte.  Scan rate 100 mVs
-1
.  Peaks 
quoted relative to Fc+ | Fc.  (a) Peak potentials are given for the oxidations, all of which were 
irreversible, and for those reductions where the return wave was ill-defined.  For reductions 
showing return waves, the quoted values refer to E½ and the peak-to-peak separation is given in 
parentheses.  (b) The reduction wave was poorly defined for this complex. 
 
2.2.2.4 Photoluminescence of the complexes 
All ten complexes with thiolate ligands are luminescent in dilute room 
temperature solutions upon excitation in the UV or blue regions of the spectrum 
and display broad, structureless emission bands with maxima in the region of 
600-750 nm.  The emission spectra, luminescence lifetimes and quantum yields 
of the complexes were measured in room temperature degassed solutions, 
while the spectra and lifetimes were also recorded at 77 K in 2:2:1 diethylether / 
isopentane / ethanol (EPA).  The data from these measurements, as well as the 
calculated rate constants for both radiative and non-radiative decay, are given 
in Table ‎2.3.  This table also includes the rate of quenching by oxygen in room 
temperature solutions. 
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The normalised emission spectra for the complexes at room temperature are 
shown in Figure ‎2.10 and Figure ‎2.11.  In terms of the position and band-shape, 
the emission profiles of the two complexes with a methane thiolate ligand are 
essentially identical to those of the corresponding complexes containing 
thiophenolate ligands which appear at the highest energy.  The emission of the 
aromatic thiolate complexes are red shifted in the order tp < mtp < motp < ntp 
for the series with the L1 ligand while the pattern in the series with L2 is similar 
with tp < mtp < motp ~ ntp.  This sequence at first inspection seems unrelated 
to the electronic properties of the thiolate ligand substituents. 
 
A similar discontinuity is observed in the data obtained for the lifetimes and 
quantum yield.  While the complexes show a decrease in luminescence lifetime 
in line with decreasing emission energy in the sequence tp > mtp > motp, the 
complexes [PtLn(ntp)] show much longer lifetimes, in the order of microseconds, 
rather than nanoseconds.  Equally, the quantum yields for the ntp complexes 
are discontinuous with the other aromatic thiolate complexes which again, 
decrease with decreasing emission energy. 
 
Another notable feature is that while the [PtL1(thiolate)] complexes are 
predominantly blue shifted compared to the [PtL2(thiolate)] analogues, again, 
the two ntp complexes do not meet with this trend, instead showing a small red 
shift in the emission of [PtL1(ntp)] compared to [PtL2(ntp)]. 
  
 
6
8
 
Complex Emission 
max / nm 
lum
 
 102 
 / ns 
degassed 
kQO2 / 
108 M–1s–1 
(a) 
kr / 
103 s–1 
(b) 
∑knr / 
104 s–1 
(b) 
Emission 77 K 

max / nm  / s
[PtL1Cl] 491, 524, 562 60 7200 9.1 83 5.5 486, 
516, 548 
6.4 
[PtL1(mt)] 636 2.6 430 54 60 230 538 6.6 
[PtL1(tp)] 634 17 770 65 220 110 539 6.8 
[PtL1(mtp)] 661 6.9 510 53 140 180 548 7.4 
[PtL1(motp)] 691 1.4 48 110 290 2100 570 8.2 
[PtL1(ntp)] 714 0.21 7400 2.6 0.28 13 574, 610 760 
[PtL2Cl] 481, 513, 550 58 8.0 4.4 72 5.3   
[PtL2(mt)] 642 3.8 510 90 75 190 558 6.6 
[PtL2(tp)] 643 16 880  180 95 550 7.8 
[PtL2(mtp)] 668 6.0 370  160 250 581 8.9 
[PtL2(motp)] 701 0.35 29  120 3400 597 9.5 
[PtL2(ntp)] 703 0.64 11300 8.0 0.57 8.8 567, 603 470 
Table ‎2.3 Luminescence data for the platinum complexes in CH2Cl2 solution at 298 K and in EPA at 77 K (EPA = diethylether / isopentane / ethanol, 2:2:1 v/v.)  
(a) k
Q
O2 is the bimolecular rate constant for quenching by molecular oxygen at 298 K, estimated from the relative emission intensities in degassed and aerated 
solutions, assuming [O2] at 1 atm pressure of air = 2.2 mmol dm
–3
.  (b) kr and ∑knr are the radiative and non-radiative rate constants estimated from the quantum 
yield and lifetime at 298 K.  [PtL
1
Cl] and [PtL
2
Cl] are included for comparison.
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Figure ‎2.10 Normalised emission spectra of [PtL
1
(thiolate)] complexes.  Emission intensity in 
arbitrary units. 
 
 
Figure ‎2.11 Normalised emission spectra of [PtL
2
(thiolate)] complexes.  Emission intensity in 
arbitrary units. 
 
At low temperature, the complexes show blue shifted emission as would be 
expected for charge transfer excited states due to decreased molecular re-
orientation at low temperature leading to a smaller Stokes‟ shift.  The spectra of 
the complexes at 77 K in EPA are shown in Figure ‎2.12 and Figure ‎2.13. 
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Figure ‎2.12 Normalised emission spectra of [PtL
1
(thiolate)] complexes at 77 K in EPA.  
Emission intensity in arbitrary units. 
 
Figure ‎2.13 Normalised emission spectra of [PtL
2
(thiolate)] complexes at 77 K in EPA.  
Emission intensity in arbitrary units. 
 
The complexes [PtLn(tp)], [PtLn(mtp)] and [PtLn(motp)] all show structureless 
bands and, in line with the trend observed at room temperature, the emission 
wavelength increases in the sequence tp < mtp < motp.  Emission from the two 
[PtLn(mt)] complexes is, again, at similar energy to the corresponding tp 
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complex, however the emission profile of these appears noticeably broader than 
the aromatic thiolate complexes.  While the emission of the complexes L2 are, 
again, red-shifted compared to the corresponding L1 analogues in most cases, 
[PtL1(ntp)] and [PtL2(ntp)] show the opposite trend, as observed in the room 
temperature data.  In addition, the emission of these two complexes at low 
temperature is structured, unlike that of the other eight complexes.  This band 
structure appears to be vibrational in character and implies that the emissive 
state in these two complexes may be ligand-centred in character. 
 
2.2.3 Discussion of photophysical and electrochemical results 
The introduction of thiolate ligands, particularly dithiolates, into platinum diimine 
complexes commonly results in the observation of new low energy excited 
states which have been variously assigned to thiolate→diimine LLCT,201,202 
Pt→thiolate MLCT203 and mixed Pt/thiolate→diimine charge transfer204,205 
states.  It is apparent from the observed data in the synthesised class of 
[Pt(N^C^N)(thiolate)] complexes that the substitution of chloride with a thiolate 
ligand has similarly led to new excited states.  Figure ‎2.14 shows a comparison 
between the absorption and emission spectra for Pt(N^C^N) complexes with a 
chloride or a thiolate ligands. 
 
 
Figure ‎2.14 Comparison of absorption and emission spectra for [PtL
2
Cl] and [PtL
2
(tp)]. 
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In absorption, while the high energy features are similar between the thiolate 
and chloride complexes, in the near UV and visible range ( > 300 nm) there is 
a marked contrast between the new compounds and the previously reported 
chloride complexes.  [PtL1Cl] and [PtL2Cl] display relatively intense absorption 
at around 375 nm and the lowest energy feature is a shoulder at around 400 nm 
(excluding weak spin-disallowed transitions which are observed in these 
complexes at ~480-490 nm).  As discussed above, the introduction of thiolate 
ligands leads to lower energy absorption bands resulting from charge-transfer 
transitions. 
 
The change in emission properties is equally clear from the comparison.  While 
the parent complexes [PtL1Cl] and [PtL2Cl] both show strong, long-lived, 
vibrationally structured phosphorescence from a 3-* excited state,62 the 
emission of the new thiolate complexes is significantly red-shifted and 
structureless.  Again, this is indicative of new low energy charge transfer states. 
 
2.2.3.1 Consequences of thiolate substitution on the ground state 
The electrochemical data indicate that, while the oxidation of the complexes is 
largely affected by the substituents of the thiolate ligand, the first reduction is 
largely unaffected by these changes.  The trend in these data is consistent with 
the HOMO being either localised on the thiolate ligand or the metal centre 
where an increase in the electron donating properties of the para-substituent 
leads to more facile oxidation.  The relative invariance of the reduction potential 
indicates that the LUMO is most likely localised on the N^C^N ligand.  This 
would imply that the lowest energy absorption arises from transitions of MLCT 
or LLCT character. 
 
These possible assignments are also indicated by the trends in absorption 
maxima for the lowest energy band.  Stronger electron withdrawing groups on 
the N^C^N ligand lead to a red-shift, consistent with lowering the LUMO energy, 
while more strongly electron donating groups on the thiolate also result in a red-
shift by increasing the energy of the HOMO.  The solvatochromic effect 
observed for the lowest energy absorption band indicates a transition with a 
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large change in dipole moment, giving weight to an assignment of MLCT, LLCT 
or a mixed metal-thiolate to N^C^N charge transfer. 
 
2.2.3.2 The effect of thiolate substitution on the emissive state 
The results from studies of the emission of these complexes is complicated 
somewhat by noticeable discontinuities in the data with respect to the 
complexes [PtL1(ntp)] and [PtL2(ntp)].  If these two complexes are discounted, 
the trends in the data show that an assignment of 3MLCT, 3LLCT or a mixed 
metal-thiolate to N^C^N CT state is justified.  Again, the observed trends in 
emission maxima in relation to the ligand substituents follow those observed in 
absorption which would be expected for excited states of this character. 
 
2.2.3.3 Adherence to the energy gap law 
The energy gap law states that for related excited states, the non-radiative 
decay constant is related to the energy of emission from these states.  While 
the precise mathematical expression is quite complex, it can be reduced to the 
relatively simple expression shown in Equation ‎2.1.206,207 
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Equation ‎2.1 
Where knr is the rate of non-radiative decay, a is a constant resulting from the 
simplification, ħm is the average medium-frequency acceptor mode coupled to 
the excited state, E00 is the energy of the zero-zero transition and 0 is given by  
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Equation ‎2.2 
Sm is the Huang-Rhys factor (electron-vibration coupling constant). 
 
This indicates that for a series of complexes with the same excited state, a plot 
of ln(knr) vs emission energy should give a straight line.  The data for the ten 
[PtLn(thiolate)] complexes, treated in this manner is shown in Figure ‎2.15 
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Figure ‎2.15 Plot of ln(knr) vs emission energy showing linear best fit for all complexes except 
those with 4-nitrothiophenolate ligands.  Error bars indicate calculated error based on 10% 
uncertainty in measured  and  values. 
 
The plot of ln(knr) shows a reasonable fit for all the complexes with the 
exception of [PtL1(ntp)] and [PtL2(ntp)].  A linear fit to the data excluding these 
two complexes gives a value of R2 = 0.82.  In this case, a relatively large 
variation from a perfect linear fit is not unexpected due the simplification of the 
mathematical expression, which does not account for variation in vibrational 
mode frequencies and other excited state properties which affect the measured 
data.  These data clearly indicate that while eight complexes from the series 
obey the energy gap law, the emission displayed by complexes with the ntp 
ligand must be from a different type of excited state.  This observation is 
supported by the noticeably different excited state properties, particularly the 
long luminescence lifetime.  One final point of note from these data is that the 
complexes with methanethiolate ligands lie within the fit of the aromatic thiolate 
complexes indicating that these share a similar excited state.  This makes an 
assignment of a thiolate()→N^C^N(*) 3LLCT phosphorescence unlikely since 
the [PtLn(mt)] complexes do not possess the required delocalised  system.  An 
assignment of S(p)→N^C^N(*) LLCT is still feasible although it is likely that 
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such a state will have a large amount of MLCT character due to Pt-S bonding 
interactions. 
 
2.2.3.4 Excited state assignment for [PtLn(thiolate)] complexes 
Despite the difference in emission in the ntp complexes, when comparing 
absorption data with that from electrochemical studies, the absorption energy of 
the lowest energy band and the band-gap between oxidation and reduction 
waves show a strong linear correlation for all four aromatic thiolates, particularly 
within the series with the ligand L2 (Figure ‎2.16).  This correlation, however, is 
not repeated with the emission energies with [PtL2(ntp)] lying considerably away 
from the co-linearity of the other three complexes. 
 
 
Figure ‎2.16 Plot of lowest energy absorption maxima (squares) and emission maxima (circles) 
vs. electrochemical bandgap for PtL
2
 complexes with aromatic thiolates. 
 
This supports the notion that while in the singlet manifold, the first excited state 
is of the same type throughout the whole series, in the triplet manifold, the 
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lowest excited state is indeed of a different character, as indicated by the study 
of the energy-gap law. 
 
Given the data that have been discussed, it seems that the most likely 
assignment for the phosphorescence from the majority of the new complexes is 
of Pt-S()→N^C^N(*) charge transfer character since it is strongly affected by 
the para-substituent of the aromatic thiolates while a pure 3LLCT excited state is 
ruled out by the aliphatic thiolate complexes.  It has been confirmed that the 
emission from this state obeys the energy gap law with increased knr upon 
decreasing emission energy leading to lower quantum yields and shorter 
observed lifetimes.  The radiative decay constants for the eight complexes 
exhibiting this emissive state are also relatively similar. 
 
In contrast, the introduction of a nitro group into the thiolate ligand leads to a 
new, lower energy triplet excited state from which phosphorescence is 
observed.  The observation of vibrational structure in the low-temperature 
emission, coupled with a luminescence lifetime of the order of microseconds, 
indicate a predominantly ligand-centred or intra-ligand excited state localised on 
the 4-nitrothiophenolate ligand.  A similar effect has been observed in the study 
of platinum diimine acetylide complexes, where the use of a nitro group on the 
acetylide ligand causes a switch from 3MLCT to acetylide 3-* 
phosphorescence.207 
 
The proposed energy level structure and the effect of the nitro group on the 
emissive state are shown in Figure ‎2.17.  This structure accounts for a mixed 
metal-sulfur HOMO giving charge transfer to N^C^N(*) in the majority of the 
complexes and to thiolate(*) in complexes with ntp.  The proposed structure 
also accounts for the blue shift of [PtL2(ntp)] compared to [PtL1(ntp)] since the 
inductive effect of the ester will reduce the ligand field effect of the 
cyclometallated carbon.  This results in a decrease in energy of the metal 
centred orbitals which, in turn, will reduce the energy of the Pt-S filled orbital 
interaction. 
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Figure ‎2.17  Schematic diagram of proposed energy level structure in [PtL
n
(thiolate)] 
complexes.  A Pt-S() filled orbital interaction accounts for mixed MLCT/LLCT character and the 
observed effect of the N^C^N substituent on [PtL
n
(ntp)] LC state. 
 
2.2.4 DFT calculations on [Pt(N^C^N)(thiolate)] complexes 
In order to further investigate the excited states of these complexes, some 
preliminary DFT calculations were performed using these structures.  Firstly, 
geometry optimisations were carried out to ensure the structures were in their 
lowest energy conformation and from these coordinates the ground state 
electronic states were calculated.  This gave an indication of the localisation of 
the HOMO and LUMO in these systems.  Representations of these orbitals for 
some of the [Pt(N^C^N)(thiolate)] complexes are shown in Figure ‎2.18 and 
Figure ‎2.19. 
 
The data from these calculations show that in all cases the HOMO contains a 
large contribution from the sulfur orbitals as well as involvement of the metal 
and the aromatic substituent, where present.  Meanwhile the LUMO is located 
on the N^C^N ligand, also with a small amount of metal involvement.  This is 
consistent with the model inferred from the absorption and electrochemical data 
that the lowest energy singlet state is primarily of mixed metal/thiolate to N^C^N 
charge transfer character.  It is also the case that there are only very small 
observed differences upon the change from L1 to L2. 
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Figure ‎2.18 HOMO and LUMO plots for [PtL
1
(motp)], [PtL
1
(mt)] and [PtL
1
(ntp)] calculated using 
the B3LYP hybrid functional with LanL2DZ and 6-31G basis sets. 
 
 
Figure ‎2.19 Comparison of [PtL
1
(tp)] and [PtL
2
(tp)] HOMO and LUMO plots calculated using the 
B3LYP hybrid functional with LanL2DZ and 6-31G basis sets. 
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As the calculated data is for the singlet manifold, these results are not 
representative of the emissive behaviour of the complexes.  Recent, more 
detailed work within the group carried out by Gemma Freeman on these 
systems indicates that for the complexes excluding those with ntp ligands, the 
calculations for the triplet states confirm the assignment of emission from triplet 
states of the same character as the lowest singlet state.  The situation with 
[PtL1(ntp)] and [PtL2(ntp)] is found to be more complicated with various orbital 
contributions to the lowest energy transition.208  This, again, is consistent with 
the observation that introduction of a nitro group leads to a change in the 
emissive state. 
 
2.3 Concluding remarks 
A series of potential N^C^N coordinating ligands have been synthesised in the 
hope that when complexed to platinum, these will lead to both luminescence 
under ambient conditions as well as potential axial interactions with sulfur-
containing analytes.  These ligands, therefore, contained one pyridyl substituent 
as part of a ppy moity to activate luminescence while also containing alternate 
nitrogen donors.  The formation of complexes with these ligands was 
unsuccessful, most likely due to poor chelation prior to cyclometallation and 
multiple binding modes. 
 
In addition, a series of platinum complexes have been synthesised containing a 
fully aromatic N^C^N ligand and a thiolate ligand.  The effect of the introduction 
of these thiolate ligands into the coordination sphere of platinum has been 
investigated.  In contrast to the „parent‟ [Pt(N^C^N)Cl] complexes which show 
vibrationally structured 3LC emission, these novel complexes instead, show 
predominantly mixed metal/thiolate to N^C^N charge transfer emission, with the 
exception of complexes containing 4-nitro-phenylthiolate ligands, where the 
electronic properties of this particular ligand lead to a new, low lying 
3LC(thiolate) or 3ILCT(thiolate) emissive state. 
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Chapter 3 
 
Cyclometallated iridium 
complexes with thiolate 
ligands 
 
  81 
3 Cyclometallated iridium complexes with thiolate 
ligands 
 
Complexes of iridium with polypyridyl and cyclometallating ligands are 
becoming more common in studies involving photoluminescence as discussed 
in the introduction.  Complexes containing bidentate N^C  bound and terdentate 
N^C^N bound ligands often show particularly bright phosphorescence.  
However the studies on the introduction of alternate ligands in these systems 
still lag behind other, more heavily studied, second and third row transition 
metals.  In this chapter the interactions of cyclometallated complexes of iridium 
with thiolate ligands are discussed. 
 
3.1 Bis(2-phenylpyridine)iridium complexes 
As discussed in the introduction, the complex [Ir(ppy)3] displays strong 
phosphorescent emission from 3MLCT excited states.  Related heteroleptic 
compounds with only two cyclometallating ppy ligands can be utilised in a 
variety of applications depending on the ancillary ligands used.  In many cases, 
these complexes can be synthesised through the intermediacy of the dimer 
[Ir(ppy)2(µ-Cl)]2, formed by the treatment of IrCl3 with two equivalents of ppy, 
and its subsequent cleavage with the desired ancillary ligand.  In much of the 
reported work on such compounds, any aromatic ligands used to form such 
complexes are bidentate species such as 2,2'-bipyridine (bpy).  Conversely, 
there have been very few reports of cleavage with monodentate aromatic 
ligands to give mixed systems of the type [Ir(ppy)2(L)(X)] where L and X are 
neutral and anionic ligands respectively. 
 
The results of one study show that cleavage of the [Ir(ppy)2(µ-Cl)]2 dimer with 
various neutral ligands to give [Ir(ppy)2(L)Cl] complexes is possible and 
subsequent reactions using AgOTf will yield mixed complexes of the type 
[Ir(ppy)2(L)(L')]
+.209  In addition using AgOTf in the initial reaction with the dimer 
leads to [Ir(ppy)2(L)2]
+ species, including the bis-pyridine complex 
[Ir(ppy)2(py)2]
+. 
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It was therefore decided, in the first instance, to explore the cleavage of this 
dimer with a neutral monodentate ligand, giving a monometallic complex with a 
monodentate chloride ligand that could potentially be displaced by a thiolate as 
shown in Scheme ‎3.1. 
 
 
Scheme ‎3.1 Cleavage of iridium phenylpyridine dimer with a neutral monodentate ligand. 
 
3.1.1 Cleavage of [Ir(ppy)2(µ-Cl)]2 with neutral ligands 
Initially, cleavage of the dimer was attempted using pyridine as the neutral 
ligand in refluxing dichloromethane.  This gave a yellow product that could not 
immediately be identified.  It appeared that the resulting material was a single 
component by TLC and the yielded mass of product after work-up was 
equivalent to that which would be expected by the stoichiometric addition of 
pyridine to the dimer.  However, the expected product did not appear in either 
electrospray or MALDI mass spectrometry, which instead showed m/z = 542, 
583 or m/z = 536 respectively.  These correspond to acetonitrile adducts of an 
Ir(ppy)2
+ fragment in the electrospray spectrum (i.e. Ir(ppy)2(MeCN)
+ and 
Ir(ppy)2(MeCN)2
+) and an Ir(ppy)2Cl
+ fragment in MALDI.  1H NMR, however, 
clearly showed that the symmetry of the 2-phenylpyridine ligands had been 
broken as these presented 16 signals indicating that the 5th and 6th coordination 
sites contained inequivalent species.  In addition to the ppy signals, the 1H NMR 
integrals showed only an additional three proton signals in the form of a broad 
2H signal and a 1H signal overlapped by a ppy multiplet, both in the aromatic 
region.  If the product was indeed the expected [Ir(ppy)2(py)Cl] complex then 
there should have been another aromatic signal integrating to two protons 
which was not visible.  The aromatic region of the 1H NMR spectrum of the 
product is shown in Figure ‎3.1. 
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Figure ‎3.1 
1
H NMR (400 MHz) spectrum (aromatic region) of possible [Ir(ppy)2(py)Cl] complex.  
Smaller impurity signals are free pyridine (also contributing approx 0.6 to integral of 3H (ppy) + 
1H multiplet). 
 
The solution to the identification of this unusual product came when, in a 
second reaction, it was decided to attempt to cleave the dimer using N,N-
dimethylaminopyridine (DMAP), rather than pyridine.  This reaction, like the first, 
gave a single product in relatively high yield.  In this case, however, the MALDI 
mass spectrum showed a peak for the expected product at m/z = 623 as well as 
the fragments corresponding to (M-Cl)+ and (M-DMAP)+.  With this product as 
well, however, the 1H NMR spectrum again showed some unusual 
characteristics.  There were, again, 16 separate aromatic signals corresponding 
to two inequivalent ppy ligands, but in this case there was only one additional 
broadened signal in the aromatic region with an integral corresponding to two 
protons.  As expected there was also a singlet in the aliphatic region integrating 
to six protons representing the two methyl groups of the DMAP ligand.  Again, 
there was one signal corresponding to two protons missing compared to what 
would be expected.  One final notable feature of this spectrum, though, was a 
noticeable symmetrical non-linearity in the baseline between  = 9.5 – 7.5, 
which could be viewed as an extremely broadened signal.  If this feature was, in 
fact, a broadened signal corresponding to 2H then this would make the 
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spectrum consistent with the expected product that had been detected by mass 
spectrometry. 
 
Looking back at the NMR data for the previous reaction with pyridine it was 
noticed that this spectrum also contained a similar feature in the aromatic region 
that could be viewed as an extremely broadened signal, again suggesting that 
this could be the desired product.  It was possible, therefore, that the cleavage 
of [Ir(ppy)2(py)Cl] with both py and DMAP had been successful giving the 
products shown in Figure ‎3.2 but 1H NMR signals relating to the ancillary ligand 
were significantly broadened. 
 
 
Figure ‎3.2 [Ir(ppy)2(py)Cl] and [Ir(ppy)2(DMAP)Cl]. 
 
It was theorised that hindered rotation around the Ir-N bond due to a steric 
interaction between H2/6 of the pyridine ligand and H6 of the neighbouring ppy 
could lead to broadening on the NMR timescale (Figure ‎3.3).  If the rotation 
were entirely blocked, H2 and H6 of the pyridine would be expected to have 
relatively different  values and to a lesser extent H3 and H5 due to proximity to 
the chloride ligand.  Some level of hindered rotation could lead, therefore to 
broadening and/or splitting of these signals in the complex. 
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Figure ‎3.3 Steric hindrance to rotation in anciliary pyridine ligand. 
 
To discover whether this was indeed the case, variable temperature NMR 
experiments were conducted on the [Ir(ppy)2(DMAP)Cl] complex.  If this effect 
were a result of hindered rotation, it would be expected that at higher 
temperatures, rotation would be increased and the peaks relating to the DMAP 
protons should sharpen.  Conversely, at lower temperatures, it would be 
expected that the peaks would appear broader or, if the rotational motion were 
reduced sufficiently, would split into non-degenerate signals.  In addition to the 
original spectra taken at room temperature in CDCl3, experiments were 
performed at -50 C in CDCl3 and at 90 C in d4-tetrachloroethane (TCE).  The 
resulting spectra are shown in Figure ‎3.4 and it can be seen that while the 
signals relating to the ppy ligands are largely unaffected, the proposed ancillary 
ligand signals show a significant sharpening at higher temperature, with the 
appearance of a broad, 2H integral signal in the centre of the originally 
observed non-linear baseline feature.  In addition, it appears that at -50 C the 
sample is below the thermal barrier to rotation as four distinct broad, single 
integral signals are seen.  This evidence confirms that the product is, indeed, 
the [Ir(ppy)2(DMAP)Cl] complex but some signals in the ambient temperature 
1H 
NMR spectrum are broadened to the extent that they are scarcely visible. 
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Figure ‎3.4 
1
H NMR (500 MHz) spectra of [Ir(ppy)2(DMAP)Cl] at  90 C in d4-TCE (a), ambient 
temperature in CDCl3 (b) and -50 C in CDCl3 (c).  Broadening and splitting of the DMAP signals 
at  8.4 and 6.35 is clearly observed with decreasing temperature. 
 
3.1.2 Unexpected reactivity of monometallic complexes with aromatic 
thiols 
With the products of the cleavage reactions now confirmed as the complexes 
[Ir(ppy)2(py)Cl] and [Ir(ppy)2(DMAP)Cl], the behaviour of these new compounds 
when treated with thiols could be explored.  It was proposed that a series of 
thiolates could be substituted in place of the chloride ligand giving a series of 
charge neutral complexes of the type shown in Scheme ‎3.2. 
 
 
Scheme ‎3.2 Possible substitution reactions of [Ir(ppy)2(Rpy)Cl] complexes. 
 
a 
b 
c 
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The first approach was to investigate whether substitutions could occur at room 
temperature with aromatic thiolates and so in the first reaction, a solution of 
[Ir(ppy)2(DMAP)Cl] was treated with a stoichiometric amount of 4-
methylthiophenol and potassium tert-butoxide in methanol.  After work-up to 
remove any excess butanol or remaining thiol the resulting yellow product was 
shown to contain two components by TLC.  These components were separated 
by column chromatography and analysed by mass spectrometry and NMR 
spectroscopy.  It was immediately obvious that neither of these products were 
the result of chloride substitution by a thiolate since the 1H NMR spectrum of 
both showed that the 2-phenylpyridine ligands were now equivalent giving only 
8 aromatic signals, rather than 16.  In fact, the spectrum of the minor product 
was identical to that of the dimer [Ir(ppy)2(µ-Cl)]2, showing only these 8 aromatic 
signals.  In the major product there were three signals in addition to those of the 
ppy ligands – two aromatic doublets* and one aliphatic singlet with integral 
ratios of 2:2:3, consistent with a 4-methylthiophenol fragment.  The relation of 
integrals between the ppy ligands and thiol indicated that these fragments were 
present in a 2:1 ratio of ppy:thiol.  Structurally, this ratio could be rationalised in 
a number of ways, as shown in Figure ‎3.5.  Possibilities are: substitution of 
DMAP by thiol (A), substitution of chloride by thiolate with replacement of DMAP 
by some labile species (e.g. solvent) (B), or a five coordinate species where the 
thiolate has replaced both chloride and DMAP (C). 
 
 
Figure ‎3.5 Possible product structures containing 2:1 ratio of ppy to thiol and no DMAP ligand. 
 
All these structures, however present problems when compared to the data.  
Structures A and B would lead to a degeneracy in the ppy ligands in the 1H 
                                            
*
 These „doublets‟ showed the classic a,a‟-x,x‟ coupling pattern seen in para-substituted 
benzenes. 
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NMR spectrum as there are different units in the 5th and 6th coordination sites.  
As mentioned above, this does not fit with the observed spectrum.  While 
structure C could meet the criteria for degenerate ppy ligands, a 5-coordinate 
complex with iridium is unlikely and none are reported in related structures with 
ppy ligands.  The identity of the product became clearer when studying the 
MALDI mass spectrometry results which showed a peak at m/z = 1246, equal to 
twice the mass of structure C.  It appears, therefore that both the products 
isolated from the reaction with this thiol were dimers, the minor product being 
[Ir(ppy)2(µ-Cl)]2 and the major product, a dimer with two bridging thiolate ligands 
as shown in Figure ‎3.6. 
 
 
Figure ‎3.6 [Ir(ppy)2(µ-mtp)]2 
 
This result is not surprising, given the tendency of sulfur to form bridging 
compounds with a variety of metals, either as a sulfur atom or as part of a 
thiolate.  Recent examples with iridium include bridging by 2-
mercaptobenzimidazole,210 perfluorothiophenol211 and also a diiridium species 
with bipyridine ligands bridged with 4-methylthiophenol.212 
 
3.1.3 Direct reaction of [Ir(ppy)2(µ-Cl)]2 with thiolates 
Since the reaction of a monometallic complex with a thiolate gave a dimer in 
this manner, it was of interest to explore what effect addition of a thiolate 
directly to the chloride bridged dimer would have.  Given that 4-
methylthiophenol displaces both the chloride and DMAP ligands to form a 
dimer, it is possible that this product could instead be formed by direct chloride 
substitution in [Ir(ppy)2(µ-Cl)]2 making cleavage with a neutral ligand and 
subsequent reforming of a dimeric species superfluous. 
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3.1.3.1 Diastereoisomerism resulting from the direct reaction with 
[Ir(ppy)2(µ-Cl)]2 
Again, the first reaction attempted was addition of a solution of 4-
methylthiophenol and KOtBu in methanol to a solution of [Ir(ppy)2(µ-Cl)]2 in 
DCM.  This addition caused the immediate precipitation of a yellow, semi-
crystalline solid, which was collected and analysed by NMR spectroscopy.  
Although the 1H spectrum initially appeared quite complicated (Figure ‎3.7), on 
closer inspection, half of the signals present were consistent with the spectrum 
of the dimer [Ir(ppy)2(µ-mtp)]2 obtained in the previous work from the 
mononuclear iridium complex.  With these signals discounted, what remained 
was another set of signals, also consistent with a structure containing a 2:1 ratio 
of ppy:mtp.  Data from MALDI mass spectrometry, on the other hand, indicated 
only a single product, consistent with that of the thiolate bridged dimer. 
 
 
Figure ‎3.7 
1
H NMR (400 MHz) spectrum of initial precipitate from reaction of [Ir(ppy)2(DMAP)Cl] 
with mtpH/KO
t
Bu.  + marks peaks consistent with previous [Ir(ppy)2(µ-mtp)]2 sample. 
 
It appeared that this reaction had resulted in a pair of diastereoisomers, where 
the two Ir(ppy)2 units are arranged differently with respect to each other.  It is 
possible for the phenylpyridine ligands on the same side of the plane formed by 
the bridging bonds to be arranged either parallel or perpendicular to one 
another (Figure ‎3.8).  These diastereoisomers result from different combinations 
of iridium centres with either  or  symmetry.  In all, the possible combinations 
are , (meso), , and ,, the last two being a pair of enantiomers.  This is 
unusual in complexes of this type with the overwhelming majority of previously 
reported dimers adopting only a racemic mixture of , and , isomers.14-17 
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Figure ‎3.8 , and , diastereoisomers of [Ir(ppy)2(µ-mtp)]2 
 
From the NMR spectrum it was possible to determine that the ratio of isomers in 
the initial sample was 1:1.5 with the smaller proportion being the isomer similar 
to that resulting from the reaction with [Ir(ppy)2(DMAP)Cl].  It was also noted 
that the isomeric ratio changed over time when the mixture was left in solution.  
The same NMR sample, having been left at room temperature for approximately 
20 h showed an increase in the proportion of the originally discovered isomer up 
to a ratio of 1:1.  The proportion of this isomer was increased further to 1:0.5 
after the sample was heated at reflux for 45 min in chloroform.  It seems, 
therefore that the new isomer, formed initially in larger proportion, is likely to be 
the kinetically favoured product of the thiolate substitution while the alternate 
isomer (and sole product of reaction with [Ir(ppy)2(DMAP)Cl]) is more 
thermodynamically stable.  Additional reactions were carried out at different 
temperatures to discover whether these isomers could be synthesised 
independently.  The substitution was performed at -78 C to favour the new 
isomer and another reaction was refluxed for 7 h to produce the original isomer.  
These reactions, however, gave mixtures in ratios 1:1.5 and 1:1 respectively. 
 
The diastereoisomers did show a slight separation in TLC and so separation by 
column chromatography was attempted.  The column was carried out as quickly 
as possible to try to minimise interconversion of the isomers while on the 
column and in solution.  This separation was to some extent successful as a 
large proportion of the new isomer was obtained, but there was a small amount 
of the original isomer in the 1H NMR spectrum of the sample. 
 
A similar substitution was also attempted using thiophenol (tpH), 4-
nitrothiophenol (ntpH) and sodium methanethiolate (mtNa) in place of 4-
methylthiophenol on [Ir(ppy)2(µ-Cl)]2 with reflux for approximately 16 h.  While 
the reaction with sodium methanethiolate was unsuccessful, with only starting 
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materials recovered, the reactions with tpH and ntpH both gave thiolate-bridged 
dimers analogous to the result of the reaction with mtpH.  In these two cases no 
evidence of diastereoisomers was seen in the products and, based on the 
tendency of similar dimers to adopt the chiral , or , structure, it is expected 
that this is also the case for [Ir(ppy)2(µ-tp)]2 and [Ir(ppy)2(µ-ntp)]2.  However, in 
light of the observed isomerism in [Ir(ppy)2(µ-mtp)]2 this assignment is tentative.  
The synthesised dimers are shown in Figure ‎3.9. 
 
 
Figure ‎3.9 [Ir(ppy)2(µ-mtp)]2 (racemic and meso), [Ir(ppy)2(µ-tp)]2 and [Ir(ppy)2(µ-ntp)]2 
 
3.1.3.2  Assignment of [Ir(ppy)2(µ-mtp)]2 isomers from NMR data 
Although the two isomers of [Ir(ppy)2(µ-mtp)]2 can readily be distinguished by 
1H 
NMR, it is not possible to assign which set of signals correspond to which 
isomer simply by inspection.  Attempts to produce crystals for single crystal X-
ray structural analysis, which would provide the definitive solution, were 
unsuccessful but some evidence can be inferred from NMR data. 
 
By comparison of the 1H NMR spectra of the dimers shown in Figure ‎3.9, it 
seems clear that the isomerically pure samples of [Ir(ppy)2(µ-tp)]2 and 
[Ir(ppy)2(µ-ntp)]2 are likely to have the same stereochemistry as the 
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thermodynamically favoured isomer of [Ir(ppy)2(µ-mtp)]2.  The most deshielded 
protons of these three compounds are the H6 and H3 protons of the pyridine ring 
and appear at around  9.5 and 7.9 respectively, similar to the spectrum of 
[Ir(ppy)2(µ-Cl)]2, whereas these two signals in the alternate isomer (referred to 
above as the kinetic product) are quite different, at  10.49 and 7.49.  In fact, 
the comparatively more shielded position of the H3 signal has put this at a lower 
 than H4 which in this isomer is now the second highest signal at  7.65.  A 
comparison of the 1H NMR spectra of the synthesised dimers is shown in Figure 
‎3.10 and the distinct pattern of the novel isomer can clearly be seen. 
 
 
Figure ‎3.10 
1
H NMR spectra (aromatic region) of thiolate-bridged dimers showing distinctive 
peak distribution in the new isomer of [Ir(ppy)2(µ-ntp)]2. 
 
As discussed in the introduction, X-ray crystallography has shown that 
compounds related to [Ir(ppy)2(µ-Cl)]2 generally exist as a mixture of , and 
, isomers and, given the similarity in the 1H NMR spectra, it can be tentatively 
expected that these new dimers exist in the racemic , and , forms.  This 
would imply that the kinetically favoured isomer produced in the case of 
[Ir(ppy)2(µ-mtp)]2 is the meso isomer with mixed  and  metal centres.  While 
these data do suggest an assignment of , stereochemistry to the additional 
[Ir(ppy)2(µ-ntp)]2 
[Ir(ppy)2(µ-tp)]2 
[Ir(ppy)2(µ-mtp)]2 
[Ir(ppy)2(µ-mtp)]2 novel isomer 
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isomer, this evidence is somewhat circumstantial so other methods were 
explored to try to confirm this assignment. 
 
3.1.3.3 Use of Density Functional Theory to confirm assignment 
Density Functional Theory (DFT) has a wide variety of uses in chemistry, most 
commonly in the examination of the electronic structure of molecules and their 
excited states.  This can be useful in areas such as determining reaction 
dynamics as well as helping to characterise the excited state properties of 
emissive molecules.  It is also possible, using DFT, to calculate NMR spectra by 
virtue of the relationship between the electronic energy levels and the nuclear 
shielding constant.  The shielding constant of a nucleus σ defines the effective 
magnetic field at the nucleus in relation to the applied field B0 and is given by 
the mixed second derivative of the energy with respect to the magnetic moment 
of the nucleus µ and the magnetic field B as shown in Equation ‎3.1. 
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Equation ‎3.1 
 
It was therefore decided to explore the effect of the observed isomerism upon 
the calculated 1H NMR spectra using this method.  With the observed NMR 
spectra of the two isomers for comparison it was hoped that these could be 
matched to the results of calculations run on the two structures.  Assuming the 
theoretical and observed spectra were sufficiently matched, this would confirm 
or refute the initial assignment since the input structure for the theoretical 
spectra is known. 
 
Before performing calculations to produce shielding values, it is first necessary 
to perform a geometry optimisation on the two structures to ensure they are in 
their lowest energy conformation.  Since the , and , isomers are 
enantiomers of one another, in terms of DFT calculations they are identical and 
so the calculations were performed only on the , and , isomers.  The 
results of these optimisations are shown in Figure ‎3.11 and, as expected, show 
that in the , isomer the pairs of phenylpyridine ligands on the same side of 
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the iridium-sulfur plane are aligned approximately parallel, while in the , 
isomer they lie perpendicular.  It is also worth noting that the final molecular 
energies resulting from these calculations showed a difference of 3.91 × 10-3 
Hartrees, with the meso isomer being slightly higher in energy.  This is 
equivalent to 10.3 kJmol-1 and gives credit to the earlier assumption that the , 
and , isomers are more thermodynamically stable than the , meso isomer. 
 
Figure ‎3.11 Geometry optimised structures of , (left) and , (right) diastereoisomers of 
[Ir(ppy)(µ-mtp)]2.  Calculations performed with Gaussian03 using the B3LYP hybrid functional 
with basis sets 6-31G* and LanL2DZ.  Hydrogen atoms are omitted for clarity. 
 
Using the atomic coordinates from the geometry optimisations, the NMR 
shielding constants could then be calculated.  The calculated shielding values 
for the , (meso) isomer show, as expected, a fourfold degeneracy in signals 
relating to the phenylpyridine ligands since these four ligands are equivalent in 
this structure.  This leads to eight distinct signals for the protons in these ligands 
as is observed in the solution NMR spectrum.  For signals from the bridging 
thiolate ligands, while in the observed NMR spectrum these appear as two 
distinct signals each with a fourfold degeneracy, the calculated spectrum shows 
four signals of twofold degeneracy for these protons.  This is due to the fact that 
the calculated values are for the rigid structure of the optimised geometry 
making, for example, H2 and H6 symmetrically inequivalent, while in the 
observed spectrum these signals are equilibrated by rotation of this ligand faster 
than the NMR timescale. 
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The calculated results for the , isomer are slightly more complex.  In this 
case, the results do not show the observed fourfold degeneracy for signals 
relating to the phenylpyridine ligands.  This, again, is due to the lack of 
rotational equilibration in the calculated spectrum.  The non-degeneracy in the 
ppy ligands arises from the relative orientation of the mtp phenyl rings making 
the two ppy on the same side of the iridium-sulfur plane symmetrically 
inequivalent.  The signals calculated for the mtp ligands themselves show a 
similar result to the meso isomer with four separate values for each aromatic 
ring position and the two mtp fragments remaining equivalent. 
 
Essentially, the difference in degeneracy between the calculated spectra is a 
result of the positioning of the bridging ligands.  Both complexes possess a 
single C2 axis passing through the two iridium centres making the ppy ligands 
around the same metal centre symmetrically equivalent.  However, in the 
optimised structure of the , isomer, the aromatic rings of the mtp ligands are 
aligned perpendicular to this C2 axis and this, in addition to the meso 
arrangement of the ppy ligands gives this isomer a mirror plane, σh, resulting in 
a centre of inversion as it belongs to the point group C2h rather than C2.  As 
discussed above, these particular symmetry arguments only apply to the 
calculated spectra since they are rigid, while in the solution NMR spectra, 
intramolecular motion, primarily rotation of the mtp ligands leads to increased 
degeneracy.  Table ‎3.1 shows the calculated and observed δ values with their 
proton assignments, numbered as shown in Figure ‎3.12. 
 
 
Figure ‎3.12 Proton numbering in [Ir(ppy)2(µ-mtp)]2 for NMR assignment. 
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, isomer calculated 
1
H 
δ values / ppm 
(assignment) 
, isomer calculated 
1
H 
δ values / ppm 
(assignment) 
Initial isomer observed 
1
H 
δ values / ppm 
(assignment) 
Secondary isomer 
observed 
1
H δ values / 
ppm (assignment) 
10.1 (H6-py)a 
8.50 (H6-py')a 
11.0 (H6-py) 9.47 (H6-py) 10.49 (H6-py) 
7.43 (H3-py)a 
7.35 (H3-py')a 
7.85 (H4-py) 7.88 (H3-py) 7.65 (H4-py) 
7.30 (H6-ph)a 
7.24 (H6-ph')a 
7.75 (H3-py) 7.70 (H4-py) 7.49 (H3-py) 
7.24 (H4-py)a 
7.10 (H4-py')a 
7.66 (H5-py) 7.56 (H6-ph) 7.30 (H5-py) 
6.54 (H5-py)a 
6.25 (H5-py')a 
7.38 (H6-ph) 6.82 (H5-ph) 7.08 (H6-ph) 
6.25 (H5-ph)a 
6.25 (H5-ph')a 
7.21 (H2-mtp)a 6.71 (H5-py) 6.58 (H4-ph) 
6.25 (H4-ph)a 
6.25 (H4-ph')a 
7.06 (H3-ph) 6.64 (H4-ph) 6.58 (H5-ph) 
6.25 (H3-ph)a 
6.06 (H3-ph')a 
6.84 (H4-ph) 6.18 (H2/6 or 3/5-mtp) 6.20 (H3-ph) 
6.06 (H2-mtp)a 6.84 (H3-mtp)a 5.97 (H3-ph) 5.96 (H2/6 or 3/5-mtp) 
5.90 (H3-mtp)a 6.63 (H5-ph) 5.82 (H2/6 or 3/5-mtp) 5.27 (H2/6 or 3/5-mtp) 
5.82 (H5-mtp)a 6.33 (H5-mtp)a 1.92 (Me) 1.99 (Me) 
5.51 (H6-mtp)a 5.35 (H6-mtp)a   
1.74, 1.49, 1.21 
(Me)a 
2.56, 2.35, 1.93 
(Me)a 
  
Table ‎3.1 Calculated and observed 
1
H NMR δ values for the two isomers of [Ir(ppy)2(µ-mtp)]2.  
Overlapping signals are listed separately at the same δ for clarity. (a) These signals appear non-
degenerate in the calculated spectra due to the lack of rotational equilibration. 
 
As discussed in Section ‎3.1.3.2, the most notable difference in the observed 
NMR spectra of the two isomers is firstly the order of the peaks at high δ and 
secondly the difference in δ between the two most deshielded protons.  It has 
been inferred from comparisons with other dimers that the kinetically favoured 
isomer in the reaction of mtp with [Ir(ppy)2(µ-Cl)]2 was the , isomer.  When 
the data calculated for a , structure is compared to the observed spectrum of 
this alternate isomer it can be seen that the predicted sequence follows the 
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observed spectrum for the five most deshielded protons.  In addition, the gap 
between the H6-py and H4-py signals is also relatively large at 3.15 ppm in the 
calculated spectrum compared to 2.84 ppm in the solution NMR spectrum. 
 
The correlation between the more thermodynamically stable isomer and the 
calculated values for a , isomer are complicated slightly by the non-
degeneracy in signals from the ppy.  However, for the most part the separated 
signals appear at similar δ to one another and so a crude comparison with the 
observed data can still be made.  In this case, the calculation correctly places 
H3-py as the second most deshielded proton rather than H4-py as in the 
alternate isomer.  The next two highest signals in the calculated spectrum, H6-
ph and H4-py, are very close together and partially overlapped due to the issue 
of non-degeneracy and while these are indeed the next two signals in the 
observed data, the peak order is reversed.  In terms of the gap between the two 
most deshielded protons in this isomer, if averaged values for the non-
degenerate signals with the same assignment are taken this gives a gap of 
1.91 ppm in the calculated values compared to 1.59 ppm in the observed 
solution NMR. 
 
While in both the spectra obtained by DFT calculations the δ values are 
somewhat different from the observed data, with the variation in many cases 
being up to 0.5 ppm, the overall patterns of the spectra in terms of peak 
ordering and position do show similar variation to the difference in the observed 
spectra.  In trying to match the calculated spectra to those observed from 
solution NMR, there is a clear similarity between the „alternate‟ isomer and the 
calculation for the , structure, while the calculation for the , structure has 
more in common with the originally synthesised isomer.  This seems to confirm 
the previous assignment that the more common structures displayed in the new 
[Ir(ppy)2(µ-thiolate)]2 dimers is a racemic , and , mixture while the unusual 
isomer in the case of [Ir(ppy)2(µ-mtp)]2 exists as a meso , diastereoisomer. 
3.1.4 Photophysical properties of thiolate bridged dimers 
Beyond the observed isomeric changes occurring in solution with the mtp 
bridged dimer, in the case of all the synthesised dimers, a period of 2-3 days in 
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solution led to significant decomposition, with NMR samples showing up to four 
different components as evidenced by the differing H6-pyridine signals at high . 
 
All the dimers synthesised are slightly soluble in chlorinated solvents and 
acetone but insoluble in most others including alcoholic solvents such as 
methanol and ethanol, the ether solvents THF and Et2O, or non-polar solvents 
such as hexane. [Ir(ppy)2(ntp)]2 is noticeably more soluble than the other two 
dimers.  During the work-up following the synthesis of this compound, an 
intriguing effect was observed.  While the other two dimers are bright yellow in 
colour like the chloride bridged dimer, this compound is a darker orange/yellow 
colour. Upon contact with methanol, however, the solid became deep red in 
colour, whilst a subsequent wash with diethyl ether caused another colour 
change to yellow.  Upon drying under reduced pressure the solid returned to its 
original orange/yellow colour.  On further investigation it was discovered that a 
variety of solvents produced a reversible colour change upon contact with the 
solid.  For most, the colour change is relatively small, but methanol and diethyl 
ether produce marked changes towards red and yellow respectively.  It was 
also discovered that the effect is not limited to suspension of the material in a 
solvent, but in addition, contact with solvent vapour induced similar changes as 
shown in Figure ‎3.13.  While the colour change in contact with liquid solvent is 
immediate, the effect takes place over 1-2 min in the presence of a solvent 
vapour, a slower rate of change being expected in response to the vapour if the 
change results from diffusion of solvent molecules into vacant sites within the 
solid structure.  Similarly, when removed from a vapour, the solid takes between 
2 and 5 min to return to its original orange/yellow colour but can be accelerated 
by placing the sample under vacuum. 
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Figure ‎3.13 Samples of [Ir(ppy)2(µ-ntp)]2 exposed to various solvent vapours (a, b and c) and 
immediately after removal (d).  The sealed vial in (d) is the dry sample. 
 
It is not clear what solvent property is involved in this effect: it seems unlikely to 
be simply related to polarity since while ethanol and methanol produce some of 
the most noticeable changes, the more polar acetonitrile has very little effect.  A 
simple rationalisation based on the presence of heteroatoms is also difficult 
since ether and alcohols appear to produce changes in opposite directions.  It 
seems likely that the effect will be in some way related to the size of the solvent 
molecule, as it must be incorporated into holes in the solid structure. 
 
In order to better understand this effect, the three dimers were studied by 
UV/visible spectroscopy.  The solution absorption spectra of [Ir(ppy)2(µ-ntp)]2, 
[Ir(ppy)2(µ-tp)]2 and the two isomers of [Ir(ppy)2(µ-mtp)]2 in DCM are shown in 
Figure ‎3.14.  As expected, these compounds all show strong UV absorption 
resulting from the aromatic  systems in the ligands.  The dimer containing 4-
nitrothiophenol has an additional distinct band at ~440 nm, whilst the others 
show only a weak tail in this region extending to around 520 nm.  The parent 
dichloro-bridged dimer shows similar low energy absorptions which have been 
a b 
c d 
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assigned to MLCT transitions involving the ppy ligands.19  It is therefore likely 
that the observed tails arise from similar transitions in these new dimers. 
 
Another noticeable feature of these spectra is that while [Ir(ppy)2(µ-tp)]2 and the 
original [Ir(ppy)2(µ-mtp)]2 isomer have very similar profiles, the meso mtp isomer 
shows slightly increased intensity in the tail at around 350 nm and 460 nm 
relative to the corresponding racemate.  This difference is certainly not great 
enough to indicate any major change in band structure in the meso isomer, but 
could be indicative of a slight perturbation of the ligand  systems resulting from 
their differing relative orientation. 
 
 
Figure ‎3.14 Absorption spectra of [Ir(ppy)2(µ-thiolate)]2 dimers in DCM normalised for 
concentration. 
 
What is clear is that the additional band in [Ir(ppy)2(µ-ntp)]2 is due to the 
significantly lower energy  system of the bridging ligand resulting from 
conjugation with the nitro group and it is this band which contributes to the 
noticeable colour difference of this dimer.  It is certainly the case that with other 
metals such as platinum, the introduction of nitro-substituted ligands can lead to 
noticeable differences in the orbital characteristics of a complex (See Section 
‎2.2.2).  It also seems likely that the observed vapochromism of this dimer is 
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related to this transition since the effect is not observed in the other synthesised 
dimers. 
 
The absorption spectrum of [Ir(ppy)2(µ-ntp)]2 was therefore measured in a 
variety of solvents to establish whether any changes in the structure or position 
of this band would be observed.  Due to the low solubility of the dimer in non-
chlorinated solvents, samples were prepared by dilution of 0.1 mL DCM stock 
solution with the required solvent to a total volume of 3 mL giving 0.033% DCM 
in the measured sample.  In this manner, absorption spectra were obtained in 
acetone, acetonitrile, dichloromethane, diethyl ether, ethanol, ethyl acetate, 
hexane, methanol and tetrahydrofuran and these are shown in Figure ‎3.15. 
 
 
Figure ‎3.15 Absorption spectra of [Ir(ppy)2(µ-ntp)]2 in various solvents, normalised at 310 nm. 
 
While a noticeable change in the low energy band does, indeed, occur in 
different solvents, these data appear to show a pattern consistent with positive 
solvatochromism of a charge transfer band indicating an increase in polarity in 
the excited state.  Plots of the absorption maxima against the solvent dipole 
moment (Figure ‎3.16a) and dielectric constant213 (Figure ‎3.16b), however, 
indicate a more complex situation.  While the relationship with the solvent dipole 
moment does indicate a decrease in energy with increasing solvent polarity, the 
values for DCM, THF and acetonitrile lie noticeably away from a linear 
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correlation.  Meanwhile it appears that for solvents with low dielectric constants 
(r < 10) there is a linear relationship with the absorption maximum while for the 
more polar solvents, this relationship breaks down.  It is clear from these results 
that the shift in absorption energy is not simply a result of solvent polarity 
indicating there may be a signifant contribution from direct solvent-complex 
interactions in certain solvents. 
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Figure ‎3.16 Plots of max against a) dipole moment and b) dielectric constant for the low energy 
band of [Ir(ppy)2(µ-ntp)]2. 
 
As a qualitative investigation into this effect in the solid state, microscope cover 
slips were taken and coated in a thin layer of the dimer by evaporation of a 
DCM solution.  Three slides were prepared using increasing concentrations of 
solution to give slides with varying thicknesses of solid, as shown in Figure 
‎3.17.  The absorption spectra of these slides were then measured using the 
group‟s solution UV/visible spectrometer by placing them in the path of the 
sample beam in place of a cuvette.  While this is not the ideal apparatus for 
such work, it was hoped that the results would provide some indication of the 
changes occurring during exposure to solvent vapours.  As the coating on the 
slides could not be made entirely uniform, the spectrum of each slide was 
measured five times in various orientations.  The raw data from these runs were 
quite varied, however after baseline correction and normalisation the results 
were reasonably self-consistent for each slide.  There were noticeable 
differences between slides, however, with the relative intensity of lower energy 
bands appearing much higher on the more concentrated slides. 
a) b) 
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Figure ‎3.17 Glass slides coated with [Ir(ppy)2(µ-ntp)]2. 
 
Each slide was then incubated for 5 min on a stand inside a sealed jar 
containing methanol and a new scan was performed immediately upon removal.  
The slide was then replaced in the solvent vapour for a further 5 min and 
another scan taken.  This was repeated to give a total of 5 scans for each slide.  
Each slide was then left under reduced pressure for approximately 20 min to 
ensure the removal of all methanol, then the process was repeated with diethyl 
ether.  Data from the two solvent systems was again quite varied but after 
baseline correction and normalisation the separate runs were more consistent.  
Plots of averaged data from all five runs of the dry and solvent-treated slides 
are shown in Figure ‎3.18.  While there is some difference between dry and 
solvent-treated slides, including a slight red-shift of the charge transfer band at 
~450 nm, the changes are small and there appears to be very little difference 
between the spectra for the two solvents.  If the spectra were representative of 
the observed colour changes in the solid state, it would be expected that 
methanol and diethyl ether would have differing effects on the absorption profile 
since methanol produces a red colour while ether turns the solid yellow.  It is 
therefore likely that the effects of solvent absorption into the structure are not 
being observed by this method, while the minor changes observed in the 
spectra of treated slides could be instead attributed to a slight wetting of the thin 
film altering its light scattering and absorption properties. 
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Figure ‎3.18 Absorption spectra of Slide 1 (top) Slide 2 (middle) and Slide 3 (bottom). 
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While no definitive answer has been obtained as to what particular interaction 
leads to the vapochromic effect in this particular compound, it is highly likely to 
involve orbital interactions relating to the 4-nitrothiophenolate ligands in 
[Ir(ppy)2(µ-ntp)]2.  The observation that noticeable changes in the photophysical 
properties can arise from interactions with small molecules in the solid state 
justifies further investigation into the orbital characteristics of this, and the 
related dimers – in particular, what changes occur upon the introduction of the 
nitro group.  If the precise nature of the interaction can be elucidated, this could 
lead to the design of useful sensing materials utilising these, or similar 
complexes. 
 
3.2 Iridium complexes with terdentate N^C^N bound ligands 
The reaction of iridium(III) chloride with terdentate cyclometallating ligands such 
as 1,3-di(2-pyridyl)-4,6-dimethylbenzene (dpyxH) gives a chloride bridged dimer 
which can be cleaved with various ligands to give a monometallic complex.  As 
discussed in the introduction, both bidentate and terdentate ligands can be 
used, but of particular interest within the scope of this project is where the dimer 
is cleaved with diimine-type ligands such as bipyridine or a bidentate 
cyclometallating ligand such as 2-phenylpyridine thus leaving one monodentate 
chloride ligand as shown in Scheme ‎3.3.  In the case of [Ir(dpyx)(ppy)Cl] it has 
been observed that the Ir-Cl bond is relatively labile, despite the normal kinetic 
inertness associated with the Ir3+ ion, due to the high trans effect of the trans-
disposed metallated phenyl ring.  This observation indicates that such 
complexes could be suitable for facile substitution of the chloride ligand with a 
thiolate. 
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Scheme ‎3.3 Synthesis of Ir(N^C^N)(N^C)Cl and [Ir(N^C^N)(N^N)Cl]PF6 complexes. 
 
Work was undertaken, therefore, to synthesise N^C^N ligands and from there, 
produce the dimer required to give various monometallic complexes for study. 
 
3.2.1 The extent of C2/C4 competitive binding 
As discussed in Section ‎1.1.2.3, during the original investigations into N^C^N 
coordinating ligands with iridium, it was found that the formation of terdentate 
bound complexes with the simplest „parent‟ structure, 1,3-di(2-pyridyl)benzene 
was not feasible due to competition with metallation at C4 giving bidentate N^C 
binding, which is kinetically favoured in the case of iridium.46  The xylene-based 
ligand shown above was therefore introduced, where the C4 and C6 positions 
are blocked, to enforce the desired N^C^N binding.  It was decided that, 
concurrent with the preparation of iridium complexes containing this xylene 
ligand, it would be of interest to explore whether a single methyl group at the C5 
position would be sufficient in also disfavouring the bidentate binding mode.  
The ligand 1,3-di(2-pyridyl)-5-methylbenzene (dpytH) was prepared by a Stille 
coupling of 3,5-dibromotoluene with tri-n-butylstannylpyridine.  DpyxH was 
similarly prepared from 4,6-dibromo-m-xylene, itself produced by bromination of 
meta-xylene catalysed by I2 as shown in Scheme ‎3.4. 
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Scheme ‎3.4 Synthesis of N^C^N ligands dpytH and dpyxH. 
 
The reaction of this ligand with IrCl3.3H2O was attempted under conditions 
identical to those for the synthesis of [Ir(dpyx)(µ-Cl)Cl]2 by heating the metal salt 
and ligand at reflux in a mixture of 2-ethoxyethanol and water.  Similarly to the 
case with dpyxH where the resulting dimer is fairly insoluble, the product of the 
reaction with dpytH was a yellow/orange solid which was, in fact, even less 
soluble.  Despite its limited solubility, enough could be dissolved in d6-DMSO to 
give a weak NMR spectrum which was consistent with an N^C^N bound product 
and given the structural similarity with dpyxH, it can be confidently assumed that 
the product was the dimer [Ir(dpyt)(µ-Cl)Cl]2 which is cleaved by DMSO to give 
[Ir(dpyt)(DMSO)Cl2]. 
 
3.2.2 Monometallic complexes for reaction with thiols 
With these two dimers in hand, bridge cleaving reactions could be carried out to 
give monometallic complexes for subsequent reaction with thiols.  The 
synthesis of both charge neutral and cationic complexes was carried out by 
cleaving the dimers with 2-phenylpyridine and 2,2'-bipyridine, respectively, 
under the conditions shown in Scheme ‎3.3.  The synthesis of the highly 
phosphorescent complex [Ir(dpyx)(ppy)Cl] has already been reported47 and the 
data in this case were consistent with those reported.  The analogous 
procedure with [Ir(dpyt)(µ-Cl)Cl]2 resulted in a yellow product which was purified 
by column chromatography and showed an NMR spectrum consistent with the 
expected N^C2 bound complex [Ir(dpyt)(ppy)Cl].  Cleavage of both dimers with 
bipyridine in ethylene glycol was also successful, so in all, the four complexes 
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shown in Figure ‎3.19 were available.  Yields tended to be noticeably lower 
when using the methyl-substituted dipyridylbenzene than its dimethyl analogue, 
and the solubility of the complexes of the former ligand was slightly poorer than 
the corresponding complexes of a dpyx. 
 
 
Figure ‎3.19 Monometallic Ir(N^C^N) complexes prepared incorporating a monodentate chloride 
ligand. 
 
With these complexes, substitution reactions were attempted using three 
different aromatic thiols as well as the ethyl ester of L-cysteine under varying 
conditions.  The latter was selected in place of cysteine itself in order to aid 
solubility and rule out possible competitive binding of the carboxylate group.  
Two general approaches were taken to investigate whether these various 
ligands would substitute the chloride ligand in the 6th coordination site of the 
complexes. 
 
Firstly, the complexes were reacted directly with thiolates in methanol solution, 
obtained by addition of potassium tert-butoxide to the thiols in situ.  These 
reactions were attempted both at room temperature and at reflux.  In a second 
approach, the complexes were treated with silver(I) triflate (AgOTf) in refluxing 
acetone before the addition of a thiolate solution.  This approach is designed to 
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encourage chloride substitution through formation of insoluble AgCl and has 
been shown to be effective in assisting substitutions in the iridium coordination 
sphere.47  The results of these substitution attempts are shown in Scheme ‎3.5. 
 
 
Scheme ‎3.5 Attempted substitutions of the chloride ligand in the [Ir(N^C^N)(N^C)Cl] and 
[Ir(N^C^N)(N^N)Cl]
+
 complexes by thiolates. 
 
NMR data from reactions of the aromatic thiolates with neutral complexes in 
methanol showed evidence of substitution of the chloride ligand, but the yield of 
substituted product was generally very low.  In addition, the resulting products 
were relatively insoluble and difficult to separate from any residual starting 
material, with the exception of 4-nitrothiophenol where the product was soluble 
enough for isolation by column chromatography.  In comparison, the use of 
silver(I) triflate tended to give more complex product mixtures, presenting 
further problems in the isolation of products.  This could be a result of the 
affinity of Ag+ for sulfur producing undesired side-reactions, although no direct 
evidence for this, e.g. the formation of black silver(I) sulfide, was observed. 
 
In the case of the cationic complexes, in attempts at direct substitution in 
methanol it was clear that no reaction was taking place, with the starting 
material being recovered in almost quantitative yield.  The chloride ligand in 
these systems is likely to be less labile than in the equivalent neutral complex, 
owing to the trans effect of the metallating carbon in the latter.  Again, the use of 
AgOTf did not provide better results than the direct reaction with thiolates and 
the only materials isolated from these reactions appeared to be the chloride 
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complex and thiol.  In all cases, the substitutions attempted using ethyl-L-
cysteine gave complex mixtures, most likely as a result of competition between 
N and S bound products. 
 
As a result of these reactions only one complex (shown in Figure ‎3.20), from the 
reaction of [Ir(dpyx)(ppy)Cl] with 4-nitrothiophenol (ntpH), was isolated at a 
satisfactory level of purity but in very low yield.  The 1H NMR spectrum is shown 
in Figure ‎3.21 and shows signals similar to the parent chloride complex with 
eight signals for the ppy ligand, five for the dpyx ligand and an additional two for 
the new ntp ligand.  The reaction of the same complex with 4-methylthiophenol 
(mtpH) gave a product which was identifiable as the substituted complex by 1H 
NMR but this was poorly soluble and of low purity.  1H NMR also hinted at some 
substitution by thiophenol (tpH), however the quality of the sample and 
spectrum was very poor. 
 
 
Figure ‎3.20 [Ir(dpyx)(ppy)(ntp)]. 
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Figure ‎3.21 400 MHz 
1
H NMR spectrum (aromatic region) of [Ir(dpyx)(ppy)(ntp)].  Arrows 
indicate signals from the ntp ligand. 
 
It is possible that the failure in the majority of these substitutions is in part due to 
instability in the desired products.  It is likely that an Ir-S bond in these 
complexes will be quite labile, particularly in the neutral complexes due to the 
trans-carbon.  Any dissociation in aerated solution would lead to the loss of 
thiolate for re-coordination through the formation of disulfides.  The fact that the 
only isolated complex contains the very electron withdrawing nitro group is 
consistent with this proposition, since the lower electron density on sulfur will 
reduce the rate of dissociation.  It would be expected that the Ir-S bond would 
be less labile in [Ir(N^C^N)(N^N)(thiolate)]+ complexes due to the increased 
nuclear charge on the metal centre and lower trans effect of the bipyridine 
nitrogen.  It is therefore likely that in reactions with [Ir(N^C^N)(N^N)Cl]+ 
complexes, substitution of the chloride is not occurring. 
 
3.2.3 Direct reaction of Ir(N^C^N) dimers with thiolates 
In addition to attempts at thiolate substitution in these [Ir(N^C^N)(N^X)] 
complexes, in parallel with the work on bis-bidentate cyclometallated complexes 
the reactivity of the chloride-bridged dimers towards thiolates was also 
explored.  Given the observed tendency for the sulfur ligands to form bridged 
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species, it was of interest what would occur in terdentate dimers in which 
chloride ligands display both bridging and non-bridging coordination modes. 
 
The reaction of [Ir(dpyx)(µ-Cl)Cl]2 was initially attempted with 4-nitrothiophenol 
in methanol at room temperature.  1H NMR data indicated the formation of a 
new species containing both dpyx and ntp fragments, however a large amount 
of starting dimer remained in the sample as well as other impurities.  In contrast, 
treatment with the thiolate, formed by addition of potassium tert-butoxide, in 
refluxing methanol yielded an orange product soluble enough to be purified by 
column chromatography.  The NMR spectrum for this compound showed a set 
of signals consistent with a dpyx ligand as well as two sets of doublets arising 
from distinct ntp fragments.  From the signal integrals, it appeared that these 
ligands were present in the complex in a 1:1:1 ratio of dpyx / ntp / ntp'.  The 
1H NMR spectrum of the product is shown in Figure ‎3.22.  Data from MALDI 
mass spectrometry showed a peak at m/z = 760, which is representative of the 
species [Ir(dpyx)(ntp)2]
+. 
 
 
Figure ‎3.22 400 MHz 
1
H NMR spectrum (aromatic region) showing the product of the treatment 
of [Ir(dpyx)(µ-Cl)Cl]2 with ntpH.  Arrows indicate ntp fragments linked in 
1
H COSY spectrum. 
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The structure of a species conforming to these data was initially difficult to 
rationalise, with the simplest representation consistent with the MALDI MS data 
requiring a 5-coordinate iridium centre.  This species however, does not give 
the required distinction between the two ntp fragments shown in the NMR data.  
Instead, a dimeric structure is proposed similar to that of the starting chloride 
complex where two ntp ligands occupy single coordination sites while two 
others are found in bridging modes.  The proposed structure of this [Ir(dpyx)(µ-
ntp)(ntp)]2 dimer is shown in Figure ‎3.23. 
 
 
Figure ‎3.23 Possible structure of a [Ir(dpyx)(µ-ntp)(ntp)]2 dimer 
 
3.3 Concluding remarks 
A series of iridium complexes containing both bidentate and terdentate 
cyclometalling ligands has been synthesised and the reactivity of these species 
with various sulfur-containing ligands has been explored. 
 
In reactions with [Ir(ppy)2(µ-Cl)]2, two new monometallic complexes with 
pyridines as ancilliary monodentate ligands were synthesised.  While 
subsequent reactions of these complexes with aromatic thiolates did not 
produce the desired monometallic species, a novel class of thiolate bridged 
dimers has been discovered.  One of these, [Ir(ppy)2(µ-ntp)]2, displayed a 
remarkable solid-state vapochromic effect although the specific cause of this 
remains unclear.  While it seems generally the case that in their synthesis these 
new dimers adopt a racemic mixture of , and , configurations of the iridium 
centres, a small amount of the kinetic , (or meso) isomer of [Ir(ppy)2(µ-mtp)]2 
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was also synthesised and its stereochemical assignment has been confirmed 
by NMR and computational data.  This isomer, however, appears to undergo 
interconversion to the more thermodynamically stable racemic form when left in 
solution. 
 
It has also been shown that in the use of terdentate N^C^N ligands, a single 
methyl group in the ligand 3,5-di(2-pyridyl)toluene is sufficient to overcome 
issues with C2/C4 competitive binding to iridium.  While subsequent reactions of 
thiols with mononuclear complexes containing an N^C^N and a single bidentate 
ligand were mostly unsuccessful, some products were obtained and it is 
possible that by refining the reaction conditions, compounds of the type 
[Ir(N^C^N)(N^C)(thiolate)] and [Ir(N^C^N)(N^N)(thiolate)]+ could be made for 
study.  Reactions of aromatic thiolates directly with N^C^N containing dimers, 
however, did produce a novel compound with thiolates in both bridging and non-
bridging sites. 
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4 Potential luminescent PDI Mimics 
 
One of the main aims of this project was to produce novel compounds that 
might mimic the activity of Protein Disulfide Isomerase while displaying some 
fluorescence or phosphorescence that would allow their use in probing sub-
cellular sites of activity through visual assays such as fluorescence microscopy. 
 
It is clear from the structure of the PDI active site that its isomerase activity 
proceeds via thiol/disulfide interchange reactions between itself and the 
substrate.  As discussed previously, the reactivation of scrambled Rnase 
enzymes can be accelerated by a wide variety of thiol containing molecules, so 
any potential molecular mimic must therefore contain at least one thiol group 
that is free to engage in similar interactions. It would be preferable, though, to 
have two thiol groups to more accurately model the Cys-Gly-His-Cys active site, 
as shown in studies with (±)-trans-1,2-bis(2-mercapto-acetamido)cyclohexane 
(BMC) versus N-methylmercaptoacetamide (NMA)95 (shown in Figure ‎4.1).  The 
studies with BMC and NMA showed that while the mono thiol did show mimic 
activity, it was lower than the corresponding dithiol and the latter showed a 
lower tendency to become „trapped‟ due to its ability to escape from a catalyst-
substrate complex in the same manner as PDI (Section ‎1.2.1.1) 
 
 
Figure ‎4.1 BMC and NMA. 
 
Given that it is the expressed aim of the project to produce, in particular, 
fluorescent PDI mimics, two initial approaches to potential targets were 
envisaged.  Firstly, the direct functionalisation of an appropriate fluorescent 
molecule, or secondly the synthesis of an independent unit with the functionality 
of a potential PDI mimic which could be attached covalently to a range of 
fluorophores using, for example, peptide coupling chemistry or a cross-coupling 
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reaction.  It was decided that since BMC had been proven to show PDI mimic 
activity, its structure would provide a sensible motif for any target molecules.  
The synthesis of BMC is shown in Scheme ‎4.1, and it is clear that, potentially, 
any diamine can be functionalised in the same way. 
 
 
Scheme ‎4.1 Synthesis of BMC.
99
 
 
With regards to the desired fluorescence in the target molecules, there are 
many possible options to explore ranging from simple aromatics such as 
anthracene, as well as other more biocompatible organic compounds common 
in biological fluorescence labelling such as coumarin, dansyl or fluorescein 
derivatives.  Another possible group of emitters would be luminescent transition 
metal complexes.  As previously discussed, complexes of metals such as 
ruthenium and iridium with polypyridyl or phenylpyridine ligands display stable 
long-lived emission in fluid solution.  Such compounds could prove very useful 
in providing the potential for time-resolved fluorescence studies, given the 
possibility that in combination with the thiol/disulfide functionality there may be a 
significant difference in fluorescence lifetime between oxidised and reduced 
forms as a result of electron transfer quenching.  The expected long lifetimes of 
transition metal phosphors would also be useful in avoiding interference from 
autofluorescence as discussed in Section ‎1.4.2.  A further advantage in the use 
of transition metal complexes over organic emitters is the relative ease with 
which the colour of emission can be altered giving more flexibility in imaging 
applications. 
 
Synthetically, the use of d6 transition metal complexes with polypyridyl and 
cyclometallating ligands would also allow a varied approach to possible targets. 
It has been established that when correctly functionalised, certain complexes of 
this class readily undergo cross-coupling reactions to form elaborated systems 
or even multimetallic complexes,48 so a similar approach could be used to 
attach a fluorescent complex to an appropriate mimic structure by similar 
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methods.  Alternatively, the design of a functionalised ligand would provide the 
opportunity to form a complex directly. 
 
It was anticipated that complications might arise from the easily oxidised dithiol 
motif of any target molecules, especially in cases where these structures would 
have to undergo further reactions to reach a final target – for example in a case 
where a mimic structure is coupled to a separate fluorophore.  Fortunately, as is 
the case in the synthesis of BMC, thiol groups can be introduced to a molecule 
in a protected form and so possible synthetic routes were devised with this in 
mind, allowing the deprotection of the thiol groups to always be performed as a 
final step. 
 
4.1 Aromatic diamines as cores for the synthesis of BMC-like 
units 
As discussed there are potentially several approaches to the formation of a 
complete mimic structure, either by direct functionalisation or a coupling 
methodology.  It was therefore decided to attempt the synthesis of different 
classes of diamines that could be of use in these various approaches. 
 
4.1.1 Functionalised units for cross-coupling to a fluorophore 
Initially, the synthesis of brominated aromatic analogues of BMC was attempted 
to provide possible mimic structures attachable by cross-coupling reactions.  
Both 4-bromo-1,2-phenylenediamine and 5-bromo-2,3-diaminopyridine are 
available as starting materials and so these were used as the starting point of 
synthetic routes analogous to that for BMC. The pyridine analogue, however, 
did not react cleanly with chloroacetyl chloride, producing a complex mixture of 
products.  The 1,2-phenylenediamine on the other hand reacted as expected 
and was taken to the next stage by reaction with thioacetic acid.  The product at 
this stage, however, was difficult to obtain to a sufficient level of purity and 
showed a tendency to decompose.  These reactions are summarised in 
Scheme ‎4.2. 
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Scheme ‎4.2 Attempts to repeat BMC-like synthesis with aromatic bromides. 
 
Despite this instability, a test reaction to determine whether this was a suitable 
aryl halide for cross-coupling reactions was carried out.  A Suzuki reaction was 
attempted with a functionalised bipyridine in the hope that this would produce a 
ligand for use in a transition metal complex.  The functionalised bipyridine was 
prepared using the Miyaura borylation reaction which is a convenient method to 
convert aryl bromides into boronate esters for use in Suzuki couplings.214  This 
reaction follows a similar mechanism to palladium catalysed cross-coupling 
reactions only a C-B bond is formed, rather than a C-C bond (Scheme ‎4.3). 
 
 
Scheme ‎4.3 General mechanism of a Miyaura borylation reaction. 
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No product could be isolated from the Suzuki coupling since the apparent 
instability of the bromide starting material was also observed in the product 
mixture with products tending to decompose during column chromatography.  
Scheme ‎4.4 shows the Miyaura coupling to produce a boronate ester 
substituted bipyridine ligand and the subsequent Suzuki attempt. 
 
 
Scheme ‎4.4 
 
4.1.2 A diamine functionalised N^N ligand 
As well as this initial approach towards functionalised linkers, attempts were 
made to produce a directly functionalised diimine ligand for use with transition 
metals such as iridium.  It has been reported that 5,6-diamino-1,10-
phenanthroline (phen-diamine) can be synthesised under mild conditions from 
1,10-phenanthroline-5,6-dione (phen-dione), as well as this conversion being 
possible with the ligand already coordinated to ruthenium215 as shown in 
Scheme ‎4.5.  This would provide two options for synthesis of a potential target 
with functionalisation of the diamine either before or after coordination to a 
metal. 
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Scheme ‎4.5 The conversion of 1,10-phenanthroline-5,6-dione to 5,6-diamino-1,10-
phenanthroline as both a free and coordinated ligand.
215
 
 
Attempts to react the uncoordinated 5,6-diamino-1,10-phenanthroline with 
chloroacetyl chloride were unsuccessful, with reactions tending to give complex 
mixtures.  Any attempt to purify by column chromatography returned only 
starting material and it appeared that the product was unstable on the column.  
It is likely that this aromatic diamine, being very electron rich, is prone to 
oxidation which could be a factor in the complex reaction mixtures and 
instability of the product.  No specific side-products could be identified to try and 
determine more specifically why this reaction was unsuccessful. 
 
Since the functionalisation of this ligand was not possible in its uncoordinated 
form, it was decided to try and prepare complexes with the phenanthroline 
diamine or dione ligand before attempting to add the mimic structure.  It is 
possible that by coordination to a metal, the oxidative instability of this system 
could be lessened, as the electron richness of the aromatic system would be 
attenuated by bonding to the metal. 
 
Complexes of iridium(III) containing two 2-phenylpyridine ligands and a diimine 
ligand are usually easily prepared from the dimer tetrakis(2-phenylpyridine)(µ-
dichloride)diiridium(III) (Figure ‎4.2) and the appropriate diimine ligand as 
discussed in Section ‎3.1. 
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Figure ‎4.2 [Ir(phpy)2(µ-Cl)]2 
 
Initially, the synthesis of a complex with 5,6-diamino-1,10-phenanthroline was 
attempted but this ligand failed to react cleanly with the iridium dimer, possibly 
as a result of alternate binding modes introduced by the ortho-diamine 
structure.  Instead, the ligand 1,10-phanthroline-5,6-dione was reacted with the 
dimer to give the corresponding mononuclear complex [Ir(phpy)2(phen-
dione)]PF6.  Since it has been reported that this ligand could be converted to 
the diamine via the hydroxyl imine while coordinated to ruthenium it was 
expected that a similar conversion could be carried out here.  When treated with 
hydroxylamine, however, the only product that could be identified was the 
complex where only one of the two ketones had undergone the conversion to 
the hydroxyl imine (Scheme ‎4.6). 
 
 
Scheme ‎4.6 Direct and indirect attempts to synthesise a diamine-containing iridium complex. 
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4.1.3 Directly functionalised organic emitters 
In addition to the attempted functionalisation of phenylenediamine type 
compounds and the phenanthroline ligand and complex, it was also decided to 
explore the possibility of directly functionalising an organic fluorescent molecule 
and so anthracene derivatives were selected as a simple starting point.  While 
the emissive properties of anthracene are not as tuneable and long-lived as 
those available from transition metal complexes, it does display relatively strong 
blue emission.216  As a relatively simple system it was also expected that there 
should be few complications in the synthesis of potential mimics based on this 
structure.  2-Aminoanthracene is available and 1,8-diaminoanthracene can be 
obtained by the reduction of 1,8-dinitroanthraquinone.217,218  The use of these 
two amines as staring materials would provide singly and doubly functionalised 
compounds respectively which, as well as both being potential mimics, also 
provide the opportunity to study the difference in activity between the two. 
 
Attempts to repeat the one step reduction of 1,8-dinitroanthraquinone with 
NaBH4 as reported in ref 218 were unsuccessful so instead the reduction was 
performed with Sn/HCl giving 1,8-diaminoanthraquinone. This was then 
subsequently reduced to the diamine with NaBH4.  Unfortunately a pure product 
could not be isolated from the reaction of this diamine with chloroacetyl chloride.  
The equivalent reaction with 2-aminoanthracene, on the other hand, did 
proceed as expected, as did the substitution of chloride with thioacetate, 
however the products throughout these steps were difficult to purify by column 
chromatography or recrystallisation and showed some tendency towards 
decomposition.  All attempts to deprotect the thiol group to give the final 
structure gave only complex mixtures.  These reactions are summarised in 
Scheme ‎4.7. 
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Scheme ‎4.7 Attempted syntheses of anthracene based mimics. 
 
All the synthetic routes described have utilised aromatic amines, unlike the 
aliphatic amines in the structure of BMC.  It is possible that problems 
encountered during the substitution reaction with chloroacetyl chloride could be 
the result of the lower nucleophilicity of aromatic amines compared to their 
aliphatic counterparts, although it would be expected that the reaction should 
still proceed due to the reactivity of the acyl chloride unit.  It is feasible that a 
slower rate in the substitution at the carbonyl group could lead to an 
intramolecular cyclisation reaction with chloroacetyl chloride rather than two 
intermolecular substitutions as desired.  Unfortunately, no evidence of any side 
reaction in particular was found to provide clues of where the problems were 
arising.  It was the case, in fact, that the majority of compounds handled in 
these reaction steps showed a tendency towards decomposition, with most 
reactions producing complex mixtures in which it was difficult to identify any 
individual components or products degrading to dark insoluble matter.  It may, 
then, be the case that, due to the very electron rich nature of the aromatic 
diamine structure, most of these compounds are prone to oxidation leading to 
the observed instability of the desired intermediate compounds. 
 
4.2 Non-aromatic diamines 
Given the lack of success with aromatic diamines it was decided to continue 
with a similar approach to the synthesis of a potential mimic but using aliphatic 
amines instead of the problematic aromatic amines. 
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4.2.1 Non-aromatic diamines with cross-coupling potential 
With this in mind it was decided to follow a synthesis analogous to that shown in 
Scheme ‎4.4 above, but, instead of an ortho-phenylenediamine structure, to use 
a starting compound like that shown in Figure ‎4.3.  Here, a CH2 spacer has 
been introduced to insulate the amines from the aromatic ring.  While this small 
molecule is not commercially available, a synthetic route, shown in Scheme ‎4.8, 
adapted from one reported for the synthesis of 4-bromophthalonitrile,219 was 
devised. 
 
 
Figure ‎4.3 
 
 
Scheme ‎4.8 Possible routes to 3,4-di(aminomethyl)bromobenzene. 
 
The steps up to the synthesis of the diamide were completed successfully and 
several attempts were made to reduce this product directly to the diamine using 
I2/NaBH4.
220  While there was evidence of the desired product shown by mass 
spectrometry, the reaction did not proceed cleanly so it was decided instead to 
perform the conversion to the nitrile compound using phosgene.  This approach 
proved advantageous in that the phthalonitrile compound could be obtained 
easily, in high yield and was relatively easy to purify by column 
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chromatography.  Also, given that the intent in this approach was leading 
towards a cross-coupling reaction with a fluorescent moiety or possible 
transition metal ligand, this structure provided a useful point within the overall 
scheme for the cross-coupling to be carried out.  The nitrile groups present at 
this stage would be unlikely to interfere with a cross-coupling reaction whereas, 
if the coupling were carried out at a later stage, the functional groups present 
(namely amine, amide and thioester added sequentially) would possibly cause 
complications with the cross-coupling reaction.  It was therefore decided at this 
stage to couple the 4-bromophthalonitrile with a bipyridine unit using a Suzuki-
Miyaura coupling as shown in Scheme ‎4.9. 
 
 
Scheme ‎4.9 Miyaura Borylation and Suzuki-Miyaura coupling to give a functionalised bipyridine 
ligand. 
 
At this point it would be possible to use this bipyridine unit as a ligand to form a 
complex with iridium before subsequent functionalisation.  However, since the 
next step in functionalisation involves the reduction of nitriles to amines, it was 
decided to delay the formation of the complex until a later stage to avoid 
exposing it to reagents such as borane or NaBH4.  However, upon the 
attempted reduction of the nitriles with BH3.THF, a pure product could not be 
isolated from the reaction.  Similarly, attempts to perform the reduction with 
NaBH4 were also unsuccessful.  While it seemed that some product was formed 
by the reaction, the components in the mixture were highly immobile or streaky 
in column chromatography.  It was therefore not possible to purify the product 
by this means, and the mixture did not seem suitable for purification by 
recrystallisation or distillation. 
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4.2.2 Organic emitters with non-aromatic amine substituents 
In another approach analogous to the synthetic route attempted with 
anthracene, the option of functionalising a different organic fluorophore with 
non-aromatic amines was investigated.  The phenolic structures in fluorescein 
(shown in Figure ‎4.4) will undergo Mannich reactions to form amines and this 
approach had previously been used to synthesise fluorescent sensors for metal 
ions in biological systems.221,222  These sensors were produced using the 2,7-
dichlorofluorescein derivative, to ensure that substitution occurred only at the 4 
and 5 positions of the molecule.  While in these reports, the Mannich reactions 
were performed with secondary amines, giving tertiary amine products, if this 
reaction would proceed with ammonia the resulting primary amines could be 
functionalised to give a possible mimic. 
 
 
Figure ‎4.4 Fluorescein 
 
Mannich reactions were therefore attempted using 2,7-dichlorofluorescein with 
both aqueous ammonia and ammonium chloride to give the primary amines 
required for functionalisation, however the products isolated from the reaction 
were highly insoluble and could not be positively identified as the required 
diamine.  The only component identified was the starting material, which was 
detected in negative electrospray mass spectrometry.  It was unclear, however, 
whether the material was a mixture of products including some starting material 
or whether there had been no reaction. 
 
In an attempt to overcome this problem with insolubility, Mannich reactions were 
instead performed with benzyl amines with the intention of subsequently 
removing the benzyl groups by hydrogenation.  These reactions were carried 
out using both benzylamine and dibenzylamine which would give secondary 
and tertiary amine products respectively.  The reactions carried out with 2,7-
dichlorofluorescein are summarised in Scheme ‎4.10. 
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Scheme ‎4.10 Attempted Mannich reactions with 2,7-dichlorofluorescein and subsequent 
deprotection of amines. 
 
In the reaction with benzylamine the products were, again, very insoluble and 
could not be identified.  The reaction with dibenzylamine, on the other hand, 
resulted in a red solid that could be purified by column chromatography, 
although the yield was very low.  This was identified as the expected product of 
a Mannich reaction by mass spectrometry, however evidence that it was the 
correct product was less clear using NMR spectroscopy due to the large 
number of overlapped benzyl aromatic signals.  When this product was treated 
with hydrogen gas in the presence of 10% palladium on activated carbon as a 
catalyst in methanol, a red/purple precipitate was produced.  When isolated, 
though, this again was too insoluble to be positively identified as the desired 
primary diamine. 
 
By this point there had been very little success, for various reasons, in 
synthesising a potential PDI mimic structure, even without the attachment of a 
fluorescent unit to give a finished target molecule.  As discussed previously, the 
reactions using aromatic amines were problematic in terms of stability, while up 
to this point, a system with aliphatic amines suitable for functionalisation had not 
yet been synthesised successfully.  It was therefore decided to look into 
alternate strategies for the synthesis of a mimic structure that would perhaps 
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cause fewer complications.  While it is the case that a variety of structures 
containing thiol groups have been shown to isomerise non-native disulfide 
bonds in proteins, the functional groups used by PDI itself are, of course, 
cysteine residues.  In light of this, it seemed feasible that the amino acid 
cysteine could be used as the mimic part of a final target, and could be attached 
to a variety of structures by the formation of an amide with either an amine or a 
carboxylic acid. 
 
4.3 Cysteine as a mimic structure 
Amides are found in many natural molecules as well as being a common 
feature in many compounds with pharmaceutical relevance and as such, their 
synthesis has been studied in depth.223  They are, of course, ubiquitous in 
biological systems given that all proteins rely on the amide functional group as 
the covalent link between amino acids in their primary structure.  The formation 
of an amide between cysteine and an appropriate fluorophore or linker could 
provide a simple, one-step addition of a potential mimic structure.  It is possible 
to attach cysteine to the fluorophore via either its amine or acid group as shown 
in Figure ‎4.5, however, given the lack of success so far in the synthesis of 
appropriate amines, it was decided to concentrate on the synthesis of carboxylic 
acid functionalised linkers and fluorescent molecules. 
 
 
Figure ‎4.5 
 
In using an amide to link cysteine to a fluorophore, the unused amine or 
carboxylic acid group will remain unbound.  It was therefore considered that the 
need may arise for the use of a protecting group to mask this functional group in 
order to avoid possible side reactions or reactivity in the final product.  Bearing 
this in mind, the coupling of cysteine through its amine functional group would 
also be advantageous in comparison to a coupling using the carboxylic acid due 
to the possible protecting groups for the unused functional group. The 
carboxylic acid can easily be protected as a relatively small ester group while 
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appropriate protecting groups for the amine such as FMOC or BOC groups 
would be much larger and could introduce steric problems to the action of a 
mimic. 
 
In order to determine whether this approach was worth following, the formation 
of a diamide was attempted by the reaction of phthalic acid with L-cysteine ethyl 
ester using the peptide coupling reagent 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride (EDCI).  This reaction did not proceed cleanly, 
however, possibly as a result of steric hindrance with the acid groups being 
ortho to one another.  Instead, the reaction was attempted with 5-
bromoisophthalic acid, obtained by diazotisation of 5-aminoisophthalic acid 
ethyl ester and subsequent copper catalysed reaction with bromide.  It was 
expected that this would reduce these steric factors and the desired diamide 
was successfully isolated as shown in Scheme ‎4.11.  Purification of this 
compound was not straightforward as in solution it showed a tendency to 
degrade, almost certainly through the formation of intra and intermolecular 
disulfides through oxidation.  It could be stored for a few weeks under nitrogen 
when dry with only a small amount of apparent degradation. 
 
 
Scheme ‎4.11 Peptide couplings of phthalic acid derivatives with L-cysteine ethyl ester. 
 
4.3.1 Carboxylic acid functionalised luminophores 
Having established that the isophthalic acid structure could successfully be 
coupled to cysteine, it became necessary to devise a fluorescent probe 
containing this, or a similar structure. 
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4.3.1.1 Diacids suitable for cross-coupling reactions 
The compound 5-bromoisphthalic acid which was used in the peptide coupling 
should in principle undergo cross-coupling reactions and so initially, attempts 
were made to perform a Suzuki reaction with anthracene-9-boronic acid to give 
a fluorescent diacid which could then be reacted with cysteine to give a 
potential mimic.  Unusually, this reaction did not proceed as expected, with the 
only product identified being the result of deborylation of the anthracene starting 
material, i.e. anthracene itself.  One possibility for the lack of reaction with the 
bromide is interference by the carboxylic acid groups so an alternate method 
was tried where these were protected as esters for the cross-coupling reaction. 
 
In a reaction analogous to the preparation of 5-bromoisophthalic acid it is 
possible to react the diazotised compound with potassium iodide under milder 
conditions which does not give concurrent hydrolysis of the methyl esters.  It 
was therefore decided to try the cross-coupling with dimethyl-5-
iodoisophthalate, prepared in this manner.  This reaction was attempted several 
times and while a trace amount of the required product was sometimes 
obtained, most of the material recovered from the reaction was, again, 
anthracene or the starting halide compound.  It is has been shown that similar 
problems with deborylation in Suzuki couplings are more common with aryl 
boronic acids with sterically hindering ortho substituents,224,225 however in many 
cases these problems can be overcome through varying the reaction 
conditions.226,227  The sterically hindered position of the boronic acid on the 
central ring of anthracene was therefore likely to be the cause of the resulting 
deborylation.  A highly active class of palladium catalysts with N-heterocyclic 
carbene (NHC) ligands for use in Suzuki228 and Negishi229 had recently been 
reported and so a further attempt at the coupling was made using one of these 
PEPPSI™ catalysts.  The conditions used in this reaction, however, also failed 
to yield the desired product.  The results of these attempted cross-couplings are 
illustrated in Scheme ‎4.12. 
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Scheme ‎4.12 Attempted cross-coupling reactions with anthracene-9-boronic acid. 
 
In light of the problems associated with anthracene-9-boronic acid various other 
cross-coupling strategies were attempted to achieve the desired functionalised 
anthracene unit.  If the functional groups used in the previous Suzuki coupling 
were reversed, i.e. with a halide substituted anthracene and a boronate ester or 
boronic acid funtionalised isophthalic acid, this could avoid the steric issues 
observed in the previous attempts.  Using dimethyl-5-iodoisophthalate as a 
starting material, several Miyaura borylation reactions were performed to give a 
boronate ester which could subsequently be coupled with 9-bromoanthracene 
as shown in Scheme ‎4.13.  The initial Miyaura reaction, however, did not yield 
the expected boronate ester but instead, the major product was the 
tetrasubstituted biphenyl compound tetramethyl-1,1'-biphenyl-3,5,3',5'-
tetracarboxylate.  It appeared that the boronate ester produced in the coupling 
was reacting immediately with unreacted starting material under the reaction 
conditions to give this homo-coupled product. 
 
 
Scheme ‎4.13 Unexpected homo-coupled product from Miyaura coupling. 
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An alternative cross-coupling reaction to the Suzuki coupling is the Stille 
reaction where an arylstannane is used in place of an arylboronic acid or ester.  
Appropriate stannanes can be formed by treatment of an aryl halide with n-BuLi 
followed by addition of a trialkylstannyl chloride.  It was therefore decided to 
attempt this methodology using 9-bromoanthracene with the resulting stannane 
used in a Stille reaction with dimethyl-5-iodoisophthalate.  The formation of 
stannanes of anthracene was attempted using both tri-n-butylstannyl chloride 
and trimethyl stannyl chloride (Scheme ‎4.14) however reactions using both of 
these reagents failed to yield a functionalised anthracene compound.  While 
lithiation of the 9-bromoanthracene appeared to occur during the reaction 
evidenced by a rapid colour change from colourless to yellow upon addition of 
n-BuLi, after quenching with the stannyl chlorides the only product that was 
obtained from the reaction was unsubstituted anthracene, in one case 
recovered in 90% yield. 
 
 
Scheme ‎4.14 The formation of anthracene-9-stannanes via lithiation with n-BuLi. 
 
Finally, in addition to the cross-coupling reactions with anthracene, a Suzuki 
coupling was also attempted with dimethyl-5-iodoisophthalate and (4-(2,2'-
bipyridin-4-yl)phenyl)(neopentyl glycolato)boron (Scheme ‎4.15) however no 
products could be isolated from this reaction. 
 
 
Scheme ‎4.15 Suzuki coupling to give a functionalised bipyridine ligand. 
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4.3.1.2 Functionalised dansyl compounds 
Since there had been little success in using cross-coupling methods to 
synthesise a carboxylic acid functionalised emitter, a new approach was begun 
utilising the dansyl group as the fluorescent unit.  Dansyl chloride has been 
used extensively in many sensing applications from early work in peptide and 
protein sequence determination through to modern chemosensing 
applications.230,231,232  A distinct advantage of dansyl chloride is that it will react 
readily with most amines to form a relatively stable sulfonamide link, a property 
that led to its early use in labelling N-terminal peptide residues.  Since the 
molecule 5-aminoisophthalic acid dimethyl ester was already being used as a 
starting material for the halo-isophthalates discussed above, it was thought that 
the formation of a sulfonamide between dansyl chloride and this amine would 
lead very simply to a fluorescent unit with the possibility for coupling to cysteine. 
 
 
Scheme ‎4.16 Formation of a sulfonamide linked fluorophore and diacid species. 
 
It was expected that the reaction of dansyl chloride with dimethyl-5-
iodoisophthalate in the presence of a base would lead to a sulphonamide-
coupled product, and subsequent hydrolysis of the methyl esters would then 
give the desired fluorescent diacid (Scheme ‎4.16).  Initially, the reaction was 
performed using DMAP as the base, but it transpired that this base was in fact 
strong enough to allow the resulting sulfonamide to react a second time with 
dansyl chloride and the N,N-bis dansyl structure shown in Scheme ‎4.17 was the 
only product isolated.  While this structure could be of interest, the desired 
mono sulfonamide would be a simpler, lower molecular weight alternative.  The 
reaction was therefore repeated using a weaker base, pyridine, giving the 
required mono sulfonamide in good yield. 
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Scheme ‎4.17 Unexpected and desired products of the reaction of dimethyl-5-aminoisophthalate 
with dansyl chloride. 
 
The methyl esters of this compound were then successfully hydrolysed under 
basic conditions to give the dicarboxylic acid.  In addition, since 4-aminobenzoic 
acid is commercially available, this was also reacted with dansyl chloride to give 
a comparable structure which would only be singly functionalised (Scheme 
‎4.18).  As discussed previously with reference to functionalised anthracenes, 
this pair could provide useful comparisons between singly and doubly 
functionalised mimics should they lead to a successful mimic structure. 
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Scheme ‎4.18 Final steps to singly and doubly acid functionalised dansyl-based fluorophores 1a 
and 2a. 
 
Here, then, were two acid functionalised emitters 1a and 2a that could be 
coupled to cysteine in order to give potential fluorescent PDI mimics. 
 
4.3.1.3 Carboxylic acid functionalised iridium complexes 
It was desirable to have as many structures as possible to provide a wider 
range of mimic structures, in particular, transition metal complexes were still of 
great interest given their longer luminescence lifetimes.  While the first attempts 
to produce a bipyridine ligand by the Suzuki coupling shown above in Scheme 
‎4.15 were unsuccessful, it was decided not to continue with this particular 
approach as a simpler, more compact solution presented itself.  It was reported 
around this time that the directly functionalised bipyridines 4-carboxy-4'-methyl-
2,2'-bipyridine (cmbpy) and 4,4'-dicarboxy-2,2'-bipyridine (dcbpy) could be used 
as ligands in complexes with iridium and rhodium233 and such compounds are 
emissive at room temperature in oxygenated solution.  Such complexes would 
be ideal for attempted couplings with cysteine to form mimic structures and so 
the iridium complexes shown in Figure ‎4.6 were synthesised according to the 
reported procedure.  This provided two more fluorescent units, 3a and 4a, to be 
coupled with cysteine, again as a pair to compare any difference in activity 
between a single thiol and a dithiol. 
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Figure ‎4.6 Iridium complexes [Ir(ppy)2(cmbpy)]PF6 (3a) and [Ir(ppy)2(dcbpy)]PF6 (4a) with 
carboxylic acid functional groups. 
 
In addition to these two iridium complexes, the same bipyridine ligands were 
also used to prepare iridium complexes with a terdentate N^C^N 
cyclometallated structure as shown in Scheme ‎4.19.  Synthesis of this type of 
[Ir(N^C^N)(bpy)Cl]PF6 complexes was performed at high temperature in 
ethylene glycol in a method analogous to the incorporation of terpyridines into 
Ir(N^C^N) complexes,47 however in this case reactions performed in this solvent 
tended to give glycol esters of the required product.  To resolve this issue the 
reactions were carried out under the same conditions, only using triglyme as a 
solvent instead.  It also transpired that in this case, silver(I) triflate was needed 
to encourage cleavage of the chloride bridged dimer, where normally, when 
these reactions are carried out at high temperature, this is not required. 
 
 
Scheme ‎4.19 Synthesis of carboxylate functionalised [Ir(dpyx)(N^N)Cl]
+
 complexes 5a and 6a. 
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4.3.2 Peptide coupling reactions with cysteines 
It was now required to find conditions under which these various carboxylic 
acids 1a-6a could be reliably coupled to cysteine in order to give a library of 
potential mimics.  Initially, conditions similar to those used for the synthesis of 
di(O-ethyl-L-cysteinyl)-5-bromoisophthalamide using EDCI as a coupling 
reagent were used.  While in some cases the desired products were detected 
by mass spectrometry, invariably these reactions did not proceed cleanly or fully 
to completion giving mixtures of singly and doubly functionalised fluorophores.  
Reactions with L-cysteine ethyl ester were also attempted via the formation of 
acid chlorides from the respective acids.  In reactions where a significant 
amount of product was obtained, purification of these products proved 
problematic.  Due to the ease of oxidation of the free thiols in these products, 
attempts to purify these compounds by recrystallisation or column 
chromatography resulted in mixtures equally or more complex than the initial 
reaction products.  Evidence from mass spectrometry suggested that oxidative 
disulfide formation could be responsible for some of this observed instability.  In 
the case of the singly functionalised compounds this was necessarily 
intermolecular disulfide formation while the doubly functionalised mimics 
showed more complex mixtures of possible intermolecular and intramolecular 
disulfides. 
 
It was decided to attempt the couplings with a range of S-protected cysteines 
that would give products stable enough to be isolated and purified which could 
then be deprotected when required.  Various methods of amide formation were 
attempted with several different protected cysteines which were either obtained 
from commercial sources or synthesised as shown in Scheme ‎4.20. 
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Scheme ‎4.20 Preparation of non-commercially available protected cysteines. 
 
The results of the various couplings are summarised in Table ‎4.1.  For reactions 
using carbodiimide coupling reagents the carboxylic acids were treated with the 
carbodiimide at 0 C before addition of the cysteine derivative.  Where attempts 
were made using either acid chlorides or N-hydrosuccinimide (NHS) active 
esters as intermediates, the starting acids were reacted to form the intermediate 
and the crude product redissolved after work-up and treated with the cysteine 
derivative.  The majority of reactions were tested on the acids 2a and 3a as 
more of these two materials were available at the time. 
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Cysteine Acids used Conditions* Result 
CO2Et
H2N
SH
 
2a EDCI Incomplete 
 2a EDCI, HOBt Incomplete 
 2a EDCI, Heat No Product 
 2a SOCl2 No Product 
 2a, 3a, 4a (COCl)2 No Product.  Evidence 
of SM for 3a 
CO2Et
H2N
S NHEt
O  
2a (COCl)2 No product 
 2a, 3a EDCI Some impure product.  
Failure in deprotection 
CO2H
H2N
S NHEt
O  
3a EDCI Acetyl transfer giving 
EDU
†
 adduct 
 2a EDCI, HATU, DMAP No Product 
CO2H
H2N
S
S  
2a EDCI, HATU, DMAP No Product 
 1a, 2a, 3a NHS, DCC No Product.  Some 
starting materials 
recovered 
 2a NHS, EDCI No Product 
CO2Me
H2N
S
S  
1a-6a EDCI Successful coupling.  
Products stable in 
column 
chromatography except 
N^C^N complexes 
Table ‎4.1 Peptide coupling reactions. 
 
There was some success in the coupling of S-(N-ethylaminocarbonyl)-cysteine 
ethyl ester using EDCI, where the correct products were obtained and 
purification was feasible using column chromatography, although the products 
tended to separate poorly from some impurities.  Attempts to remove the 
carboxamide protecting groups using NaHCO3 (aq), a pH 10.6 NaHCO3/NaOH 
buffer or 0.1M NaOH were unsuccessful, with only unreacted material 
recovered from the reaction.  However, when the deprotection was attempted 
on the singly functionalised iridium complex, 3a, using 1M NaOH, the product 
                                            
*
 Reactions were either carried out in dry THF for the organic fluorophores or a mixture of dry 
THF and either DCM or dry acetonitrile for iridium complexes where solubility in pure THF was 
poor. 
†
 Ethyl(3-(N,N-dimethylamino)propyl)urea 
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isolated was not the free thiol as expected but the complex shown in Figure ‎4.7, 
identified by HRMS.  It was theorised that instead of attack of hydroxide as a 
nucleophile at the carboxamide functional group, the hydroxide acted as a base, 
removing the ester -hydrogen leading to loss of sulfur as shown in Scheme 
‎4.21.  This is unusual since the original report of the use of this protecting group 
found no evidence of dethiolation.234 
 
 
Figure ‎4.7 Unexpected product of deprotection. 
 
 
Scheme ‎4.21 Mechanisms for the desired removal of carboxamide protecting group (above) 
and the undesired dethiolation reaction (below). 
 
It was therefore decided to attempt the coupling with the free acid equivalent, S-
(ethylaminocarbonyl)-L-cysteine, since the -hydrogen in this case would not be 
acidic so this side reaction could be avoided.  However, as with all the coupling 
reactions attempted on cysteines with unprotected acid functional groups, no 
product was obtained. 
 
In fact, as noted in Table ‎4.1, when this cysteine was reacted with 3a, there was 
evidence from mass spectrometry of acetyl transfer after reaction with EDCI 
giving an N-acylurea species as shown in Scheme ‎4.22.  This tends to occur in 
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the use of carbodiimides when reaction with the amine is very slow allowing the 
competing intramolecular acetyl transfer reaction to take over. 
 
 
Scheme ‎4.22 Acetyl transfer giving N-acylurea in reactions with carbodiimides. 
 
In the end, S-(tert-butylmercapto)-L-cysteine methyl ester was found to give 
reproducible results in couplings using EDCI with compounds 1a-4a giving 
products stable enough to isolate and purify by column chromatography.  As a 
result of these reactions the four compounds, 1b-4b, shown in Figure ‎4.8 were 
available for testing as potential PDI mimics.  Given the likelihood of instability 
with respect to oxidation after deprotection, these compounds were stored in 
their protected forms until required for assays. 
 
 
Figure ‎4.8 S-protected potential luminescent PDI mimics 1b, 2b, 3b and 4b. 
 
Reactions using the two Ir(N^C^N) complexes 5a and 6a, however, were less 
successful, yielding mixtures of products.  The desired compounds were 
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possibly isolated in low yield by column chromatography and identified by mass 
spectrometry, however these products were not sufficiently pure and their 
identity could not be confirmed by other spectroscopic methods such as NMR.  
In the case of the singly functionalised complex 5a, one of the major side 
products isolated and identified (in approx 50% yield) was the acetyl transfer 
product, indicating that one possible issue with these structures is slow 
reactivity between the EDC activated acid and the cysteine amine.  
Unfortunately, despite these complexes with terdentate ligands showing 
promise, a lack of material and insufficient time to synthesise fresh complexes 
meant that the synthesis of potential mimics using these particular 
luminophores could not be completed. 
 
4.3.3 Deprotection of potential mimics 
With the four potential mimics in hand in their protected forms, some assays 
could be performed on these compounds in their own right as discussed later in 
the chapter.  For the purposes of the project, however, it was necessary to have 
some samples of these compounds as free thiols.  It was therefore necessary to 
determine conditions suitable for the removal of the S-tert-butyl protecting 
groups. 
 
 
Figure ‎4.9 The reducing agents DTT and TCEP. 
 
Common methods for the reduction of disulfide bonds in biological systems 
involve the use of thiols such as 2-mercaptoethanol, dithiothreitol (DTT)235 or 
phosphines such as tris(2-carboxyethyl)phoshine (TCEP)236, with the latter 
normally used in its hydrochloride salt form.  It was decided, therefore, that DTT 
and TCEP (shown in Figure ‎4.9) were good candidates for the clean reduction 
of the disulfide bonds linking the protecting groups to the mimic structures.  A 
series of small-scale test reactions, monitored by mass spectrometry, were 
carried out to determine the conditions required to achieve the reduction of 
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these disulfide bonds and the initial attempts are summarised in Table ‎4.2.  The 
reactions were carried out on samples of 1b in mass spectrometry vials under 
nitrogen.  The first test was performed with DTT in acetonitrile at approx 
1 mg/mL concentration of mimic, and after this various other sets of conditions 
were explored including higher reaction concentration and the use of mixed 
acetonitrile/water as a solvent.  When using TCEP.HCl, since the reductive 
mechanism involves one molecule of H2O, there was no need to perform these 
reactions in pure acetonitrile so only mixed MeCN:H2O solvent systems were 
used. 
 
Reducing 
Agent 
No. of 
equivalents 
Solvent Conditions Result 
DTT 1 1 mL MeCN RT, 30 min No reaction.  Re-
run MS after 20 h, 
still no reaction. 
DTT 1 1 mL 4:1 
MeCN:H2O 
RT, 30 min Ditto 
TCEP.HCl 1 1 mL 4:1 
MeCN:H2O 
RT, 30 min Ditto 
TCEP.HCl 1 1 mL 1:1 
MeCN:H2O 
RT, 30 min No reaction 
TCEP.HCl 4 0.5 mL 1:1 
MeCN:H2O 
RT, 2 h No reaction 
TCEP.HCl 2 0.5 mL 1:1 
MeCN:H2O 
Reflux, 1 h No reaction 
DTT 5 0.2 mL MeCN RT, 30 min No reaction 
DTT 10 0.2 mL MeCN 60 °C, 1 h No reaction 
DTT 10 0.2 mL 4:1 
MeCN:H2O 
60 °C, 1 h Partial reaction 
DTT 10 0.2 mL 1:1 
MeCN:H2O 
60 °C, 1 h Successful 
deprotection 
Table ‎4.2 Mass spectrometry scale reactions of 1b with DTT and TCEP.HCl 
 
It appeared from these test reactions that TCEP.HCl was ineffective in this case 
at reducing these disulfide bonds and that for the use of DTT, a significant 
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excess was required as well as some heating in order to achieve deprotection.  
It was therefore decided to attempt the deprotection using excess DTT at reflux.  
While performing these reactions it became apparent that while the singly 
functionalised mimics 1b and 3b were easily deprotected under these 
conditions, the doubly functionalised counterparts required a higher 
concentration of DTT for the reaction to proceed cleanly in a short time.  It was 
discovered that longer reaction times at reflux, in these cases, resulted in the 
formation of more complex mixtures of by-products, likely candidates being 
intramolecularly cyclised disulfides or mixed intermolecular disulfides, and 
therefore a higher DTT concentration was needed in order to reduce the 
reaction time.  This gave suitable conditions for the conversion of the protected 
compounds 1b-4b into the free thiols 1c-4c (Figure ‎4.10). 
 
 
Figure ‎4.10  Deprotected potential mimics 1c, 2c, 3c and 4c. 
 
4.3.4 Photophysical properties of the mimic structures 
In order to understand any results from potential cellular applications involving 
fluorescence using the synthesised compounds, e.g. fluorescence microscopy, 
it is necessary to, first, assess the photophysical properties of the compounds 
themselves in solution.  With this in mind, the absorption and emission 
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characteristics of the four compounds were studied.  Initially, the compounds 
were studied in their protected forms (1b-4b) with the S-tbutylmercapto groups 
in place, since in this state they are unlikely to be unstable with respect to 
oxidation during the experiments.  With the properties of the compounds in this 
form determined it would then be possible to determine what changes, if any, 
occur upon reduction to the free thiols 1c-4c. 
 
The absorption spectra of the compounds were measured in acetonitrile at 
room temperature in aerated solution and the extinction coefficients for the 
observed bands were determined by a dilution method according to the Beer-
Lambert Law (Section ‎5.1.3).  The data from these experiments is summarised 
in Table ‎4.3.  The emission properties were also measured in acetonitrile at 
room temperature in both degassed and aerated solution (Table ‎4.4). 
 
Compound Absorption λmax / nm (ε / dm
3mol-1cm1) 
1b 205 (50900), 254 (26800), 345 (4165) 
2b 215 (60900), 260sh (16100), 305 (3520), 345 (4035) 
3b 252 (43050), 268 (38580), 320sh (14430), 380 
(6330), 460 (845) 
4b 252 (36600), 270 (30200), 295 (22550), 330sh 
(10540), 367 (6780), 480 (680) 
Table ‎4.3 Absorption data for S-
t
butylmercapto protected mimics in acetonitrile solution at 
295 K. 
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Compound λmax / nm τ degassed 
(aerated) / ns 
Φ degassed 
(aerated) × 102 
1b 550 20 (13) 37 (29) 
2b 555 19 (16) 33 (29) 
3b 652 170 (80) 3.5 (2.0) 
4b 665 96 (82) 1.5 (1.6) 
[Ir(ppy)2(cmbpy)]
+ 565 (71) 17 (3.7) 
[Ir(ppy)2(dcbpy)]
+ 624 (70) 2.0 (1.9) 
Table ‎4.4 Luminescence data for S-
t
butylmercapto protected mimics in acetonitrile solution at 
295 K.  Data for [Ir(ppy)2(cmbpy)]PF6 and [Ir(ppy)2(dcbpy)]PF6 are included for reference.
233
 
 
Plots of the absorption, excitation and emission profiles are shown in Figures 
4.11-4.14*.  Since the dansyl group is a purely organic fluorophore while the 
photophysical properties of the iridium complexes will be largely affected by the 
high spin-orbit coupling of this metal, the results from the two types of 
luminophores will be discussed separately. 
 
4.3.4.1 Dansyl based mimics 
1b and 2b show similar absorption profiles with bands largely confined to the 
UV region.  Both the highest and lowest energy bands are noticeably similar 
between the singly and doubly functionalised mimics, while the intervening 
bands show a slightly different structure.  In the case of 2b, two weak 
bands/shoulders are present between the two distinct outer bands while 1b 
shows a single, stronger, more distinct band in this region.  It seems likely, 
therefore, that these intermediate energy bands are related to transitions in the 
isophthalate/benzoate moieties while the retained band structure results from 
1π-π* and CT transitions within the dansyl group. 
 
                                            
*
 The spikes visible in the excitation spectra (~320 nm) and emission spectra (~680 nm) are due 
to the detection scattered ½λem and 2λex respectively. 
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Figure ‎4.11 Absorption spectrum, emission spectrum (λex = 335 nm) and excitation spectrum 
(λem = 537 nm) of the singly functionalised dansyl compound 1b in MeCN at 295 K. 
 
Figure ‎4.12 Absorption spectrum, emission spectrum (λex = 345 nm) and excitation spectrum 
(λem = 537 nm) of the doubly functionalised dansyl compound 2b in MeCN at 295 K. 
 
Both compounds display a structureless band with a large Stokes shift, typical 
of dansyl amides.237,238  There is very little difference between the two 
compounds in terms of the energy of this band indicating that there is little, if 
any, electronic communication between the dansyl moiety and the attached 
mimic structure. 
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The excited state lifetimes of the two compounds are both short, at around 
20 ns as expected for fluorescence from an organic structure and as such show 
a low sensitivity to oxygen quenching.  Both compounds also show similar 
quantum yields which, again, are relatively insensitive to oxygen. 
 
In general, the photophysical properties of the dansyl group have been shown 
to be highly sensitive to its environment, in particular the polarity of the solvent.  
Studies of dansylglycine in mixtures of dioxane and water have shown an 
increase in quantum yield from 0.07 in pure water to 0.66 in dioxane 
accompanied by blue shift in emission of around 80 nm.237  Quantum yields of 
up to 0.84 have also been reported for complexes with the enzyme Bovine 
erythrocyte carbonic anhydrase.239  Despite this wide variation in properties of 
dansyl compounds, the mimics studied show similar quantum yields and 
emission maxima to a full series of dansyl-functionalised amino acids in 
solutions of acetonitrile.238 
 
4.3.4.2 Iridium based mimics 
In absorption these compounds also show strong bands in the UV region which 
can be attributed to 1π-π* transitions within the aromatic ligands.  However, 
unlike the dansyl-based mimics, these structures also show weak absorption 
bands extending into the visible region which most likely arise from charge 
transfer states common in cyclometallated complexes of this type.25,146  The 
overall band structures of the two complexes are very similar which, again, is 
not unexpected.  The only change in the photophysically active moiety is the 
substitution of a methyl group for second amide in the bipyridine ligand which 
would lead to a lowering of the π* energies in this ligand. 
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Figure ‎4.13 Absorption spectrum, emission spectrum (λex = 470 nm) and excitation spectrum 
(λem = 600 nm) of the singly functionalised iridium complex 3b in MeCN at 295 K. 
 
Figure ‎4.14 Absorption spectrum, emission spectrum (λex = 480 nm) and excitation spectrum 
(λem = 645 nm) of the doubly functionalised iridium complex 4b in MeCN at 295 K.  Discontinuity 
at ~320 nm in excitation spectrum is due to removal of ½λem scattering peak. 
 
The emission characteristics for the two iridium complexes are also very similar, 
with both displaying a structureless band at around 650 nm.  Given the 
structural similarity of the phosphorescent moiety in these compounds to 
[Ir(phpy)2bpy]PF6 it would be reasonable to suppose that the emissive state 
would be of the same type.  As discussed in Section ‎1.1.2.2 [Ir(phpy)2(bpy)]PF6 
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is known to emit from a 3MLCT state involving the bipyridine ligand,25 and the 
two compounds do show a similar emission profile, only significantly red-shifted, 
with the parent complex having λmax ~ 606 nm in methanol
25 and a similar value 
in MeCN.  This red-shift is consistent with a 3MLCT excited state involving the 
bipyridine ligand.  The electron withdrawing effect of the amide groups will 
significantly lower the LUMO which is located on the bpy ligand leading to the 
observed red-shift.  This red shift is similar to that observed in the parent 
carboxylic acid substituted bipyridine complexes where, for example, 
[Ir(ppy)2(dcbpy)]
+ has λmax = 624 nm.
233  The luminescence lifetimes and 
quantum yields in aerated solution are remarkably similar between the mimics 
and the parent structures.  In degassed solution, 3b does show a reduced 
quantum yield compared to [Ir(ppy)2(cmbpy)]
+ which may be a result of the 
comparative red-shift of the former compared to its parent structure.  Also in 
comparison to the carboxylic acid complexes, 3b and 4b show very similar 
quantum yields to their respective parent complexes, however both show 
increased lifetimes compared to the carboxylic acids, particularly 3b. 
 
4.3.4.3 Comparison of dansyl and iridium based mimics 
One notable difference between the two complexes 3b and 4b is in the 
observed luminescence lifetime, with the doubly functionalised mimic having a τ 
value of just over half that of its singly functionalised counterpart.  It is possible 
that this reduction in lifetime is the result of intramolecular quenching by the 
pendant mimic structures which would be expected to be more pronounced with 
two such groups attached.  This difference is not observed in the dansyl based 
mimics 1b and 2b, possibly due to their inherently much shorter lifetimes.  A 
final point of interest is that all four compounds show little reduction in the 
quantum yield in aerated solutions compared to degassed solutions which 
qualitatively indicates a low rate of quenching by O2.  This could be of 
importance in bioimaging applications as these species are therefore unlikely to 
show phototoxicity related to singlet oxygen sensitization. 
 
4.3.5 Effect of reduction of the S-S bond on photophysical properties 
In order for these potential mimics to be useful in assays where there may be 
interchange between disulfide bonds and free thiols, the effect of such changes 
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on the photophysics of the compounds must be explored.  Since the results 
discussed in section  4.3.4 are of the S-tbutylmercapto protected compounds, 
this data provides a model for the mimics in an oxidised disulfide form.  It was 
therefore necessary to investigate what changes, if any, occur upon reduction of 
the protecting groups to give the corresponding free thiols. 
 
Absorption and emission spectra of the four compounds were therefore 
recorded in acetonitrile with the addition of increasing concentration of DTT.  
Solutions were made up for measurements in 3 mL cuvettes from stock 
solutions of compound and DTT with a final concentration of 10 µM compound 
in all solutions and DTT concentrations of 0, 10, 20, 50, 100, 200 and 300 µM.  
After making up each solution, the cuvettes were shaken for 5 min before 
measurement.  The resulting absorption and emission plots for the compounds 
are shown in Figure ‎4.15. 
 
In the absorption spectra, all the data shows an increase in absorbance in the 
region between 250 – 300 nm.  This correlates directly to the main absorption 
band of oxidised DTT which appears ~285 nm, which is not present in reduced 
DTT.  The increase in intensity in this region during the assay shows a linear 
relationship with the concentration of DTT.  Clearly this indicates an increasing 
concentration of oxidised DTT in the measured sample, although this could 
feasibly arise from air oxidation of DTT, rather than the reductive action of DTT 
on the substrate. 
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Figure ‎4.15 Absorption and emission profiles of 10 µM solutions of 1b, 2b, 3b and 4b with 
increasing DTT concentration. 
 
Data from the emission spectra show an increase in peak intensity of emission 
with increasing DTT concentration for all the compounds, although the effect is 
much less pronounced in 3b.  Figure ‎4.16 shows a plot of the percentage 
change in the maximum emission intensity with increasing DTT concentration.  
This effect is unusual, in that it may be expected that the free thiols would be 
more effective in the quenching of luminescence than the corresponding 
disulfides.  The reasons behind this increase are, as yet, undetermined and 
certainly warrant further study.  In any case, despite this unusual observation, 
these results show that there is very little change in the emissive properties 
upon reduction, if, indeed, reduction is occurring under these conditions.  While 
emission from the deprotected compounds 1c-4c does indicate that these will 
still be useful as bioimaging agents, the lack of distinction between reduced and 
oxidised forms rules out their use as ratiometric probes of the reductive 
environment in cells.  It is still possible however that they may show intracellular 
localisation properties related to an ability to participate in disulfide exchange. 
 
1b 2b 
3b 4b 
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Figure ‎4.16 Percentage change in maximum intensity vs. DTT concentration. 
 
4.3.6 Potential reductive activity of the mimics 
As discussed in the introduction, many small molecule thiols have the capability 
to accelerate the reactivation of scrambled proteins such as Rnase, by 
catalysing isomerisation through disulfide interchange reactions.  The potential 
of a particular thiol to engage in such processes in vivo can be assessed by an 
assay involving the cleavage of insulin.  Insulin is a small protein of around 
5.7 kDa in size whose structure is highly preserved in a wide range of species, 
being particularly similar in many mammals.240 It is comprised of two 
independent peptide chains, A and B, linked by two disulfide bonds.241  When 
separated, these chains have noticeably different solubility properties, with the 
A chain being highly soluble in aqueous media while the B chain shows a strong 
tendency to aggregate and precipitate from solution.  The extent of cleavage 
can easily be measured by the apparent increase in absorbance due to light 
scattering induced by the precipitated B chain.  The simplicity of this assay has 
led to it being used in various studies of protein aggregation where, in general, 
DTT has been used to induce the reductive cleavage of insulin.242,243 This assay 
is also useful in the study of potential PDI mimics as the addition of thiol-
containing molecules with the capability to perform disulfide interchange 
reactions (such as BMC and NMA) to a solution of insulin also causes cleavage 
of the disulfide bonds leading to aggregation and precipitation of the B chain. 
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This method was therefore attempted using bovine insulin as an initial test of 
the viability of the synthesised compounds as functioning PDI mimics.  Samples 
of the four compounds were deprotected as discussed in Section ‎4.3.3 and 
taken for use in this assay.  Initially, the assay was performed using DTT as the 
active compound to establish the criteria for a positive result while a range of 
blank runs were also used to determine a negative result. 
 
 
Figure ‎4.17 Blank runs and DTT + insulin to establish negative and positive results. 
 
The first set of assays attempted with test compounds used 20 mM stock 
solutions in DMSO with the intention of running the assay at a concentration of 
5 mM so, in addition to the usual blank, runs of phosphate buffered saline 
(PBS), insulin, DTT, test compounds, and a 1:3 DMSO:PBS blank were also 
run.  The results of these blank runs, as well as DTT + insulin, are shown in 
Figure ‎4.17.  Unfortunately, however, it transpired that addition of the stock 
solutions of test compounds to PBS at the required concentration when 
preparing the blank runs caused precipitation of the material meaning that the 
assay could not be performed under these conditions.  It was therefore required 
to find a different solvent system in which to run the assays so various 
percentages of DMSO in PBS and several concentrations of pH 6.8 Tris buffer 
were tested for suitability.  No system was found using these solvents in which 
the test compounds were soluble.  Instead, acetonitrile was used for the stock 
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solutions of test material as it was found that 1:1 MeCN:PBS was suitable for 
keeping the compounds in solution. 
 
When the assays were run using this mixture, the increase in absorbance due 
to the precipitation of insulin B chain was not observed, even with the use of 
DTT.  The assay was repeated in this solvent system using increased 
concentrations of DTT to determine whether the acetonitrile was interfering with 
reduction of the substrate and again a negative result was observed.  In 
addition to the assays run at higher concentration, another assay was 
performed using high concentration DTT in PBS followed by addition of MeCN 
once precipitation was complete. 
 
 
Figure ‎4.18 High concentration DTT assays.  In 40 mM DTT in PBS, an equal volume of MeCN 
was added at 20 min. 
 
The results of the assays run with 20 mM and 40 mM DTT in 1:1 MeCN:PBS 
and 40 mM DTT in PBS are shown in Figure ‎4.18 and it can be clearly seen in 
the latter that addition of MeCN causes the rapid dissolution of the precipitated 
insulin.  It is unclear when using the mixed solvent system whether the cleavage 
of insulin is occurring without precipitation or whether the process is not 
occurring at all.  In any case, the solubility of cleaved insulin in this solvent 
system unfortunately makes this assay unviable as a test of activity for the 
synthesised compounds. 
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4.3.7 Cytotoxicity of mimic compounds 
For intracellular probes to be of use in assays involving live cells it is important 
that treatment with the probe does not lead to a significant amount of cell death.  
While it is possible to carry out assays using compounds with relatively high 
cytotoxicities, providing they enter the cells rapidly and the assay is short, the 
toxicity could lead to abnormal cell behaviour and so compounds with lower 
cytotoxicities are preferred.  The toxicity of compounds can be represented by 
the half maximal inhibitory concentration value (IC50) which represents the 
concentration causing 50% cell death over the length of the dose. 
 
IC50 values can be measured in an assay using the compound 3-(4,5-
dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)244 which is reduced 
to the purple dye formazan by the enzyme mitochondrial reductase as shown in 
Scheme ‎4.23.  This process only occurs in living cells and so the intensity of 
absorption by the resulting formazan is proportional to the number of live cells in 
a sample.  Therefore after dosing a batch of cells with a test compound followed 
by incubation with MTT, the proportion of live cells can be determined by 
comparison to a sample of un-dosed cells. 
 
 
Scheme ‎4.23 Reduction of MTT to formazan by mitochondrial reductase. 
 
It seems likely that the cytotoxicity of the synthesised compounds could be 
related strongly to the action of the mimic structure, as this has the potential to 
affect the oxidative balance of cellular processes involving disulfide exchange.  
If the potential mimics were to act as desired and assist in the isomerisation of 
non-native disulfide bonds then it would be expected that the viability of cells 
would not be greatly affected.  On the other hand, high cytotoxicity could 
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indicate that the mimics are interfering with these processes, for example by 
binding to PDI or other oxidative chaperones and inhibiting their activity.  
However, the toxicity of these compounds could also be greatly affected by the 
luminophore used since the dansyl group and complexes of iridium are 
significantly different in their structure, charge and lipophilicity.  The dansyl 
group is rarely associated with high levels of cytotoxicity, in fact it has been 
shown that capping relatively cytotoxic dendrimers with the dansyl group leads 
to a significant reduction in their inhibitory activity.245  On the other hand there is 
a wide variation in the reported cytotoxicities of cyclometallated complexes of 
iridium(III).  While complexes with the cyclometallating ligand 2-(2,4-
difluorophenyl)pyridine (dfpyH) and a bipyridine-type ligand of the type 
[Ir(dfpy)2(N^N)]
+ show relatively low cytotoxicity,246 other similar [Ir(N^C)2(N^N)]
+ 
compounds have been reported as relatively toxic with IC50 values in the 1-
20 µM range.247,248 
 
This MTT assay was carried out to determine the cytotoxicity values of the four 
mimic compounds 1b-4b and the results are shown in Table ‎4.5.  IC50 values 
were determined for a 24 h dose of the compounds. 
 
Compound IC50 / µM 
1b 343 ± 21 
2b 192 ± 18 
3b 70 ± 20 
4b 165 ±13 
Table ‎4.5 IC50 values for CHO cells treated with S-
t
butylmercapto protected mimics (24 h dose). 
 
All four compounds show relatively high inhibitory concentrations, with all but 
one being above 100 µM.  This should allow treatment of live cells with these 
compounds at concentrations below 100 µM without high levels of atypical 
behaviour or cell death.  Also, it is expected that in assays such as fluorescence 
microscopy, the dosage times will be significantly shorter than 24 h so it is 
feasible that higher doses could be tolerated for short periods if necessary.  
One point of particular note is that the iridium complexes exhibit increased cell 
inhibition compared with those containing the dansyl group as a fluorophore.  
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As discussed, this is not unexpected due to the potential cytotoxicity of the 
iridium phosphor. 
 
4.3.8 Flow cytometry 
Flow cytometry is an ideal tool for monitoring the uptake of fluorescent 
molecules into cells as it can determine the overall proportion of labelled and 
unlabelled cells in a large population very quickly.  This method was therefore 
used to investigate whether the synthesised compounds would be internalised 
by live cells, making them suitable for fluorescence microscopy. 
 
The uptake of both the S-tbutylmercapto protected compounds 1b-4b and the 
free thiols 1c-4c was investigated over a range of concentrations.  CHO cells 
were seeded into twelve well plates and dosed with the test compounds for 3 h 
at final concentrations of 0 µM, 5 µM, 25 µM, 100 µM and 500 µM.  These 
populations were then analysed by flow cytometry with excitation using 50 mW 
UV excitation and measuring at 530 nm with 40 nm bandpass or 630 nm with a 
30 nm bandpass for the dansyl compounds and the iridium compounds 
respectively.  The scans were run until a total of approximately 3 ×104 events 
had been counted using forward scattering.  Figure ‎4.19 and Figure ‎4.20 show 
plots of the dosage concentration versus the number of labelled cells for the 
dansyl and iridium compounds respectively. 
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Figure ‎4.19 Plot of counts vs dose concentration for fluorescent population for 1b, 1c, 2b and 
2c. 
 
 
Figure ‎4.20 Plot of counts vs dose concentration for phosphorescent population for 3b, 3c, 4b 
and 4c. 
 
The results show that all eight compounds successfully label cells during the 
course of the 3 h dose however it is clear that the uptake of the free thiols is 
considerably lower than that of the disulfide protected compounds.  There are 
several factors that determine the cellular uptake of compounds, predominantly 
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size, charge and hydrophobicity.  It has been found in the case of transition 
metal complexes that a positive charge aids in the internalisation of the 
compound by interaction with the negative surface charge of live cells.6  It is 
possible that in the case of the deprotected compounds, deprotonation of the 
thiol leading to a higher negative charge inhibits uptake.  In addition, in both 
classes of compounds, the singly functionalised mimics show slightly increased 
uptake when compared to the doubly functionalised analogues. 
 
It appears that for most, a 500 µM dose is close to the saturation limit for 
labelling cells while a significant number of cells are still successfully labelled at 
100 µM.  Given the results from the cytotoxicity study, it therefore seems that 
concentrations of around 100 µM or below will be most suitable for fluorescence 
microscopy. 
 
4.3.9 Fluorescence microscopy 
With the photophysical properties of the four potential mimics known and results 
from the cytotoxicity assays indicating that these have the potential for the 
treatment of live cells, some preliminary fluorescence microscopy assays were 
undertaken.  It was decided to investigate the intracellular properties of the 
compounds by dosing cells with the potential mimics in their protected disulfide 
forms both with and without the presence of DTT as a reducing agent.  It is 
possible that even in the absence of DTT, the protecting groups would be 
removed by reductive processes in cellulo which would be a useful advantage 
in the use of the S-tbutylmercapto group in these compounds. 
 
Samples of CHO cells were seeded in 12 well plates containing microscope 
cover slips and the cells were dosed with 100 µM final concentration of the 
potential mimics ± 10 mM DTT.  Due to the compounds‟ low water solubilities, 
stock solutions were made up in DMSO at 20 mM concentration.  While DMSO 
is cytotoxic at high concentrations, dilution to 100 µM gives only 0.5% DMSO in 
the dosage medium so there were no problems anticipated with the toxicity of 
this solvent.  The cells were incubated in the dosed medium for 3 h and were 
imaged immediately after mounting on microscope slides. 
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All the compounds showed successful uptake into the cells over the course of 
the 3 h dose, as expected from the flow cytometry results, and so fluorescence 
microscopy images of the cells could be recorded.  Figures 4.21 – 4.24 show 
the fluorescence microscopy images of CHO cells dosed with the four 
compounds incubated both with and without DTT. 
 
All four compounds appear to localise predominantly in the cytosol with little or 
no staining of the nucleus.  Also, in all four cases it appears that dosing with 
compound + DTT leads to significantly higher cytotoxicity with many of the cells 
becoming detached and showing a loss of membrane integrity.  The cells dosed 
only with test compound, on the other hand, appeared mostly healthy although 
while imaging it was apparent that more cells were showing signs of dysfunction 
when treated with the iridium compounds in comparison to the dansyl 
compounds.  This observation is consistent with the observed lower IC50 values 
of 3b and 4b from the MTT assays. 
 
Also in comparison of the two types of luminophore, the iridium complexes 
show a slightly more punctate localisation pattern, particularly in the case of 4b, 
compared to a smoother distribution in the localisation of the dansyl compounds 
1b and 2b.  This could indicate that the two luminophores convey different 
localisation patterns, possibly targeting discrete vesicles such as lysosomes or 
endosomes.  Punctate cytosolic staining has recently been reported for 
complexes of iridium functionalised with biotin and this was attributed to 
endosome localisation.176  It is also possible that this distribution pattern could 
be the result of aggregation of the luminophores after internalisation. 
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Figure ‎4.21 Bright field and fluorescence microscopy images of CHO cells dosed with a) 
100 µM 1b and b) 100 µM 1b + 10 mM DTT. 
 
  
  
Figure ‎4.22 Bright field and fluorescence microscopy images of CHO cells dosed with a) 
100 µM 2b and b) 100 µM 2b + 10 mM DTT. 
a) 
b) 
a) 
b) 
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Figure ‎4.23 Bright field and fluorescence microscopy images of CHO cells dosed with a) 
100 µM 3b and b) 100 µM 3b + 10 mM DTT. 
 
  
  
Figure ‎4.24 Bright field and fluorescence microscopy images of CHO cells dosed with a) 
100 µM 4b and b) 100 µM 4b + 10 mM DTT. 
a) 
a) 
b) 
b) 
  165 
 
One point of particular note is that in the case of 2b, as well as cytosolic 
distribution similar to that of 1b, the former also displays bright localised 
emission from areas both inside and outside the cells.  It seems likely in this 
case that this is the result of aggregation both in solution and in cellulo, 
probably as a result of poor solubility in the cell medium. 
 
4.4 Concluding remarks 
The synthesis of luminescent molecules with the potential to mimic Protein 
Disulfide Isomerase was attempted.  Initially, an approach was followed 
analogous to the synthesis of the known small molecule mimic BMC.  This 
approach, however proved unsuccessful due to various complications in the 
attempted synthesis of amine-functionalised luminophores. 
 
Instead, a new approach was devised leading to carboxylate functionalised 
emitters allowing the attachment of protected cysteine units via the use of 
peptide coupling methodology.  This route yielded four potential mimics utilising 
both the dansyl group and a cyclometallated iridium complex as an organic and 
an inorganic luminescent moiety respectively.  This synthetic route also showed 
potential for the synthesis of further potential mimics using different emissive 
structures, in particular different classes of transition metal complexes utilising a 
functionalised bipyridine ligand. 
 
It was attempted to determine whether these compounds do display oxidative 
activity upon protein disulfide bonds by the use of an insulin cleavage assay.  A 
positive result from this assay would be an indicator for potential mimicry, 
however due to the low aqueous solubility of the compounds the tests were 
unsuccessful. 
 
The photophysical properties of the synthesised compounds were investigated 
and were found not to suffer from significant quenching by the appended mimic 
structures.  In addition to the photophysical properties, the compounds were 
also tested for cytotoxicity and were shown not to significantly affect cell viability 
at concentrations below ~ 100 µM.  Consequently, these compounds were 
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utilised in fluorescence microscopy imaging of live cells and showed acceptable 
levels of cellular uptake and cytosolic localisation upon internalisation. 
 
It could be expected that if these compounds were to show the desired PDI 
mimic activity, they may show a tendency towards Endoplasmic Reticulum 
localisation and this, in particular, is an area which requires further investigation. 
 
4.4.1 Scope for future work 
4.4.1.1 Cellular studies 
In addition to the preliminary fluorescence microscopy assays carried out it 
would be of great interest to further explore the intracellular localisation of these 
compounds as well as to better determine their uptake properties.  Variable 
temperature studies or uptake studies with metabolic inhibitors would be of use 
in determining whether the compounds achieve internalisation via passive 
diffusion or some active transport mechanism.  The localisation could be 
investigated through the use of co-staining in fluorescence microscopy, for 
example the use of stains such as ER Tracker™ Blue-White DPX249 could be 
used to determine the extent of ER localisation. 
 
The activity of these compounds as mimics should also be explored more 
directly.  Assays involving the reactivation of reduced and randomly oxidised 
RNase enzymes would confirm the activity of these species as functioning 
disulfide isomerism catalysts in biological systems. 
 
4.4.1.2 Structural considerations 
As well as exploring a wider range of emissive species for such mimics, there is 
also scope for improving the properties of the synthesised compounds.  As 
discussed, there have been particular issues relating to the water solubility of 
the compounds leading to problems in some biological assays.  In addition, 
while the compounds are not highly cytotoxic, any reduction in their inhibitory 
properties would be of value.  Both these issues could possibly be addressed in 
the same manner since the addition of polyethylene glycol (PEG) groups to 
compounds used in cellulo has recently been shown to reduce cytotoxicity in 
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compounds containing the dansyl group250 and iridium complexes.251  In 
addition, the incorporation of PEG groups in the latter study was shown to 
increase their solubility in water. 
 
A modified structure such as that shown in Figure ‎4.25 could therefore greatly 
improve the properties of the iridium based mimics with regards to use in the 
imaging of live cells. 
 
 
Figure ‎4.25 Potential iridium based mimic structure with improved solubility and reduced 
cytotoxicity. 
 
Very recent work in the field of isomerase catalysts has also shown that the use 
of selenium in place of sulfur leads to increased performance as a disulfide 
isomerisation catalyst compared to the analogous sulfur compounds.252,253  This 
could also be a potential area for investigation, for example coupling 
selenocysteine to a carboxylate functionalised luminophore (Figure ‎4.26). 
 
 
Figure ‎4.26 The structure of a possible selenium-based PDI mimic. 
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Chapter 5 
 
Experimental 
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5 Experimental 
 
5.1 Materials, equipment and methods 
5.1.1 General synthetic procedures 
All organic solvents used were of analytical reagent grade except MeCN which 
was of HPLC grade and were used as supplied unless noted as dry.  Dry 
solvents were of HPLC grade and dried by passage through a Pure Solv 400 
solvent purification system and stored under nitrogen.  Water for use in 
reactions was purified using the „PuriteSTILL Plus‟ system and had 
conductivity ≤ 0.04 µScm-1.  Reactions performed under nitrogen were carried 
out using Schlenk line techniques.  Reagents were used as supplied by 
commercial sources. 
 
Thin layer chromatography was carried out using either silica (Merck Art 5554) 
or aluminium oxide (Merck Art 5550) plates, both of which are fluorescent when 
irradiated at 254 nm.  Preparative column chromatography was carried out 
using silica (Merck Silica Gel 60, 230-400 mesh) or neutral alumina (Merck 
Aluminium Oxide 90, activity I, 70-230 mesh). 
 
5.1.2 Characterisation techniques 
NMR spectra were recorded using a Varian Mercury-200 spectrometer 
(200 MHz for 1H), Varian Mercury-400 spectrometer (400 MHz for 1H, 100 MHz 
for 13C), Bruker Avance-400 spectrometer (400 MHz for 1H, 100 MHz for 13C), 
Varian Inova-500 spectrometer (500 MHz for 1H, 125 MHz for 13C) or Varian 
VNMRS-700 spectrometer (700 MHz for 1H, 175 MHz for 13C).  Chemical shifts 
are quoted in ppm relative to residual proteo-solvent resonances.  1H NMR 
spectra assignment was assisted by 1H-1H COSY (correlation spectroscopy, 
through-bond interactions).  13C NMR spectra were recorded with proton 
decoupling and assigned with the aid of 1H-13C HSQC (heteronuclear single 
quantum correlation) and 1H-13C HMBC (heteronuclear multiple bond 
correlation) experiments. 
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Low resolution electrospray mass spectra (ES MS) were recorded with a 
micromass LCT spectrometer or Thermo-Finnigan LTQ FT spectrometer using 
either acetonitrile or methanol as the carrier solvent and MALDI mass spectra 
were recorded using an Applied Biosystems Voyager-DE STR instrument or a 
Bruker Daltonics Autoflex II ToF/ToF instrument.  High resolution ES mass 
spectra were recorded using a Micromass LCT spectrometer or a Thermo-
Finnigan LTQ FT spectrometer.  Electron ionisation (EI) mass spectra were 
recorded by the EPSRC National Mass Spectrometry Service at the University 
of Wales, Swansea.  Gas chromatography-mass spectrometry (GCMS) was 
performed using a Thermo-Finnigan Trace GCMS instrument.  Infrared (IR) 
spectra were measured using a Perkin Elmer FTIR Paragon 1000 with ATR 
attachment. 
 
Elemental analysis was carried out using an Exeter Analytical E-440 elemental 
analyser and melting points were determined using a Gallenkamp 889339 
capillary melting point apparatus. 
 
5.1.3 Photophysical measurements 
UV/Visible spectra were measured with a Biotek Instruments XS spectrometer 
operating with LabPower software.  Samples were held in a quartz cuvette with 
1 cm pathlength and measurements were performed against a reference of 
pure solvent in a matched cuvette.  Exctinction coefficients were determined 
through graphical application of the Beer-Lambert law (Equation 2) using 
dilution techniques.254 
 
( ) ( )A cl    
Equation 2 
 
A(λ) is the absorbance at a specific wavelength, c is the concentration of the 
absorbing species (mol dm-3), l is the path length and ε is the extinction 
coefficient at the given wavelength (dm3mol-1cm-1). 
 
Steady state emission and excitation spectra were measured with a Jobin Yvon 
FluoroMax-2 spectrofluorimeter, equipped with a red-sensitive Hamamatsu 
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R928 photomultiplier tube (PMT) using DataMax operating software.  To 
minimise inner filter effects, solutions being studied were sufficiently dilute as to 
have absorbance below 0.1 at the excitation wavelength.  Samples in aerated 
solutions were contained in quartz cuvettes of 1 cm pathlength while samples 
run in degassed solution were contained in quartz cuvettes modified for 
attachment to a high-vacuum line.  These samples were degassed with a 
minimum of three freeze-pump-thaw cycles leaving a final vapour pressure 
of ≤ 8×10-2 mbar at 77 K.  The acquired emission spectra were corrected for 
dark count and the spectral response of the detector, while excitation spectra 
were automatically corrected for lamp output through use of a beam splitter 
which directs 8% of the excitation light to a reference photodiode. 
 
The quantum yields were calculated by comparison to a reference standard of 
ruthenium(II) tris(2,2'-bipyridine) chloride in aerated aqueous solution which has 
Φst = 0.028.
255  The quantum yield (Φ) of the sample is calculated relative to the 
standard using Equation 3. 
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Equation 3 
 
Where I is the integrated emission intensity, A is the absorbance at the 
wavelength of excitation and n is the refractive index of the solvent.  Subscript 
„st‟ refers to the respective values of the standard. 
 
Excited state lifetimes were measured using time-correlated single-photon 
counting (TCSPC) with an Edinburgh Instruments OB 920 fluorimeter, using a 
pulsed-diode laser as the excitation source with 374 nm excitation for iridium 
and dansyl compounds or 475 nm excitation for the [PtLn(thiolate)] complexes. 
The laser repetition rate was selected so that the pulse period was at least 5-10 
times longer than the measured lifetime. The emission was detected at 90° to 
the excitation source, after passage through a monochromator using a Peltier-
cooled R928 PMT.  The observed photon count at a given time is proportional 
to the concentration of the excited state and can be expressed by a 
monoexponential decay of the form shown in Equation 4. 
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Equation 4 
 
Where C is the counts at time, t, C0 is the initial count after excitation and τ is 
the excited state lifetime.  τ values were obtained from a least-squares fit to 
such a monoexponential decay. 
 
5.1.4 Electrochemistry 
Cyclic voltammetry was carried out using a µAutolab Type III potentiostat with 
GPES Manager software.  Samples were made to ~1 mM concentration in 
CH2Cl2 with 0.1 M [Bu4N][PF6] as the supporting inert electrolyte.  A three-
electrode assembly was employed, consisting of a glassy-carbon working 
electrode, and platinum wire counter and reference electrodes.  Solutions were 
purged with solvent-saturated nitrogen gas for 5 minutes with stirring, prior to 
measurements being taken without stirring.  The voltammograms were 
referenced to the ferrocence-ferrocenium couple (E1/2 = 0.42 V versus SCE). 
 
5.1.5 DFT 
Calculations were performed with Gaussian03 software using the B3LYP hybrid 
functional.  The platinum and iridium core orbitals were modelled with a 
relativistic effective core potential (ECP), with the outer core and valence 
orbitals (5s, 5p and 5d) represented using the LANL2DZ basis set.  All other 
elements were represented using the 6-31G* or 6-31G basis sets.  The results 
from calculations were visualised using Gaussview 4.1 software. 
 
5.1.6 Cellular studies 
A Chinese hamster ovary (CHO) adherent cell line was maintained in 
exponential growth as a monolayer in appropriate F-12 (Ham) medium 
supplemented with 10% foetal bovine serum (FBS) and 1% penicillin and 
streptomycin. To prevent overcrowding and build up of toxins (both of which 
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could cause uncharacteristic behaviour of the cells) the cells were sub-cultured 
every three-to-four days. 
 
Sub-culturing was performed as follows: in preparation, sterile solutions of pH 
7.5 phosphate buffered saline (PBS), trypsin and fresh growth medium were 
warmed to 37°C.  The old medium was removed from the culture flask and the 
cells were rinsed with PBS followed by addition of 1.5 mL trypsin.  The cells 
were then incubated for 3 min until they became detached from the flask 
surface.  Fresh medium was then added and the suspension of cells was 
centrifuged at 1500 rpm for 3 min.  The medium containing residual trypsin was 
removed by pipette and the cells were resuspended in 4 mL medium.  Approx 
0.5 mL of this suspension was transferred to a fresh culture flask containing 
10 mL medium while the remaining cells could be transferred to microplates for 
assays. 
 
5.1.6.1 Cytotoxicity measurements 
A suspension containing approximately 1 × 106 cells in media (10 mL) was 
prepared from the 4 mL stock solution during sub-culturing. This was 
transferred to a 96-well microplate in 100 µL aliquots giving approximately 
1 × 104 cells per well and the cells were incubated at 37 °C and 5% CO2 
overnight, during which time adhesion occurred. The cells were then dosed with 
a range of concentrations of the test compounds (with each concentration 
repeated in 3 separate wells) and incubated for a further 24 h. The dosing 
media was then removed and the cells were rinsed with sterile PBS (pH 7.5, 
100 µL), and 100 µL fresh media was added. The cells were incubated for 4 h 
with a 1.0 mM solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT). After this time, the culture medium was removed, and DMSO 
(150 µL) was added to each well. The plate was shaken for 2 min and the 
absorbance of each well at 541 nm was measured against a blank microplate 
containing 150 µL DMSO.  Measurement of the absorbance was performed 
using an Analytic Jena FLASHScan 530, using WinFLASH version 1.5 software. 
The proportion of live cells in each well was calculated by the average 
absorbance for a given concentration divided by the average absorbance of 
wells containing un-dosed cells.  The IC50 values for the compounds were 
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obtained graphically from a plot of the proportion of live cells versus 
log(concentration). 
 
5.1.6.2 Fluorescence microscopy 
Cells were seeded into 12 well plates with each well containing a microscope 
coverslip and allowed to grow to around 70% confluence in an incubator.  The 
old medium was removed and replaced by fresh medium dosed with the test 
compounds and incubated for 3 h.  The coverslips were then removed and 
mounted on microscope slides.  The slides were imaged immediately using 
Zeiss Axiovert 200M epifluorescence microscope with a digital camera, and 
were processed using the Zeiss Axiovision software. A × 40 oil-immersion 
objective lens was used to visualize the image.  The filter sets used were G365 
(Zeiss) for excitation in all compounds while FITCem and 12803 filters were used 
for emission with the iridium-based and dansyl-based luminophores 
respectively. 
 
5.1.6.3 Flow Cytometry 
Cells for analysis were seeded in twelve-well plates and grown to around 80% 
confluence.  The old medium was removed and replaced with fresh medium 
dosed with varying concentrations of compound and the cells were incubated 
for 3 h at 37 °C and 5% CO2.  The cells were then treated with 200 µL trypsin 
for 3 min at 37°C and the resulting suspension was centrifuged at 1500 rpm for 
3 min.  The dosed medium was removed and the cell plug was resuspended in 
2 mL sterile PBS and stored on ice.  The samples were filtered before 
measurement to remove cell clumps. 
 
Flow cytometry measurement was conducted using a DakoCytomation Inc. 
MoFlo multi-laser flow cytometer (Fort Collins, CO, USA) operating with a 70 
µM nozzle at 60 Psi.  Samples were interrogated with a UV-laser operating at 
50 mW.  Luminescence signals were detected through interference filters with 
bandpasses of 530/40 or 630/30 for compounds with dansyl or iridium 
luminophores respectively.  Fluorescence signals were collected in the 
logarithmic mode and the data was analysed using Summit v4.3 (Beckman 
Coulter) software. 
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5.2 Synthesis of compounds 
In many cases procedures were repeated several times.  In these cases, 
masses and yields given are from a typical example. 
 
5.2.1 Compounds from Chapter 2 
 
3-(2-Pyridyl)benzonitrile 
 
2-(Tri-n-butylstannyl)pyridine (84% purity by mass, 5.24 g, 11.96 mmol), 3-
bromobenzonitrile (1.83 g 10.05 mmol), lithium chloride (2.15 g, 50.7 mmol) and 
bis-(triphenylphosphino)palladium dichloride (150 mg, 0.214 mmol) were placed 
in toluene (20 mL) and the mixture was degassed using the freeze-pump-thaw 
method.  The reaction was then heated at reflux for 24 h under a nitrogen 
atmosphere.  The reaction was cooled to room temperature, a saturated 
solution of KF(aq) (10 mL) was added and the mixture was stirred for 1 h.  The 
reaction was filtered and the insoluble material was washed with toluene.  The 
combined filtrate and washings was reduced to dryness under reduced 
pressure and the residue was taken into 50 mL DCM.  The organic phase was 
washed with 4  50 mL 5% NaHCO3 (aq), separated and dried over K2CO3.  The 
solution was filtered and the solvent was removed under reduced pressure to 
yield the crude product.  This was purified by column chromatography on silica 
with gradient elution from 0% to 20% diethyl ether in hexane.  Coincidentally, 
the required product co-eluted with the by-product 2,2'-bipyridine so the 
following procedure was adopted for the removal of this impurity:  The 
proportion of by-product was determined by NMR assay and an appropriate 
amount of (NH4)2Fe(SO4)2 (3:1 mole ratio of bpy to Fe
2+) was dissolved in H2O 
(25 mL).  The impure product was taken into DCM (25 mL) and shaken with the 
iron (II) solution producing a red pink colour in the aqueous layer indicating the 
formation of iron(II)-tris-bipyridine.  The organic phase was separated and the 
aqueous part was extracted with DCM (25 mL).  The combined organics were 
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dried over MgSO4 and the solvent was removed under reduced pressure to 
yield a fluffy white solid (1.75 g, 96%).  1H NMR (400 MHz, CDCl3):  8.73 (1H, 
d, 3J 5.2 Hz, H6-py), 8.32 (1H, s, H2-bn), 8.24 (1H, d, 3J 8.0 Hz, H4-bn), 7.82 
(1H, td, 3J 8.0 Hz, 4J 2.0 Hz, H4-py), 7.74 (1H, d, 3J 7.6 Hz, H3-py), 7.70 (1H, d, 
3J 7.6 Hz, H6-bn), 7.59 (1H, t, 3J 8.0 Hz, H5-bn), 7.32 (1H, dd, 3J 7.2 Hz, 4.8 Hz, 
H5-py).  13C NMR (125 MHz, CDCl3):  155.1 (C
2-py), 150.2 (C6-py), 140.6 (C1-
bn), 137.3 (C4-py), 132.4 (C6-bn), 131.2 (C4-bn), 130.8 (C2-bn), 129.7 (C5-bn), 
123.3 (C5-py), 120.7 (C3-py), 118.9 (CN), 113.1 (C3-bn).  HRMS (ES+): m/z 
181.07621 (M+H)+; calculated for C12H9N2: 181.07602. 
 
3-(2-Pyridyl)benzylamine 
pybzaH 
 
3-(2-Pyridyl)benzonitrile (2.05 g, 11.35 mmol) was placed in a flask under 
nitrogen.  Borane (1M in THF, 32 mL) was added and the solution was refluxed 
under nitrogen for 48 h.  After cooling to room temperature, MeOH (10 mL) was 
added carefully and the solvent removed under reduced pressure.  This was 
repeated with a further 3  10 mL MeOH.  The resulting oil was refluxed in 6M 
HCl (15 mL) for 6 h.  The reaction was made basic by careful addition of 10 mL 
20% NaOH forming a white emulsion.  This was extracted with 2  25 mL DCM 
and the combined organic phases were separated and dried over K2CO3.  The 
solution was filtered and the solvent was removed under reduced pressure to 
yield a pale brown oil (1.11 g, 53%).  1H NMR (400 MHz, CDCl3):  8.69 (1H, d, 
3J 4.4 Hz, H6-py), 7.97 (1H, s, H2-bn), 7.83 (1H, d, 3J 6.8 Hz, H4-bn), 7.75 (2H, 
m, H3-py and H4-py), 7.44 (1H, t, 3J 7.6 Hz, H5-bn), 7.37 (1H, d, 3J 8.0 Hz, H6-
bn), 7.22 (1H, t, 3J 5.2 Hz, H5-py), 3.89 (2H, s, CH2), 1.59 (2H, s, NH2).  
13C 
NMR (100 MHz, CDCl3):  157.5 (C
2-py), 149.8 (C6-py), 143.7 (C1-bn), 139.8 
(C3-bn), 136.9 (C4-py), 129.1 (C5-bn), 127.9 (C6-bn), 125.9 (C2-bn), 125.6 (C4-
bn), 122.3 (C5-py), 120.8 (C3-py), 46.6 (CH2). 
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N,N-dimethyl-3-(2-pyridyl)benzylamine 
dmpybzaH 
 
3-(2-Pyridyl)benzylamine (192 mg, 1.04 mmol) was placed in formic acid 
(0.5 mL) and formaldehyde (37% in H2O, 0.5 mL) was added.  The reaction was 
stirred for 2 h and then heated at reflux for 2.5 h.  The reaction was cooled to 
room temperature and c.HCl (1 mL) was added.  After stirring for 10 min the 
solvent was removed under reduced pressure then 5 mL H2O was added 
followed by 20% NaOH(aq) (20 mL).  The resulting emulsion was extracted with 
2  20 mL DCM and the combined organic phases were dried over K2CO3, 
filtered and the solvent removed under reduced pressure.  The crude product 
was purified by column chromatography on silica with gradient elution from 0% 
to 30% diethyl ether in hexane.  Yield 132 mg (60%).  1H NMR (400 MHz, 
CDCl3):  8.69 (1H, d, 
3J 4.4 Hz, H6-py), 7.93 (1H, s, H2-bn), 7.88 (1H, d, 3J 
7.6 Hz, H4-bn), 7.75 (2H, m, H3-py and H4-py), 7.44 (1H, t, 3J 7.6 Hz, H5-bn), 
7.38 (1H, d, 3J 7.6 Hz, H6-bn), 7.23 (1H, m, H5-py), 3.51 (2H, s, CH2), 2.27 (6H, 
s, Me).  13C NMR (125 MHz, CDCl3):  157.6 (C
2-py), 149.8 (C6-py), 139.6 (C3-
bn), 139.2 (C1-bn), 136.9 (C4-py), 129.9 (C6-bn), 128.9 (C5-bn), 127.8 (C2-bn), 
126.0 (C4-bn), 122.2 (C5-py), 120.9 (C3-py), 64.4 (CH2), 45.5 (Me). 
 
N-(3-(2-pyridyl)benzyl)benzylimine 
pybzbiH 
 
3-(2-Pyridyl)benzylamine (152 mg, 0.825 mmol) and benzaldehyde (81 mg, 
0.763 mmol) were placed in ethanol (25 mL) and refluxed for 45 min.  The 
reaction was cooled to room temperature and the solvent was removed under 
reduced pressure.  The crude product was taken into ethyl acetate and filtered 
rapidly through a short silica plug to remove residual starting materials.  The 
filtrate was reduced to dryness under vacuum.  Yield 180 mg (87%).  1H NMR 
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(400 MHz, CDCl3):  8.69 (1H, d, 
3J 4.4 Hz, H6-py), 8.45 (1H, s, N=CH), 7.97 
(1H, s, H2-bn), 7.88 (1H, d, 3J 7.2 Hz, H4 or 6-bn), 7.80 (2H, m, H2/6 or 3/5-bn'), 7.74 
(2H, m, H3-py and H4-py), 7.47 (1H, t, 3J 7.6 Hz, H5-bn), 7.43 (4H, m, H4-bn', 
H2/6 or 3/5-bn' and H4 or 6-bn), 7.23 (1H, dd, 3J 8.8 Hz, 4.8 Hz, H5-py), 4.92 (2H, s, 
CH2). 
 
5-Chloropentanal 
 
5-Chloropentan-1-ol (4.04 g, 32.9 mmol) was dissolved in dry DCM (10 mL) 
under nitrogen.  This solution was transferred to a suspension of pyridinium 
chlorochromate (9.35 g, 43.4 mmol) in dry DCM (80 mL) under nitrogen.  The 
mixture was heated at reflux for 1.5 h then allowed to cool to room temperature.  
Diethyl ether (100 mL) was added and the solution was decanted off.  The 
remaining black gum was extracted with 3  40 mL ether.  The combined 
organics were filtered through celite and the solvent was removed by gentle 
distillation.  The dark brown residue was placed on a short silica plug and 
washed through rapidly with diethyl ether.  The solvent was removed, again by 
distillation to yield 2.80 g (71%) brown oil.  1H NMR (400 MHz, CDCl3):  9.78 
(1H, s, CHO), 3.55 (2H, t, 3J 6.4 Hz, CH2Cl), 2.49 (2H, t, 
3J 6.4 Hz, CH2CHO), 
1.80 (4H, m, C3H2 and C
4H2). 
 
Ethyl 7-chloro-2(E)-heptenoate 
 
Sodium hydride (0.56 g, 23.3 mmol) was suspended in dry THF (80 mL) under 
nitrogen.  Triethyl phosphonoacetate (4.7 mL, 5.31 g, 23.7 mmol) was added 
over 5 min with stirring.  The solution was stirred for a further 10 min to allow H2 
evolution and then 5-chloropentanal (2.8 g, 23.2 mmol) in dry THF (10 mL) was 
added.  The reaction was stirred at room temperature for 1.5 h then the solvent 
removed under reduced pressure.  H2O (100 mL) was added to the residue and 
this was extracted with hexane (100 mL).  The organic phase was separated 
and washed with 2  50 mL H2O, dried over MgSO4, then the solution was 
filtered and the solvent removed under reduced pressure yielding a thin oil.  
NMR showed only approx. 50% conversion so the procedure was repeated with 
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a further 0.575 g NaH and 4.6 mL triethyl phosphonoacetate yielding 2.35 g 
(53%) light brown oil.  Spectral data are consistent with those reported.256 
 
Ethyl 7-iodo-2(E)-heptenoate 
 
Ethyl 7-chloro-2(E)-heptenoate (2.36 g, 12.4 mmol) and potassium iodide 
(8.50 g, 56.8 mmol) were placed in acetone (50 mL) and heated at reflux for 
24 h.  The reaction was cooled to room temperature and the solvent was 
removed under reduced pressure.  H2O (50 mL) was added to the residue and 
was extracted with diethyl ether (2  50 mL).  The ether was separated, washed 
with 2  50 mL H2O, and dried over MgSO4.  The solution was filtered and the 
solvent removed under reduced pressure to yield a pale red oil (3.00 g, 86%). 
Spectral data are consistent with those reported.196 
 
Ethyl 1-(3-(2-pyridyl)benzyl)piperidin-2-yl acetate 
pybzpipH 
 
3-(2-Pyridyl)benzylamine (389 mg, 2.11 mmol), ethyl 7-iodo-2(E)-heptenoate 
(590 mg, 2.09 mmol) and triethylamine (280 mg, 2.27 mmol) were placed in 
ethanol (100 mL) and heated at reflux.  The reaction was monitored by GCMS 
and after 70 h the conversion was no longer increasing.  The reaction was 
cooled to room temperature and the solvent was removed under reduced 
pressure.  50 mL H2O was added to the residue and was extracted with 
2  50 mL diethyl ether.  The combined organics were washed with H2O 
(50 mL) and 5% Na2SO3 (aq) (50 mL) then dried over MgSO4.  After filtration and 
removal of the solvent under reduced pressure the crude product was purified 
by column chromatography on silica with gradient elution from 0% to 50% 
diethyl ether in hexane yielding a colourless oil (111 mg, 16%).  1H NMR 
(400 MHz, CDCl3): δ 8.69 (1H, td, 
3J 4.4 Hz, 4J 1.4 Hz, H6-py), 7.92 (1H, s, H2-
bn), 7.85 (1H, m, H4-bn), 7.74 (2H, m, H3-py and H4-py), 7.41 (2H, m, H6-bn and 
H5-bn), 7.22 (1H, dd, 3J 8.4 Hz, 4.8 Hz, H5-py), 4.12 (2H, q, 3J 7.2 Hz, 
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OCH2CH3), 3.88 (1H, d, 
2J 13.6 Hz, ArCHHN), 3.45 (1H, d, 2J 13.6 Hz, 
ArCHHN), 3.01 (1H, m, H2-pip), 2.73 (1H, dd, 2J 14.4 Hz, 3J 4.8 Hz, 
CHHCO2Et), 2.65 (1H, m, H
6-pip), 2.45 (1H, dd, 2J 14.4 Hz, 3J 8.0 Hz, 
CHHCO2Et), 2.21 (1H, m, H
6-pip), 1.75 (1H, m, H3, 4 or 5-pip), 1.62 (1H, m, 
H3, 4 or 5-pip), 1.48 (4H, m, H3, 4 or 5-pip), 1.23 (3H, t, 3J 7.2 Hz, OCH2CH3).  
13C 
NMR (125 MHz, CDCl3):  173.1 (C=O), 157.8 (C
2-py), 149.8 (C6-py), 140.4 
(C1 or 3-bn), 139.5 (C1 or 3-bn), 136.9 (C4-py), 129.6 (C6-bn), 128.8 (C5-bn), 127.4 
(C2-bn), 125.6 (C4-bn), 122.2 (H5-py), 120.9 (C3-py), 60.5 (OCH2CH3), 58.7 
(ArCH2N), 57.8 (C
2-pip), 50.3 (C6-pip), 36.4 (CH2CO2Et), 31.0 (C
3,4 or 5-pip), 25.3 
(C3,4 or 5-pip), 22.4 (C3,4 or 5-pip), 14.3 (OCH2CH3).  HRMS (ES+): m/z 339.20658 
(M+H)+; calculated for C21H26N2O2: 339.20670. 
 
(1,3-Di(2-pyridyl)benzene)platinum(II) methanethiolate 
[PtL1(mt)] 
 
Sodium methanethiolate (50 mg, 0.15 mmol, 21% w/w in H2O) was dissolved in 
methanol (5 mL) and the solution degassed via four freeze-pump-thaw cycles 
prior to back-filling the reaction vessel with nitrogen gas.  [PtL1Cl] (63 mg, 
0.14 mmol) was added under a flow of nitrogen and the suspension stirred at 
room temperature for 18 h.  The solid was separated using a centrifuge, 
washed successively with methanol (5 mL), water (3 x 5 mL) and diethyl ether 
(2 x 5 mL), and finally dried under reduced pressure, giving the desired product 
as an orange solid (26 mg, 40%).  1H NMR (400 MHz, d6-DMSO):  δ 9.40 (2H, 
d, 3J 4.8, 3J(195Pt) 21, H6-py), 8.19 (2H, t, 3J 8.0, H4-py), 8.11 (2H, d, 3J 6.4, H3-
py), 7.81 (2H, d, 3J 7.6, H4/6-bn), 7.53 (2H, t, 3J 6.4, H5-py), 7.29 (1H, t, 3J 7.6, 
H5-bn), 2.23 (3H, s, CH3).  
13C NMR (125 MHz, d6-DMSO):  δ 167.9, 152.2, 
140.9, 140.2, 124.8, 124.1, 123.4, 120.5, 12.6.  C, H, & N analysis: 42.57% C, 
2.90% H, 5.75% N measured; 43.13% C 2.98% H, 5.92% N calculated for 
C17H14N2PtS. 
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(1,3-Di(2-pyridyl)benzene)platinum(II) phenylthiolate 
[PtL1(tp)] 
 
Thiophenol (47 mg, 0.42 mmol) was dissolved in methanol (6 mL) and the 
solution degassed via four freeze-pump-thaw cycles before being placed under 
an atmosphere of nitrogen.  Potassium tert-butoxide (48 mg, 0.43 mmol) was 
added under a flow of nitrogen gas, and the mixture stirred for 5 min followed by 
addition of [PtL1Cl] (129 mg, 0.28 mmol).  The suspension was stirred at room 
temperature for 16 h under nitrogen.  The solid was then separated using a 
centrifuge, washed successively with methanol and diethyl ether (3 x 5 mL of 
each), and dried under vacuum, to give the product as a yellow solid (120 mg, 
80%).  1H NMR (500 MHz, d6-DMSO):  δ 9.19 (2H, d, 
3J 5.5, 3J(195Pt) 19, H6-py), 
8.14 (4H, overlapping m, H3-py and H4-py), 7.81 (2H, d, 3J 7.5, H4/6-bn), 7.51 
(2H, d, 3J 8.0, H2/6-bn'), 7.40 (2H, t, 3J 6.3, H5-py), 7.31 (1H, t, 3J 7.5, H5-bn), 
6.94 (2H, t, 3J 7.5, H3/5-bn'), 6.79 (1H, t, 3J 7.5, H4-bn').  13C NMR (125 MHz, d6-
DMSO):  δ 169.1 (C2-bn), 167.8 (C2-py), 152.7 (C6-py), 148.8 (C1-bn'), 141.2 
(C1/3-bn), 140.3 (C4-py), 132.2 (C2/6-bn'), 127.6 (C3/5-bn'), 124.8 (C4/6-bn), 124.1 
(C5-py), 123.8 (C5-bn), 121.1 (C4-bn'), 120.5 (C3-py).  C, H, & N analysis: 
48.56% C, 2.95% H, 5.14% N measured; 49.34% C, 3.01% H, 5.23% N 
calculated for C22H16N2PtS. 
 
(1,3-Di(2-pyridyl)benzene)platinum(II) 4-methylphenylthiolate 
[PtL1(mtp)] 
 
This complex was prepared in a similar manner to [PtL1(tp)], starting from 
[PtL1Cl] (128 mg, 0.28 mmol), 4-methylthiophenol (55 mg, 0.44 mmol) and 
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KOtBu (60 mg, 0.54 mmol), leading to the product as an orange solid (118 mg, 
78%).  1H NMR (500 MHz, d6-DMSO):  δ 9.19 (2H, d, 
3J 5.5, 3J(195Pt) 15, H6-py), 
8.14 (4H, m, H3-py and H4-py), 7.82 (2H, d, 3J 8.0, H4/6-bn), 7.41 (2H, t, 3J 7.5, 
H5-py), 7.39 (2H, d, 3J 8.0, H2/6-bn'), 7.32 (1H, t, 3J 8.0, H5-bn), 6.77 (2H, d, 3J 
8.0, H3/5-bn') 2.12 (3H, s, CH3).  
13C NMR (125 MHz, d6-DMSO):  δ 170.0 (C
2-
bn), 168.5 (C2-py), 153.3 (C6py), 145.4 (C1-bn'), 141.8 (C1/3-bn), 141.0 (C3-py), 
132.8 (C2/6-bn'), 130.5 (C4-bn'), 129.1 (C3/5-bn'), 125.5 (C4/6-bn), 124.8 (C5-py), 
124.4 (C5-bn), 121.2 (C4-py), 20.44 (CH3).  C, H, & N analysis: 48.89% C, 
3.19% H, 4.92% N measured; 48.98% C, 3.50% H, 4.97% N calculated for 
[C23H18N2PtS].{0.8H2O}. 
 
(1,3-Di(2-pyridyl)benzene)platinum(II) 4-methoxyphenylthiolate 
[PtL1(motp)] 
 
This complex was prepared in a similar manner to [PtL1(tp)], starting from 
[PtL1Cl] (30 mg, 0.065 mmol), 4-methoxythiophenol (23 mg, 0.16 mmol) and 
KOtBu (21 mg, 0.19 mmol), giving the product as a red solid (20 mg, 55%).  1H 
NMR (400 MHz, d6-DMSO):  δ 9.18 (2H, d, 
3J 4.8, 3J(195Pt) 18, H6-py), 8.13 (4H, 
m, H3-py and H4-py), 7.82 (2H, d, 3J 7.6, H4/6-bn), 7.40 (2H, t, 3J = 7.2, H5-py), 
7.39 (2H, d, 3J 8.8, H2/6-bn'), 7.32 (1H, t, 3J 7.6, H5-bn), 6.59 (2H, d, 3J 8.8, H3/5-
bn'), 3.61 (3H, s, OCH3).  
13C NMR (125 MHz, d6-DMSO):  δ 167.9 (quat), 152.5 
(C6-py), 141.1 (quat), 140.3 (C3-py or C4-py), 133.1 (C5-py or C2/6-bn' or C3/5-
bn'), 124.8 (C4/6-bn), 124.0 (C5-py or C2/6-bn' or C3/5-bn'), 123.6 (C5-bn), 120.5 
(C3-py or C4-py), 113.6 (C2/6bn' or C3/5-bn'), 54.9 (OCH3); remaining 
quaternaries not detected.  C, H, & N analysis: 48.54% C, 3.16% H, 4.92% N 
measured; 48.85% C, 3.21% H, 4.95% N calculated for C23H18N2OPtS. 
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(1,3-Di(2-pyridyl)benzene)platinum(II) 4-nitrophenylthiolate 
[PtL1(ntp)] 
 
This compound was prepared from [PtL1Cl] (52 mg, 0.13 mmol), 4-
nitrothiophenol (36 mg, 0.23 mmol) and KOtBu (25 mg, 0.23 mmol), using the 
same procedure as for [PtL1(tp)], giving the product as a red/orange solid 
(52 mg, 72%).  1H NMR (400 MHz, d6-DMSO):  δ 9.08 (2H, d, 
3J 6.0, 3J(195Pt) 
15, H6-py) 8.17 (4H, m, H3-py and H4-py), 7.84 (2H, d, 3J 7.6, H4/6-bn) 7.82 (2H, 
d, 3J 8.8, H2/6 or 3/5-bn') 7.71 (2H, d, 3J 8.8, H2/6 or 3/5-bn'), 7.46 (2H, t, 3J 6.4, H5-
py), 7.35 (1H, t, 3J = 7.6, H5-bn).  C, H & N analysis: 44.57% C, 2.58% H, 
6.51% N measured; 44.48% C, 2.80% H, 7.07% N calculated for 
[C22H15N3O2PtS].{0.75H2O}. 
 
(Methyl-3,5-di(2-pyridyl)benzoate)platinum(II) methanethiolate 
[PtL2(mt)] 
 
This complex was prepared using the method described for [PtL1(mt)], starting 
from [PtL2Cl] (45.8 mg, 0.088 mmol) and sodium methanethiolate (31 mg, 
0.092 mmol, 21% w/w in H2O) in methanol (5 mL), leading to the product as an 
orange/red solid (24 mg, 51%).  1H NMR (400 MHz, d6-DMSO):  δ 9.39 (2H, d, 
3J 4.8, 3J(195Pt) 21, H6-py), 8.33 (2H, s, H2/6-bn), 8.73 (2H, d, 3J 7.2, H3-py), 8.21 
(2H, t, 3J 7.6, H4-py), 7.58 (2H, t, 3J 6.8, H5-py), 3.90 (3H, s, OCH3), 2.26 (3H, s, 
SCH3).  C, H & N analysis: 42.50% C, 2.98% H, 4.92% N measured; 42.94% C, 
3.03% H, 5.27% N calculated for C19H16N2O2PtS. 
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(Methyl-3,5-di(2-pyridyl)benzoate)platinum(II) phenylthiolate 
[PtL2(tp)] 
 
The title compound was prepared using the same procedure as that described 
for [PtL1(tp)], starting from [PtL2Cl] (93 mg, 0.18 mmol), thiophenol (41 mg, 
0.37 mmol) and KOtBu (46 mg, 0.41 mmol), leading to the product as a yellow 
solid (86 mg, 81%).  1H NMR (400 MHz, d6-DMSO):  δ 9.19 (2H, d, 
3J 4.8, 
3J(195Pt) 8.0, H6-py), 8.35 (2H, s, H2/6-bn), 8.29 (2H, d, 3J 8.0, H3-py), 8.18 (2H, 
t, 3J 7.2, H4-py), 7.51 (2H, d, 3J 7.6, H2/6-bn'), 7.45 (2H, t, 3J 7.2, H5-py), 6.97 
(2H, t, 3J 7.6, H3/5-bn'), 6.82 (1H, t, 3J 7.2, H4-bn'), 3.92 (3H, s, OCH3).  
13C NMR 
(100 MHz, d6-DMSO):  δ 166.7, 152.6, 140.7, 132.3, 127.8, 125.6, 124.85, 
121.3, 52.25.  MS (EI): m/z  593 (M+), 484 (M+-thiolate), 425 (M+-thiolate-
CO2Me), 110 (thiol
+).  HRMS (EI): m/z  593.0726 (M+); calculated for 
C24H18N2O2PtS: 593.0731.  C, H & N analysis: 48.34% C, 3.03% H, 4.59% N 
measured; 48.56% C, 3.06% H, 4.72% N calculated for C24H18N2O2PtS. 
 
(Methyl-3,5-di(2-pyridyl)benzoate)platinum(II) 4-methylphenylthiolate 
[PtL2(mtp)] 
 
This complex was prepared similarly, from [PtL2Cl] (98 mg, 0.19 mmol), 4-
methylthiophenol (50 mg, 0.40 mmol) and KOtBu (50 mg, 0.045 mmol), leading 
to the product as a yellow/orange solid (78 mg, 68%).  1H NMR (400 MHz, d6-
DMSO):  δ 9.22 (2H, d, 3J 4.0, 3J(195Pt) 14, H6-py), 8.40 (2H, s, H2/6-bn), 8.32 
(2H, d, 3J 8.4, H3-py), 8.20 (2H, t, 3J 8.8, H4-py), 7.48 (2H, t, 3J 6.0, H5-py), 7.38 
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(2H, d, 3J = 8.4, H2/6-bn'), 6.79 (2H, d, 3J = 8.4, H3/5-bn'), 3.92 (3H, s, OCH3), 
2.13 (3H, s, CH3).  MS (EI):  m/z 607 (M
+), 484 (M+-thiolate), 425 (M+-thiolate-
CO2Me), 124 (thiol
+), 91 (C7H7
+).  HRMS (EI): m/z 607.0889 (M+); calculated for 
C25H20N2O2PtS: 607.0888.  C, H, & N analysis: 49.20% C, 3.29% H, 4.42% N 
measured; 49.42% C, 3.32% H, 4.61% N calculated for C25H20N2O2PtS. 
 
(Methyl-3,5-di(2-pyridyl)benzoate)platinum(II) 4-methoxyphenylthiolate 
[PtL2(motp)] 
 
The title complex was prepared in the same way, starting from [PtL2Cl] (50 mg, 
0.096 mmol), 4-methoxythiophenol (28 mg, 0.20 mmol) and KOtBu (24 mg, 
0.21 mmol), leading to the product as a red solid (43 mg, 71%).  1H NMR 
(400 MHz, d6-DMSO):  δ 9.19 (2H, d, 
3J 5.6, 3J(195Pt) 19, H6-py), 8.38 (2H, s, 
H2/6-bn), 8.31 (2H, d, 3J 8.4, H3-py), 8.19 (2H, t, 3J 7.2, H4-py), 7.47 (2H, t, 3J 
6.8, H5-py), 7.38 (2H, d, 3J 8.4, H2/6-bn'), 6.61 (2H, d, 3J 8.4, H3/5-bn'), 3.92 (3H, 
s, COOCH3), 3.62 (3H, s, OCH3).  C, H & N analysis: 48.01% C, 3.17% H, 
4.46% N measured; 48.15% C, 3.32% H, 4.49% N calculated for 
C25H20N2O3PtS. 
 
(Methyl-3,5-di(2-pyridyl)benzoate)platinum(II) 4-nitrophenylthiolate 
[PtL2(ntp)] 
 
This complex was also prepared using the same general procedure, from 
[PtL2Cl] (96 mg, 0.19 mmol), 4-nitrothiophenol (59 mg, 0.38 mmol) and KOtBu 
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(44 mg, 0.39 mmol), giving the product as a yellow solid (109 mg, 92%).  1H 
NMR (300 MHz, d6-DMSO): δ 9.03 (2H d, 
3J 5.1, 3J(195Pt) 17, H6-py), 8.26 (2H, 
s, H2/6-bn), 8.91 (4H, m, H3-py and H4-py), 7.80 (2H, d, 3J 8.1, H2/6 or 3/5-bn'), 
7.66 (2H, d, 3J 8.1, H2/6 or 3/5-bn') 7.47 (2H, t, 3J 5.4, H5-py), 3.92 (3H, s, OCH3).  
MS (EI):  m/z 640 (M+), 484 (M+-thiolate), 425 (M+-thiolate-CO2Me), 155 (thiol
+).  
HRMS (EI): m/z 638.0579 (M+); calculated for C24H17N3O4PtS: 638.0582.  C, H 
& N analysis: 44.96% C, 2.67% H, 6.43% N measured; 45.14% C, 2.63% H, 
6.58% N calculated for C24H17N3O4PtS. 
 
5.2.2 Compounds from Chapter 3 
 
Bis(2-phenylpyridine)(pyridine)iridium(III) chloride 
[Ir(ppy)2(py)Cl] 
 
Tetrakis(2-phenylpyridine)(µ-dichloride)diiridium(III) (107 mg, 0.10 mmol) was 
placed in a flask under nitrogen and dissolved in 10 mL DCM.  Pyridine (18 µL, 
17.7 mg, 0.22 mmol) was added and the reaction was heated at reflux for 16 h.  
Removal of the solvent gave 122 mg (99%) yellow solid.  1H NMR (400 MHz, 
CDCl3):  9.92 (1H, d, 
3J 6.4 Hz), 9.5-8.4 (v.v. broad signal, H2/6-py) 8.07 (1H, d, 
3J 6.8 Hz), 7.89 (1H, d, 3J 8.0 Hz), 7.76-7.65 (5H, m*), 7.55 (1H, d, 3J 8.0 Hz), 
7.50 (1H, d, 3J 7.6 Hz), 7.19 (1H, s (broad), H4-py), 7.17 (1H, t, 3J 5.6 Hz), 7.00 
(1H, t, 3J 7.2 Hz), 6.86 (1H, t, 3J 7.2 Hz), 6.80 (1H, t, 3J 6.4 Hz), 6.78 (1H, t, 3J 
6.4 Hz), 6.72 (1H, t, 3J 7.2 Hz), 6.35 (1H, d, 3J 7.6 Hz), 6.19 (1H, d, 3J 7.2 Hz). 
 
                                            
*
 Includes (2H, s (broad), H
3/5
-py). 
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Bis(2-phenylpyridine)(N,N-dimethyl-4-aminopyridine)iridium(III) chloride 
[Ir(ppy)2(DMAP)Cl] 
 
Tetrakis(2-phenylpyridine)(µ-dichloride)diiridium(III) (107 mg, 0.10 mmol) and 
N,N-dimethyl-4-aminopyridine (25 mg, 0.20 mmol) were placed in a flask under 
nitrogen and dissolved in 10 mL DCM.  The reaction was heated at reflux for 
16 h, cooled to RT then the solvent was removed under reduced pressure.  The 
crude product was redissolved in 15 mL fresh DCM and the organic phase was 
washed with 2  20 mL sat. NH4Cl(aq), separated and dried over MgSO4.  
Removal of the solvent under reduced pressure gave 112 mg (85%) yellow 
solid.  1H NMR (500 MHz , CDCl3):  9.92 (1H, d, 
3J 6.0 Hz, H6-py), 8.18 (1H, d, 
3J 6.0 Hz, H6-py'), 7.85 (1H, d, 3J 8.0 Hz, H3-py'), 7.71 (1H, d, 3J 8.0 Hz, H3-py), 
7.66 (1H, t, 3J 8.0 Hz, H4-py'), 7.62 (1H, t, 3J 8.0 Hz, H4-py), 7.53 (1H, d, 3J 
8.0 Hz, H6-ph'), 7.48 (1H, d, 3J 8.0 Hz, H6-ph), 7.13 (1H, t, 3J 7.5 Hz, H5-py), 
6.98 (1H, t, 3J 8.0 Hz, H5-py'), 6.82 (1H, t, 3J 8.0 Hz, H5-ph), 6.76 (1H, t, 3J 
7.5 Hz, H5-ph'), 6.74 (1H, t, 3J 7.5 Hz, H4-ph), 6.70 (1H, t, 3J 7.5 Hz, H4-ph'), 
6.32 (1H, d, 3J 7.5 Hz, H3-ph), 6.29 (2H, s (broad), H3/5-py''), 6.24 (1H, d, 3J 
7.5 Hz, H3-ph'), 2.89 (6H, s, Me).  13C NMR (125 MHz, CDCl3):  168.9 (C
2-py'), 
167.9 (C2-py), 153.7 (C4-py''), 151.3 (C2-ph), 151.2 (C6-py), 150.5 (broad, C2/6-
py''), 149.8 (C2-ph'), 149.3 (C6-py'), 144.2 (C1-ph'), 144.0 (C1-ph), 136.6 (C4-py), 
136.4, (C4-py'), 132.3 (C3-ph'), 131.4 (C3-ph), 130.0 (C4-ph), 129.4 (C4-ph'), 
124.0 (C6-ph), 123.8 (C6-ph'), 122.0 (C5-py), 121.6 (C5-py'), 120.9 (C5-ph'), 
120.7 (C5-ph), 119.0 (C3-py'), 118.0 (C3-py), 107.5 (C3/5-py''), 39.1 (Me).  MS 
(ES+): m/z 623 (M-Cl)+.  MS (MALDI+): m/z 658 (M+), 623 (M-Cl)+, 536 (M-
DMAP)+. 
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Tetrakis(2-phenylpyridine)-bis-(µ-toluene-4-thiolate)diiridium(III) 
[Ir(ppy)2(µ-mtp)]2 
 
Method 1  (Gives Δ,Δ and Λ,Λ isomers only) 
Separate solutions of bis(2-phenylpyridine)(N,N-dimethyl-4-
aminopyridine)iridium(III) chloride (33 mg, 0.50 mmol) in 2 mL DCM and 4-
methylthiophenol (7 mg, 0.56 mmol) and potassium tert-butoxide (6.3 mg, 
0.56 mmol) in 3 mL MeOH were degassed using the freeze-pump-thaw method.  
The DCM solution was then added to the thiolate solution via cannula and the 
reaction was stirred for 6 h at RT.  The solvents were removed under reduced 
pressure and the residue was taken into 25 mL DCM.  This solution was 
washed with 2  25 mL 5% NaHCO3 (aq), dried over MgSO4 and then the solvent 
was removed under reduced pressure giving 35 mg crude product.  This was 
purified by column chromatography on silica with gradient elution from 0% to 
2.5% MeOH in DCM giving 2 products.  The major component (19 mg, Rf = 0.95 
(5% MeOH/DCM)) was the product while the minor component (3 mg, Rf 0.35 (5% 
MeOH/DCM)) appeared to be tetrakis(2-phenylpyridine)(µ-dichloro)diiridium(III).  
The primary product still contained some impurities, so was columned again, 
yielding 11 mg (35%) yellow solid.  1H NMR (400 MHz, CDCl3):  9.47 (4H, d, 
3J 
6.0 Hz, H6-py), 7.88 (4H, d, 3J 8.0 Hz, H3-py), 7.70 (4H, t, 3J 7.6 Hz, H4-py), 7.56 
(4H, d, 3J 8.0 Hz, H6-ph), 6.82 (4H, t, 3J 8.0 Hz, H5-ph), 6.71 (4H, t, 3J 7.2 Hz, 
H5-py), 6.64 (4H, t, 3J 7.6 Hz, H4-ph), 6.18 (4H, d, 3J 8.0 Hz, H2/6 or 3/5-tol), 5.97 
(4H, d, 3J 8.0 Hz, H3-ph), 5.82 (4H, d, 3J 8.0 Hz, H2/6 or 3/5-tol), 1.92 (6H, s, Me).  
MS (MALDI+): m/z 1246 (M+), 1123 (M-thiol)+, 624 (Ir(phpy)2(thiol))
+, 501 
(Ir(phpy)2)
+. 
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Method 2  (Gives mixtures of diastereoisomers) 
A solution of tetrakis(2-phenylpyridine)(µ-dichloro)diirium(III) (53 mg, 
0.049 mmol) in 2.5 mL DCM was degassed using the freeze-pump-thaw 
method.  A separate solution of 4-methylthiophenol (13 mg, 0.10 mmol) and 
potassium tert-butoxide (12 mg, 0.11 mmol) in 3 mL MeOH was degassed by 
the same method.  The solution of dimer was then transferred to the thiolate via 
cannula under nitrogen and the reaction was heated at reflux for 7 h.  The 
reaction was cooled to RT and the precipitate was collected using a centrifuge 
and washed with 2  8 mL MeOH then dried under vacuum, giving 60 mg (98%) 
yellow solid.  In this case with 4-methylthiophenol, the resulting product was an 
approx. 1:1 mixture of two distinct diastereoisomers of the product, one of which 
is identical to the product from method 1.  The two isomers were separated by 
column chromatography with gradient elution from 30% - 100% ether in hexane 
then 0% - 20% dichloromethane in ether.  This yielded 9 mg (15%) isomer from 
method 1 (Δ,Δ and Λ,Λ) and 41 mg (67%) alternate isomer (Δ,Λ meso), 
although neither product was entirely isomerically pure.  The spectral data for 
the alternate isomer is given here: 1H NMR (400 MHz, CDCl3):  10.49 (4H, d, 
3J 6.0 Hz, H6-phpy), 7.65 (4H, t, 3J 8.0 Hz, H4-phpy), 7.49 (4H, d, 3J 7.6 Hz, H3-
phpy), 7.30 (4H, t, 3J 7.2 Hz, H5-phpy), 7.08 (4H, m, H12-phpy), 6.58 (8H, m, 
H10/11-phpy), 6.20 (4H, m, H9-phpy), 5.96 (4H, d, 3J 8.0 Hz, H2/6 or 3/5-tol), 5.27 
(4H, d, 3J 8.0 Hz, H2/6 or 3/5-tol), 1.99 (6H, s, Me). 
 
Tetrakis(2-phenylpyridine)-bis-(µ-phenylthiolate)diiridium(III) 
[Ir(ppy)2(µ-tp)]2 
 
A solution of thiophenol (12 µL, 12.9 mg, 0.117 mmol) and potassium tert-
butoxide (13 mg 0.116 mmol) in 3 mL MeOH was degassed using the freeze-
pump-thaw method.  A separate solution of tetrakis(2-phenylpyridine)(µ-
dichloro)diirium(III) (53 mg, 0.049 mmol) in 3 mL DCM was degassed by the 
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same method and transferred via cannula to the thiolate solution.  The reaction 
was heated at reflux under nitrogen for 16 h.  After cooling to RT, the precipitate 
was collected using a centrifuge and washed with 3  8 mL MeOH and 8 mL 
Et2O yielding 48 mg (80%) yellow solid. 
1H NMR (400 MHz, CDCl3):  9.46 (4H, 
d, 3J 5.2 Hz, H6-py), 7.89 (4H, d, 3J 7.2 Hz, H3-py), 7.71 (4H, t, 3J 6.4 Hz, H4-
py), 7.56 (4H, d, 3J 6.4 Hz, H6-ph), 6.82 (4H, t, 3J 6.4 Hz, H5-ph), 6.72 (4H, t, 3J 
6.0 Hz, H5-py), 6.64 (4H, t, 3J 6.4 Hz, H4-ph), 6.53 (2H, t, 3J 5.6 Hz, H4-ph'), 
6.35 (4H, t, 3J 6.0 Hz, H3/5-ph'), 5.96 (8H, m, H3-ph and H2/6-ph').  MS (MALDI+): 
m/z 1220 (M+), 1109 (M-thiol)+, 610 (Ir(phpy)2(thiol))
+. 
 
Tetrakis(2-phenylpyridine)-bis-(µ-4-nitrophenylthiolate)diiridium(III) 
[Ir(ppy)2(µ-ntp)]2 
 
A solution of 4-nitrothiophenol (19 mg, 0.122 mmol) and potassium tert-butoxide 
(13 mg 0.125 mmol) in 4 mL MeOH was degassed using the freeze-pump-thaw 
method.  A separate solution of tetrakis(2-phenylpyridine)(µ-dichloro)diirium(III) 
(61 mg, 0.057 mmol) in 3 mL DCM was degassed by the same method and 
transferred via cannula to the thiolate solution.  The reaction was heated at 
reflux for 16 h under nitrogen, cooled to RT and the precipitate was collected 
using a centrifuge.  The solid was washed with 3  8 mL MeOH and 2  4 mL 
Et2O yielding 40 mg (54%) orange solid
*.  1H NMR (400 MHz, CDCl3):  9.24 
(4H, d, 3J 4.8 Hz, H6-py), 7.93 (4H, d, 3J 7.6 Hz, H3-py), 7.81 (4H, t, 3J 7.2 Hz, 
H4-py), 7.60 (4H, d, 3J 7.6 Hz, H6-ph), 7.19 (4H, d, 3J 9.2 Hz, H2/6-ph'), 6.91 (4H, 
t, 3J 7.6 Hz, H5-ph), 6.80 (4H, t, 3J 6.8 Hz, H5-py), 6.72 (4H, t, 3J 7.6 Hz, H4-ph), 
6.08 (4H, d, 3J 9.2 Hz, H3/5-ph'), 5.98 (4H, d, 3J 8.0 Hz, H3-ph).  13C NMR 
                                            
*
 Solid becomes red in contact with methanol and yellow in contact with diethyl ether.  All 
changes are reversible, with the solid returning to orange upon drying. 
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(100 MHz, CDCCl3):  168.7 (C
2-py), 153.4 (C6-py), 152.4 (C4-ph'), 150.8 (C2-
ph), 143.6 (C1-ph), 143.2 (C1-ph'), 136.8 (C4-py), 131.1 (C4-ph), 130.5 (C3/5-ph'), 
130.0 (C3-ph), 124.3 (C6-ph), 122.7 (C5-py), 122.3 (C5-ph), 122.1 (C2/6-ph'), 
119.3 (C3-py).  MS (MALDI+): m/z 1310 (M+), 1156 (M-thiol)+, 655 
(Ir(phpy)2(thiol))
+. 
 
4,6-Di(2-pyridyl)xylene 
dpyxH 
 
4,6-Dibromoxylene (200 mg, 0.76 mmol), LiCl (257 mg, 6.06 mmol) and 2-(tri-n-
butylstannyl)pyridine (918 mg, 76% purity by NMR assay, 1.90 mmol) were 
placed in 5 mL toluene and degassed using the freeze-pump-thaw method then 
placed under nitrogen.  Bis(triphenylphosphine)palladium(II) dichloride (21 mg, 
0.030 mmol) was added through a flow of nitrogen and the reaction was heated 
at reflux for 16 h.  After cooling to RT, 6 mL sat. KF(aq) was added and the 
mixture was stirred for 30 min.  The resulting solid was removed by filtration and 
washed with toluene.  The combined organic filtrate and washings were washed 
with 3  30 mL 5% NaHCO3 (aq), dried over MgSO4, filtered and the solvent was 
removed under reduced pressure.  Column chromatography on silica with 
gradient elution from 30% to 80% Et2O in hexane yielded 162 mg (82%) white 
solid.  1H NMR (400 MHz, CDCl3):  8.68 (2H, d, 
3J 5.6 Hz, H6-py), 7.72 (2H, t, 
3J 7.6 Hz, H4-py) 7.47 (1H, s, H2-xy), 7.44 (2H, d, 3J 7.6 Hz, H3-py), 7.21 (2H, 
dd, 3J 5.6 Hz, 7.6 Hz, H6-py), 2.40 (6H, s, Me). 
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Di-µ-chlorobis(4,6-di(2-pyridyl)xylene)diiridium(III) dichloride 
[Ir(dpyx)(µ-Cl)Cl]2 
 
4,6-Di(2-pyridyl)xylene (200 mg, 0.768 mmol) and IrCl3.3H2O (265 mg, 
0.752 mmol) were placed in 20 mL 7:3 2-ethoxyethanol:water under nitrogen 
and heated at 80 C for 16 h.  The resulting precipitate was collected using a 
centrifuge and washed with 2 x 8 mL each of H2O, EtOH and Et2O.  Yield 
269 mg (67%).  1H NMR (400 MHz, d6-DMSO):  9.08 (4H, s (broad)), 8.18 (4H, 
d, 3J 8.4 Hz), 7.93 (4H, t, 3J 7.4 Hz), 7.41 (4H, t, 3J 6.8 Hz), 6.90 (2H, s(broad)), 
2.76 (12H, s, Me). 
 
Di-µ-chlorobis(3,5-di(2-pyridyl)toluene)diiridium(III) dichloride 
[Ir(dpyt)(µ-Cl)Cl]2 
 
3,5-Di(2-pyridyl)toluene (50 mg, 0.20 mmol) and IrCl3.3H2O (70 mg, 0.20 mmol) 
were placed in 10 mL 7:3 2-ethoxyethanol:water under nitrogen and heated at 
80 C for 16 h.  The precipitate was collected and washed with 2 x 8 mL each of 
H2O, EtOH and Et2O yielding 62 mg (30%) of sparingly soluble yellow/orange 
solid.  1H NMR (400 MHz, d6-DMSO):  9.05 (4H, d, 
3J 4.8 Hz, H-py), 8.22 (4H, 
  193 
d, 3J 8.4 Hz, H-py), 7.95 (4H, t, 3J 8.0 Hz, H-py), 7.83 (4H, s, H2/6-tol), 7.38 (4H, 
t, 3J 7.2 Hz, H-py) 2.57 (6H, s, Me). 
 
(4,6-Di(2-pyridyl)xylene)(2-phenylpyridine)iridium(III) chloride 
[Ir(dpyx)(ppy)Cl] 
 
[Ir(dpyx)(µ-Cl)Cl]2 (70 mg, 0.067 mmol) and silver(I) triflate (88 mg, 0.34 mmol) 
were placed in 2-phenylpyridine (0.5 mL, 0.54 g, 4.7 mmol) under nitrogen and 
heated at 110 C for 16 h.  The reaction was cooled to RT and diluted with 8 mL 
DCM.  The solution was separated from the residual AgCl using a centrifuge 
and the solid was extracted with 2 x 6 mL DCM.  The combined organics were 
washed with 3 x 20 mL 1 M HCl, separated and dried over MgSO4.  Removal of 
the solvent under reduced pressure yielded 80 mg (93%) orange solid.  The 
product was identified by 1H NMR, however the sample contained some 
impurities.  1H NMR (400 MHz, CDCl3):  10.13 (1H, d, 
3J 5.6 Hz), 8.07 (1H, d, 
3J 8.4 Hz), 8.00 (2H, d, 3J 8.4 Hz), 7.96 (1H, t, 3J 6.4 Hz), 7.65 (2H, d, 3J 
6.4 Hz), 7.59 (1H, d, 3J 6.4 Hz), 7.56-7.50 (3H, m), 6.89 (1H, s, H2-xy), 6.75 
(2H, t, 3J 6.4 Hz), 6.72 (1H, t, 3J 6.4 Hz), 6.54 (1H, t, 3J 7.2 Hz), 6.01 (1H, d, 3J 
8.0 Hz), 2.83 (6H, s, Me). 
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(3,5-Di(2-pyridyl)toluene)(2-phenylpyridine)iridium(III) chloride 
[Ir(dpyt)(ppy)Cl] 
 
[Ir(dpyt)(µ-Cl)Cl]2 (51 mg, 0.50 mmol) and silver(I) triflate (55 mg, 0.21 mmol) 
were placed in 2-phenyl-pyridine (0.25 mL, 0.27 g, 4.4 mmol) and heated at 
110 C for 16 h.  The reaction was cooled to RT and diluted with 8 mL DCM. 
The solution was separated from the residual AgCl using a centrifuge and the 
solid was extracted with 2 x 6 mL DCM.  The combined organics were washed 
with 2 x 20 mL 1 M HCl, separated and dried over MgSO4.  The solvent was 
removed under reduced pressure to yield the crude product.  This was purified 
by column chromatography on silica with gradient elution from 0% to 5% MeOH 
in DCM, yielding 54 mg (70%) yellow solid.  1H NMR (400 MHz, CDCl3):  10.14 
(1H, d, 3J 5.6 Hz), 8.07 (1H, d, 3J 8.0 Hz), 7.96 (1H, t, 3J 8.0 Hz), 7.81 (2H, d, 3J 
7.6 Hz), 7.65 (2H, s, H2/6-tol), 7.61-7.51 (6H, m), 6.77 (2H, t, 3J 7.2 Hz), 6.71 
(1H, t, 3J 8.0 Hz), 6.53 (1H ,t, 3J 7.2 Hz), 6.01 (1H, d, 3J 7.6 Hz), 2.58 (3H, s, 
Me). 
 
(4,6-Di(2-pyridyl)xylene)(2,2'-bipyridine)iridium(III) chloride 
hexafluorophosphate 
[Ir(dpyx)(bpy)Cl]PF6 
 
[Ir(dpyx)(µ-Cl)Cl]2 (42 mg, 0.040 mmol) and 2,2'-bipyridine (13 mg, 0.083 mmol) 
were placed under nitrogen and 2 mL ethylene glycol was added via syringe, 
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then the reaction was heated at reflux for 2.5 h.  Once cooled to RT, the 
solution was added dropwise to 15 mL sat. KPF6 (aq) and the resulting yellow 
precipitate was collected using a centrifuge and washed with 2  5 mL each of 
H2O, EtOH and Et2O.  Yield: 49 mg (77%).  
1H NMR (400 MHz, d6-acetone):  
9.98 (1H, d, 3J 5.2 Hz, H-bpy), 8.97 (1H, d, 3J 8.4 Hz, H-bpy), 8.70 (1H, d, 3J 
7.6 Hz, H-bpy), 8.63 (1H, t, 3J 8.0 Hz, H-bpy), 8.35-8.31 (3H, m, overlapped H-
bpy triplet and H-py doublet), 8.00 (1H, t, 3J 8.0 Hz, H-bpy), 7.93 (2H, t, 3J 
8.0 Hz, H-py), 7.82 (2H, d, 3J 5.6 Hz, H-py), 7.65 (1H, d, 3J 5.6 Hz, H-bpy), 7.32 
(1H, t 3J 7.2 Hz, H-bpy), 7.16 (2H, t, 3J 6.8 Hz, H-py), 7.16 (1H, s, H2-xy), 2.92 
(6H, s, Me).  MS (ES+): m/z 643 (M-PF6)
+. 
 
(3,5-Di(2-pyridyl)toluene)(2,2'-bipyridine)iridium(III) chloride 
hexafluorophosphate 
[Ir(dpyt)(bpy)Cl]PF6 
 
[Ir(dpyt)(µ-Cl)Cl]2 (23 mg, 0.023 mL) and 2,2'-bipyridine (8 mg, .051 mmol) were 
placed in 1.5 mL ethylene glycol and heated to 195 C for 3 h.  The reaction 
was cooled to RT and the solution was separated from the residual solid.  This 
solid was extracted with 2  2 mL MeCN which was combined with the reaction 
solution.  The solution was added dropwise to 5 mL sat. KPF6 (aq), initially giving 
a yellow precipitate that redissolved.  Reduction of the solvent volume under 
reduced pressure caused the product to precipitate again and it was collected 
using a centrifuge and washed with 2  5 mL H2O, a minimum amount of 
ethanol and 2  5 mL Et2O.  Yield 10 mg (29%).  
1H NMR (700 MHz, d6-
acetone):  10.0 (1H, d, 3J 4.9 Hz, H6 or 6'-bpy) 8.98 (1H, d, 3J 8.4 Hz, H3 or 3'-
bpy), 8.71 (1H, d, 3J 7.7 Hz, H6 or 6'-bpy), 8.63 (1H, t, 3J 7.7 Hz, H4 or 4'-bpy), 8.33 
(1H, t, 3J 5.6 Hz, H5 or 5'-bpy), 8.29 (2H, d, 3J 7.7 Hz, H6-py), 8.00 (1H, t, 3J 
7.7 Hz, H5 or 5'-bpy), 8.00 (2H, s, H2/5-tol), 7.95 (2H, t, 3J 8.4 Hz, H5-py), 7.80 
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(2H, d, 3J 7.7 Hz, H3-py), 7.66 (1H, d, 3J 4.9 Hz, H3 or 3'-bpy), 7.35 (1H, t, 3J 6.3 
Hz, H4 or 4'-py), 7.18 (2H, t, 3J 7.0 Hz, H4-py), 2.67 (3H, s, Me).  13C NMR 
(175 MHz, d6-acetone):  168.8, 167.3, 158.6, 155.9, 153.5, 152.5, 149.5, 
141.5, 140.4, 139.9, 139.4, 133.4, 129.1, 128.2, 124.9, 124.8, 124.0, 121.0, 
21.2. 
 
(4,6-Di(2-pyridyl)xylene)(2-phenylpyridine)iridium(III) toluene-4-thiolate 
[Ir(dpyx)(ppy)(mtp)] 
 
A suspension of (4,6-di(2-pyridyl)xylene)(2-phenylpyridine)iridium(III) chloride 
(29.5 mg, 0.046 mmol) in 2 mL MeOH was degassed using the freeze-pump-
thaw method.  In a separate vessel 4-methyl thiophenol (6.2 mg, 0.050 mmol) in 
1 mL MeOH was also degassed.  Potassium tert-butoxide (6 mg, 0.053 mmol) 
was added to the thiol solution through a flow of nitrogen.  This solution was 
then tranfered to the suspension of complex via a cannula and the reaction was 
stirred under nitrogen for 16 h at RT.  The precipitate was collected and washed 
with 2  3 mL each of MeOH and Et2O yielding 25 mg (75%) yellow/orange 
solid.  Evidence from 1H NMR indicated that the sample was probably the 
required product, however not at an acceptable level of purity.  Full assignment 
of the 1H NMR was not possible due to the low solubility resulting in a poor 
spectrum.  1HNMR (400 MHz, CDCl3):  10.49 (1H, d), 8.06 (1H, d), 7.95 (1H, t), 
7.78 (2H, m), 7.62 (1H, d), 7.54 (3H, m), 7.39 (2H, m), 6.80 (1H, s), 6.71 (1H, t), 
6.61 (2H, m), 6.53 (1H, t), 6.23 (2H, d), 6.14 (2H, d), 6.10 (1H, d), 2.75 (6H, s), 
2.61 (3H, s). 
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(4,6-Di(2-pyridyl)xylene)(2-phenylpyridine)iridium(III) 4-nitrophenylthiolate 
[Ir(dpyx)(ppy)(ntp)] 
 
(4,6-Di(2-pyridyl)xylene)(2-phenylpyridine)iridium(III) chloride (32 mg, 
0.050 mmol) was suspended in 2 mL MeOH and degassed using the freeze-
pump-thaw method and placed under nitrogen.  A separate solution of 4-
nitrothiophenol (8.5 mg, 0.055 mmol) and potassium tert-butoxide (6.2 mg, 
0.55 mmol) in 2 mL MeOH was also degassed then transferred via cannula to 
the suspension of complex.  The reaction was stirred at RT for 16 h and then 
the solid was collected using a centrifuge.  This solid was washed with 2  4 mL 
MeOH and 2  4 mL Et2O giving 27 mg crude product.  TLC of this product 
showed two main components at Rf = 0.55 and Rf = 0.30 (silica plates, 5% 
MeOH/DCM).  The crude was columned on silica, eluting with 3% MeOH in 
DCM.  Upon loading onto silica for the column, the product changed from yellow 
to red and the first component eluted from the column was the required product, 
6 mg (16%) red solid, but now had Rf = 0.9 in 5% MeOH/DCM.  16 mg starting 
complex was also recovered from the column.  1H NMR (400 MHz, CDCl3):  
10.21 (1H, d, 3J 6.0 Hz, H-ppy), 8.09 (1H, d ,3J 8.0 Hz, H-ppy), 7.99 (1H, t, 3J 
8.0 Hz, H-ppy), 7.84 (2H, d, 3J 8.4 Hz, H-py), 7.62 (1H, d, 3J 7.6 Hz, H-ppy), 
7.60-7.55 (3H, m, H-ppy and H-py), 7.44 (2H, t, 3J 8.0 Hz, H-py), 7.28 (2H, d, 3J 
7.6 Hz, H2/6 or 3/5-ph), 6.86 (1H, s, H2-xy), 6.75-6.68 (3H, m, H-ppy and H-py), 
6.52 (1H, t, 3J 7.2 Hz, H-ppy), 6.37 (2H, d, 3J 7.6 Hz, H2/6 or 3/5-ph), 6.03 (1H, d, 
3J 7.6 Hz, H-ppy), 2.76 (6H, s, Me). 
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Bis(4,6-di(2-pyridyl)xylene)(µ-di(4-nitrophenylthiolate))diiridium(III) di(4-
nitrophenylthiolate) 
[Ir(dpyx)(µ-ntp)(ntp)]2 
 
[Ir(dpyx)(µ-Cl)Cl]2 dimer (26 mg, 0.025 mmol), 4-nitrothiophenol (16 mg, 
0.10 mmol) and potassium tert-butoxide (12 mg, 0.11 mmol) were placed in a 
flask under nitrogen.  A mixture of 2 mL DCM and 3 mL MeOH was degassed 
using the freeze-pump-thaw method in a separate vessel and added to the 
solids via cannula.  The reaction was then heated at reflux for 24 h.  The 
solvents were removed under reduced pressure and the solid was washed with 
3  8 mL MeOH.  The crude product was purified by column chromatography on 
silica with gradient elution from 0% to 0.5% MeOH in DCM yielding 23 mg 
(61%) orange solid.  1H NMR (400 MHz, CDCl3):  8.91 (4H, d, 
3J 6.8 Hz, H6-
py), 7.99 (4H, d, 3J 8.0 Hz, H3-py), 7.74 (4H, t, 3J 8.0 Hz, H4-py), 7.52 (4H, d, 
8.8 Hz, H-ph or H-ph'), 7.20 (4H, d, 8.8 Hz, H-ph or H-ph'), 7.00 (2H, s, H2-xy), 
6.94 (4H, d, 8.8 Hz, H-ph or H-ph'), 6.85 (4H, t, 3J 6.8 Hz, H5-py), 6.28 (4H, d, 
8.8 Hz, H-ph or H-ph'), 1.55 (12H, s, Me).  MS (MALDI+): m/z 760 
(Ir(NCN)(thiol)2)
+. 
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5.2.3 Compounds from Chapter 4 
 
4-Bromophthalic acid 
 
Potassium hydrogen phthalate (12.30 g, 60.2 mmol) and KOH (3.42 g, 
61.0 mmol) were placed in 75 mL H2O.  Br2 (5 mL, 97.1 mmol) was added and 
the reaction was stirred vigorously for 24 h.  The excess bromine was removed 
by boiling for 30 min and upon cooling the potassium hydrogen salt precipitated 
from solution.  This was collected by filtration, washed with ice cold water and 
purified by recrystallisation from water. Yield 4.70 g (28%).  The final product 
was obtained by acidification of potassium hydrogen 4-bromophthalate with HCl 
in water followed by extraction with diethyl ether (4.02 g, 27%).  1H NMR 
(500 MHz, d6-DMSO):  7.82 (1H, d, 
4J 2.0 Hz, H3), 7.80 (1H, dd, 3J 8.0 Hz, 4J 
2.0 Hz,  H5), 7.64 (1H, d, 3J 8.0 Hz, H6).  13C NMR (125 MHz, d6-DMSO):  
167.7 (C1C=O), 167.4 (C2C=O), 135.4 (C2), 133.6 (C5), 131.4 (C1), 130.8 (C3), 
130.7 (C6), 124.3 (C4). 
 
4-Bromophthalimide 
 
4-Bromophthalic acid (4.02 g, 16.4 mmol) and ammonium thiocyanate (1.27 g, 
16.7 mmol) were ground together using a pestle and mortar then heated to 
165 ºC for 20 min.  The reaction was cooled and the solid broken up and 
dispersed in water using a sonicator.  This was then washed four times with 
H2O using a centrifuge.  The resulting cream solid was dried under reduced 
pressure (2.05 g, 55%).  1H NMR (500 MHz, d6-DMSO):  11.48 (1H, s, NH), 
8.01 (1H, dd, 3J 8.0 Hz, 4J 1.5 Hz, H5), 8.00 (1H, d, 4J 2.0 Hz, H3), 7.75 (1H, d, 
3J 8.0 Hz, H6).  13C NMR (125 MHz, d6-DMSO):  168.5 (C
1-C=O), 167.9 (C2-
C=O), 137.0 (C5), 134.7 (C2), 131.6 (C1), 127.9 (C4), 125.9 (C3), 124.9 (C6).  C, 
H, & N analysis: 42.26% C, 1.73% H, 6.21% N measured; 42.51% C, 1.78% H, 
6.20% N calculated for C8H4NO2Br.  IR: (C=O) 1715 cm
-1.  Mp 206 – 208 °C. 
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4-Bromophthalamide 
 
4-Bromophthalimide (3.62 g, 16.0 mmol) was added in portions to 100 mL conc. 
NH3 (aq) and stirred for 2 days producing a white precipitate.  This was isolated 
by filtration, washed with H2O and dried under reduced pressure.  Yield 1.74 g 
(45%). 1H NMR* (400 MHz, d6-DMSO):  7.83 (1H, s (broad), NH), 7.77 (1H, s 
(broad), NH), 7.65 (1H, dd, 3J 8.0 Hz, 4J 2.0 Hz, H+), 7.60 (1H, d, 4J 2.0 Hz, H3), 
7.43 (1H, s (broad), NH), 7.40 (1H, d, 3J 8.0 Hz, H6), 7.39 (1H, s (broad), NH).  
13C NMR (100 MHz, d6-DMSO):  169.8 (C
1-C=O), 169.2 (C2-C=O), 139.1 (C2), 
136.1(C1), 132.6 (C5), 130.9 (C3), 130.4 (C6), 122.8 (C4).  HRMS (ES+): m/z 
242.9764 (M+H)+; calculated for C8H8BrN2O2: 242.9765.  C, H, & N analysis: 
39.34% C, 1.77% H, 11.50% N measured; 39.53% C, 2.90% H, 11.53% N 
calculated for C8H7N2O2Br.  IR: (N-H) 3430, 3320, 3170 cm
-1, (C=O) 
1650 cm-1.  Mp 207 – 208 °C. 
 
4-Bromophthalonitrile 
 
4-Bromophthalamide (2.5 g, 10.3 mmol) was placed under nitrogen and 
suspended in 90 mL dry THF.  DMF (1.75 mL, 22.6 mmol) was added followed 
dropwise by triphosgene (6.71 g, 22.6 mmol) in 20 mL dry THF.  The reaction 
was heated at reflux for 3 h then, after cooling to RT, the solvent was removed.  
50 mL H2O was added to the residue and this was extracted with 3 x 30 mL 
DCM.  The combined organics were washed with 2 x 50 mL 5%  NaHCO3 (aq), 
dried over MgSO4 and reduced to dryness.  The crude product was purified by 
column chromatography on silica eluting with 30% diethyl ether in hexane 
yielding a white solid (1.94 g, 91%).  1H NMR (500 MHz, CDCl3):  7.97 (1H, d, 
4J 1.5 Hz, H3), 7.90 (1H, dd, 3J 8.0 Hz, 4J 2.0 Hz, H5), 7.68 (1H, d, 3J 8.5 Hz, 
H6).  13C NMR (125 MHz, CDCl3):  136.8 (C
5), 136.6(C3), 134.6(C6), 128.3 (C4), 
                                            
*
 Note – Due most likely to H-bond interactions, all amide protons appear as individual peaks in 
the 
1
H NMR 
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117.5, 114.9, 114.8, 114.2.  MS (EI): m/z 208 (M+ (81Br)), 206 (M+ (79Br)), 127 
(M-Br)+.  C, H, & N analysis: 46.33% C, 1.58% H, 13.05% N measured; 
46.41% C, 1.46% H, 13.53% N calculated for C8H3N2Br 
 
(4-(2,2'-Bipyridin-4-yl)phenyl)(neopentyl glycolato)boron 
 
4-(4-Bromophenyl)-2,2'-bipyridine (311 mg, 1.00 mmol), bis(neopentyl 
glycolato)diboron (245 mg, 1.08 mmol) and potassium acetate (295 mg, 
3.00 mmol) were placed in 10 mL dry DMSO and degassed using the freeze-
pump-thaw technique.  With the reaction maintained under nitrogen (bis-
diphenylphosphinoferrocene)palladium dichloride (35 mg, 0.048 mmol) was 
added then the reaction was heated at 85 ºC for 4 h.  After cooling to RT the 
reaction was diluted with 30 mL DCM and this was washed with 5 x 100 mL 
H2O, separated, dried over Na2SO3 and reduced to dryness.  The crude product 
(229 mg, 67%) was used without further purification.  1H NMR (200 MHz, 
CDCl3):  8.71 (3H, m), 8.45 (1H, d, J 8.0 Hz), 7.95-7.75 (5H, m), 7.57 (1H, dd, 
J 5.2 Hz, 1.8 Hz), 7.35 (1H, dd, J 7.6 Hz, 4.8 Hz), 3.80 (4H, s, CH2), 1.05 (6H, s, 
CH3).  MS (EI): m/z 344 (M
+). 
 
4-(3,4-Dicyano-4'-biphenylyl)-2,2'-bipyridine 
 
4-Bromophthalonitrile (135 mg, 0.65 mmol) and (4-(2,2'-bipyridin-4-
yl)phenyl)(neopentyl glycolato)boron (210 mg, 0.65 mmol) in DME (3 mL) and 
sodium carbonate (210 mg, 1.98 mmol in 0.5 mL H2O) were degassed together 
using the freeze-pump-thaw method.  Tetrakis(triphenylphino)palladium(0) 
(35 mg, 0.03 mmol) was added through a positive flow of nitrogen then the 
reaction was stirred for 30 min followed by reflux for 16 h under nitrogen.  The 
reaction was then cooled to RT and diluted with 50 mL DCM and the organic 
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phase was washed with 4 x 50 mL H2O, dried over MgSO4 and the solvent 
removed.  The crude product was purified by column chromatography on silica 
with gradient elution from 0 – 15% MeOH in DCM yielding 140 mg (64%) white 
solid.  1H NMR (500 MHz, CDCl3):  8.78 (1H, d, J 5.0 Hz), 8.73 (2H, s), 8.48 
(1H, d, J 8.0 Hz), 8.08 (1H, s), 8.00 (1H, d, J 8.0 Hz), 7.95-7.89 (3H, m), 7.87 
(1H, t, J 8.0 Hz), 7.73 (2H, d, J 8.0 Hz), 7.59 (1H, d, J 5.0 Hz), 7.36 (1H, t, J 
6.0 Hz).  13C NMR* (125 MHz, CDCl3):  157.1, 156.0, 150.0, 149.3, 148.0, 
145.7, 139.9, 137.6, 137.3, 134.2, 132.0, 131.5, 128.4, 128.0, 124.2, 121.6, 
121.5, 119.0, 116.8, 115.5(4), 115.4(8), 114.4.  HRMS (ES+): m/z 359.12929 
(M+H)+; calculated for C24H15N4: 359.12912.  C, H, & N analysis: 78.32% C, 
3.89% H, 15.04% N measured; 78.30% C, 3.89% H, 15.13% N calculated for 
C24H14N4.{0.14(CH2Cl2)}.  Mp 246 – 248 °C. 
 
5-Bromoisophthalic acid 
 
Dimethyl-5-aminoisophthalate (2.5 g, 12.0 mmol) was placed in 50 mL 1:1 
MeOH/6M H2SO4.  Sodium nitrite (2.5 g, 36.2 mmol) in 20 mL H2O was added 
slowly while cooling the reaction in an ice bath.  The reaction was stirred for 
30 min at RT then CuBr2 in 20 mL 48% HBr was added followed by heating for 
15 min at reflux.  The reaction was then neutralised with 40% NaOH (aq) and 
filtered while hot.  Acidification of the filtrate with HCl gave a precipitate which 
was collected and dissolved in a minimum amount of 10% NaOH (aq).  The 
product was then precipitated again with HCl, collected by filtration and washed 
with cold H2O.  Yield 0.98 g (33%).  
1H NMR (500 MHz, d6-DMSO):  8.41 (1H, 
s, H2), 8.24 (2H, H4/6).  13C NMR (125 MHz, d6-DMSO):  165.3 (C=O), 135.5 
(C4/6), 133.6 (C1/3), 128.7 (C2), 121.8 (C5).  MS (ES-):  m/z 245 (M(81Br)-H)-, 243 
(M(79Br)-H)-.  Mp 279 – 283 °C. 
 
                                            
*
 Weak spectrum, 2 signals not resolved from noise. 
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Dimethyl-5-iodoisophthalate 
 
Sodium nitrite (1.00 g, 14.5 mmol) in 15 mL H2O was added dropwise to 
dimethyl-5-aminoisophthalate (2.62 g, 12.5 mmol) in 7.5 mL 20% HCl (aq) at      –
5 ºC.  20 mL toluene was added followed, dropwise, by potassium iodide (4.2 g, 
25.3 mmol) in 10 mL H2O.  The reaction was stirred vigorously overnight at RT 
then heated to reflux for 1 h.  The reaction was then cooled to RT and the 
organic phase separated.  The aqueous part was extracted with 2 x 20 mL 
toluene and the combined organic phases were washed with 3 x 50 mL H2O, 
dried with MgSO4 and the solvent was removed under reduced pressure.  
Recrystallisation from MeOH gave a light brown solid and further purification by 
column chromatography on silica eluted with DCM gave 0.593 g (15%) of white 
solid.  1H NMR (400 MHz, CDCl3):  8.63 (1H, t, 
4J 1.6 Hz, H2), 8.54 (2H, d, 4J 
1.6 Hz, H4/6), 3.95 (6H, s, Me).  13C NMR (125 MHz, CDCl3):  164.8 (C=O), 
142.5 (C4/6), 132.2 (C1/3), 129.9 (C2), 93.5 (C5), 52.7 (Me).  MS (EI): m/z 320 
(M+).  Mp 101 – 102 °C. 
 
Di(L-cysteine ethyl ester)-5-bromoisophthalamide 
 
5-Bromoisophthalate (61 mg, 0.25 mmol) was placed under nitrogen in 10 mL 
dry THF.  At 0 ºC, EDCI (105 mg, 0.55 mmol) was added through a positive flow 
of nitrogen and the reaction was stirred for 15 min.  Ethyl-L-cysteine (100 mg, 
0.54 mmol) was then added through nitrogen and the reaction was warmed to 
RT and stirred overnight.  The solution was decanted from the white gum and 
the solvent was removed under reduced pressure.  The crude material was then 
columned under nitrogen on silica with gradient elution 0 – 5% MeOH in DCM. 
Yield 20 mg (16%).  1H NMR (400 MHz, CDCl3):  8.20 (1H, t, 
4J 2.0 Hz, H2), 
8.10 (2H, d, 4J 2.0 Hz, H4/6), 7.20 (2H, d (broad) or two s (broad), NH), 5.04 (2H, 
m, *CH), 4.30 (4H, q, 3J 7.2 Hz, CH2CH3), 3.14 (4H, m, CH2SH), 1.34 (6H, t, 
3J 
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7.2 Hz, CH2CH3).  MS (ES+): m/z 507 (M(
79Br)+H)+, 509 (M(81Br)+H)+, 1015 
(2M+H)+. 
 
Bis(N-dansyl) dimethyl-5-aminoisophthalate 
 
Dansyl chloride (135 mg, 0.500 mmol), dimethyl-5-aminoisophthalate (105 mg, 
0.502 mmol) and DMAP (65 mg, 0.532 mmol) were placed in 10 mL dry THF 
under nitrogen and the reaction was stirred overnight.  The solvent was 
removed under reduced pressure and DCM (25 mL) was added to the residue.  
The organic phase was washed with 3  25 mL H2O, separated and dried over 
MgSO4.  Removal of the solvent yielded 225 mg crude product.  Column 
chromatography on silica, eluting with 3% MeOH in DCM, gave 79 mg (47%) 
product (Rf = 0.78) and a mixture of two other components, the main constituent 
of which was N-dansyl dimethyl-5-aminoisophthalate (Rf = 0.42).  
1H NMR 
(400 MHz, CDCl3):  8.64 (1H, t, 
4J 1.6 Hz, H2-bn), 8.60 (2H, d, 3J 8.4 Hz, H-np), 
8.31 (2H, d, 3J 8.4 Hz, H-np), 7.85 (2H, d, 4J 1.6 Hz, H4/6-bn), 7.72 (2H, d, 3J 
8.0 Hz, H-np), 7.49 (2H, t, 3J 8.4 Hz, H-np), 7.14 (2H, t, 3J 8.0 Hz, H-np), 7.10 
(2H, d, 3J 8.0 Hz, H-np), 3.85 (6H, s, OMe), 2.89 (12H, s, NMe).  13C NMR 
(100 MHz, CDCl3):  164.9 (C=O), 152.1, 137.7, 134.6, 133.6, 133.1, 132.5, 
132.2, 131.7, 130.1, 128.6, 123.2, 118.9, 115.5.  MS (ES+): m/z 676 (M+H)+, 
1351 (2M+H)+. 
 
N-dansyl dimethyl-5-aminoisophthalate 
 
Dimethyl-5-aminoisophthalate (210 mg, 1.00 mmol) and pyridine (0.10 mL, 
0.1 g, 1.3 mmol) were placed in 5 mL dry DCM under nitrogen and dansyl 
chloride (280 mg, 1.04 mmol) in 10 mL dry DCM was added via cannula.  The 
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reaction was heated at reflux for 16 h then the solvent was removed under 
reduced pressure.  The crude product was purified by column chromatography 
on alumina eluting with 3% MeOH in DCM (Rf = 0.42) yielding 428 mg (96%) 
white solid.  1H NMR (500 MHz, CDCl3):  8.51 (1H, d, 
3J 9.0 Hz, H4-np), 8.31, 
(1H, s, H2-bn), 8.30 (1H, d, 3J 9.0 Hz, H8-np), 8.27 (1H, d, 3J 7.5 Hz, H2-np), 
7.86 (2H, s, H4/6-bn), 7.56 (1H, t, 3J 8.5 Hz, H7-np), 7.47 (1H, t, 3J 9.0 Hz, H3-
np), 7.31 (1H, s (broad), NH), 7.17 (1H, d, 3J 7.5 Hz, H6-np), 3.89 (6H, s, OMe), 
2.86 (6H, s, NMe).  13C NMR (125 MHz, CDCl3):  165.7 (C=O), 152.4 (C
5-np), 
137.7 (C5-bn), 133.7 (C1-np), 131.7 (C1/3-bn), 131.5 (C4-np), 130.8 (C2-np), 
130.0 (C4a-np), 129.6 (C8a-np), 129.1 (C7-np), 126.8 (C2-bn), 125.4 (C4/6-bn), 
123.2 (C3-np), 118.2 (C8-np), 115.5 (C6-np), 52.7 (OMe), 45.5 (NMe).  HRMS 
(ES+): m/z 443.12636, 465.10901; calculated for C22H23N2O6S
+: 443.12714, 
C22H22N2O6Na
+: 465.10908. 
 
N-dansyl-5-aminoisophthalic acid 
1a 
 
N-dansyl dimethyl-5-aminoisophthalate (88 mg, 0.20 mmol) was dissolved in 
5 mL THF and 5 mL 15% NaOH in water was added.  The reaction was heated 
at reflux for 2 h then the THF was removed under reduced pressure.  The 
remaining aqueous solution was diluted to approx 10 mL and brought to approx. 
neutral pH by dropwise addition of 2M HCl, producing a white precipitate.  A 
saturated aqueous solution of NH4Cl (20 mL) was added and the product was 
extracted with 2  25 mL EtOAc.  The combined organics were dried over 
MgSO4 and the solvent was removed under reduced pressure to yield a 
yellow/green solid (82 mg, 99%).  1H NMR (500 MHz, d6-acetone):  8.57 (1H, 
d, 3J 8.5 Hz, H4-np), 8.50 (1H, d, 3J 9.0 Hz, H8-np), 8.36 (1H, d, 3J 7.5 Hz, H2-
np), 8.32 (1H, t, 4J 1.5 Hz, H2-bn), 8.01 (2H, d, 4J 1.5 Hz, H4/6-bn), 7.63 (1H, t, 3J 
9.0 Hz, H7-np), 7.62 (1H, t, 3J 9.0 Hz, H3-np), 7.29 (1H, d, 3J 7.5 Hz, H6-np), 
2.86 (6H, s, NMe).  13C NMR (125 MHz, d6-acetone):  166.8 (C=O), 152.9 (C
5-
np), 139.3 (C5-bn), 135.5 (C1-np), 133.6 (C1/3-bn), 131.6 (C4-np), 131.2 (C2-np), 
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130.7 (C4a-np), 130.4 (C8a-np), 129.3 (C7-np), 126.7 (C2-bn), 124.8 (C4/6-bn), 
124.1 (C3-np), 119.7 (C8-np), 116.3 (C6-np), 45.5 (NMe).  MS (ES-): m/z 413 
(M-H)-, 827 (2M-H)-.  IR: (O-H) 3250-2725 cm-1 (broad), (C=O) 1693 cm-1. 
 
N-dansyl-4-aminobenzoic acid 
2a 
 
Dansyl chloride (67 mg, 0.25 mmol) and 4-aminobenzoic acid (35 mg, 
0.26 mmol) were placed in 8 mL DCM and pyridine (20 mg, 0.25 mmol) in 2 mL 
DCM was added.  The reaction was heated at reflux for 16 h, cooled to RT then 
diluted to approx. 20 mL with DCM.  The organic phase was washed with 
2  20 mL sat. NH4Cl (aq), dried over MgSO4 and the solvent was removed 
under reduced pressure.  The crude product was purified by column 
chromatography on silica eluting with 4% MeOH in DCM (product Rf = 0.15, 5% 
MeOH/DCM).  Yield 31 mg (34%).  1H NMR (700 MHz, CDCl3):  8.52 (1H, d, 
3J 
8.4 Hz, H4-np), 8.33 (1H, d, 3J 9.1 Hz, H2-np), 8.30 (1H, d, 7.0 Hz, H8-np), 7.85 
(2H, d, 3J 9.1 Hz, H1/6 or 3/5-bn), 7.56 (1H, t, 3J 8.4 Hz, H7-np), 7.48 (1H, t, 3J 
8.4 Hz, H3-np), 7.17 (1H, d, 3J 7.0 Hz, H6-np), 7.06 (2H, d, 3J 9.1 Hz, H1/6 or 3/5-
bn), 2.84 (6H, s, NMe).  13C NMR (100 MHz, CDCl3):  170.7 (C=O), 152.1, 
148.1, 141.9, 134.0, 131.6, 131.4, 130.6, 130.0, 129.6, 128.9, 124.5, 123.2, 
118.4, 115.5, 45.5 (Me).  MS (ES+): m/z 371 (M+H)+.  IR: (O-H) 3260-
2780 cm-1 (broad), (C=O) 1705 cm-1. 
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Bis(2-phenylpyridine)(4'-methyl-2,2'-bipyridine-4-carboxylic 
acid)iridium(III) hexafluorophosphate 
3a 
 
Tetrakis(2-phenylpyridine)(µ-dichloro)diiridium(III) (98 mg, 0.091 mmol) was 
dissolved in 10 mL DCM and added via cannula to a suspension of 4'-methyl-
2,2'-bipyridine-4-carboxylic acid (39 mg, 0.18 mmol) in 10 mL dry MeOH under 
nitrogen.  The reaction was heated at reflux for 16 h.  The solvents were 
removed under reduced pressure and 20 mL 0.5 M HCl and 20 mL DCM were 
added to the residue.  The mixture was shaken and the organic phase was 
separated and washed with 20 mL sat. KPF6 (aq), dried over MgSO4, filtered and 
the solvent removed under reduced pressure yielding 139 mg (90%) red solid.  
1H NMR (400 MHz, CDCl3):  9.08 (1H, s, H
3 or 3'-bpy), 8.41 (1H, s, H3 or 3'-bpy), 
8.02 (1H, d, 3J 5.2 Hz), 7.96 (1H, d, 3J 5.2 Hz), 7.88 (2H, d, 3J 7.2 Hz, H-ph), 
7.56-7.71 (3H, m), 7.66 (2H, d, 3J 8.0 Hz, H-ph), 7.54 (1H, d, 3J 6.0 Hz), 7.51 
(1H, d, 3J 6.8 Hz), 7.22 (1H, d, 3J 6.0 Hz), 7.09-7.00 (4H, m) 6.90 (2H, t, 3J 
7.2 Hz, H-ph), 6.28 (2H, t, 3J 6.8 Hz, H-ph), 2.57 (3H, s, Me).  MS (ES+): m/z 
715 (M-PF6)
+. 
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Bis(2-phenylpyridine)(2,2'-bipyridine-4,4'-dicarboxylic acid)iridium(III) 
hexafluorophosphate 
4a 
 
2,2'-Bipyridine-4,4'-dicarboxylic acid (75 mg, 0.33 mmol) was suspended in 
20 mL dry MeOH under nitrogen.  A solution of tetrakis(2-phenylpyridine)(µ-
dichloro)diiridium (166 mg, 0.15 mmol) in 20 mL dry DCM was transferred to the 
ligand suspension via cannula and the reaction was heated at reflux for 3.5 h.  
Sodium acetate (220 mg, 2.68 mmol) in 4 mL MeOH was then added and the 
reaction was refluxed for a further 2 h.  The reaction was cooled to RT, the 
solvents were removed under reduced pressure and 16 mL 1 M HCl was added 
to the residue.  After stirring for 20 min the red solid was collected and washed 
with H2O.  This solid was extracted with MeOH
* and 4 mL sat. NH4PF6 in MeOH 
was added to the extracts.  The solvent was removed under reduced pressure 
and the residue extracted with DCM.  Removal of the solvent gave 91 mg (34%) 
red solid. 1H NMR (400 MHz, d3-acetonitrile):  9.09 (s, 2H, H
3-bpy), 8.14 (2H, 
d, 3J 5.6 Hz), 8.06 (2H, d, 3J 4.8 Hz), 7.95 (2H, d, 3J 5.6 Hz), 7.87-7.80 (4H, m), 
7.56 (2H, d, 3J 4.8 Hz), 7.09-6.99 (4H, m), 6.94 (2H, t, 3J 7.2 Hz), 6.26 (2H, d, 3J 
6.4 Hz).  MS (ES+): m/z 745 (M-PF6)
+. 
 
                                            
*
 In several repeats of this prep. a large amount of yellow/orange solid remained after extraction 
with MeOH.  In most cases this was the neutral monohydro-2,2‟-bipyridine-4,4‟-dicarboxylate 
complex which is fairly insoluble.  Addition of a few drops of 1 M HCl to this solid in MeCN gave 
a red solution showing a single component LCMS trace with m/z 745.  In one particular prep 
178 mg (80%) was recovered. 
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(4,6-Di(2-pyridyl)xylene)(4'-methyl-2,2'-bipyridine-4-carboxylic 
acid)iridium(III) chloride hexafluorophosphate 
5a 
 
[Ir(dpyx)(µ-Cl)Cl]2 (52 mg, 0.050 mmol) and 4'-methyl-2,2'-bipyridine-4-
carboxylic acid (22 mg, 0.10 mmol) were placed in 2 mL triglyme under nitrogen 
and heated at 190 C for 3 h.  No reaction appeared to have occurred so after 
cooling to a more ambient temperature, silver(I) triflate (25.7 mg, 0.05 mmol) 
was added then the reaction was heated again at 190 C for a further 3 h.  The 
solution was collected using a centrifuge and the residual solid was extracted 
with ~ 5 mL acetonitrile.  The combined solution and extracts were added 
dropwise to 20 mL sat. KPF6 (aq).  This, however, did not precipitate the product 
as expected so the aqueous mixture was extracted with 2  20 mL DCM.  The 
combined organics were washed with 3  20 mL H2O, dried over MgSO4, 
filtered and the solvent was removed under reduced pressure.  This left a yellow 
solid suspended in residual triglyme.  This solid was collected using a centrifuge 
and washed with 3  8 mL H2O, 4 mL EtOH and 2  8 mL Et2O giving a yield of 
28 mg (33%).  1H NMR (400 MHz, d3-acetonitrile):  9.92 (1H, d, 
3J 5.2 Hz, H6-
bpy), 9.13 (1H, s, H3-bpy), 8.61 (1H, d, 3J 5.2 Hz, H5-bpy), 8.40 (1H, s, H3'-bpy), 
8.22 (2H, d, 3J 8.4 Hz, H6-py), 7.81 (2H, t, 3J 7.6 Hz, H5-py), 7.65 (2H, d, 3J 
5.6 Hz, H3-py), 7.23 (1H, d, 3J 6.0 Hz, H6'-bpy), 7.13 (1H, s, H2-xy), 7.04 (2H, t, 
3J 6.8 Hz, H4-py), 6.94 (1H, d, 3J 6.0 Hz, H5'-bpy), 2.88 (6H, s, xy-Me), 2.42 (3H, 
s, bpy-Me).  MS (ES+): m/z 701 (M-PF6)
+. 
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(4,6-Di(2-pyridyl)xylene)(2,2'-bipyridine-4,4'-dicarboxylic acid)iridium(III) 
chloride hexafluorophosphate 
6a 
 
[Ir(dpyx)(µ-Cl)Cl]2 (52 mg, 0.050 mmol), 2,2'-bipyridine-4,4'-dicarboxylic acid 
(25 mg, 0.10 mmol) and silver(I) triflate (25.7 mg, 0.050 mmol) were placed in 
2 mL triglyme under nitrogen and heated at 195 C for 2 h.  After this time the 
solid in the reaction appeared slightly redder in colour but very little had 
dissolved.  Sodium acetate (17 mg, 0.21) was added and the reaction was 
heated for a further 12 h.  After cooling to RT, 1 mL 2 M HCl was added turning 
the solution red.  The solution was separated using a centrifuge and the 
residual solid was extracted with 3  3 mL acetonitrile.  The combined reaction 
solution and extracts were added dropwise to 20 mL sat. KPF6 (aq) producing a 
red/orange precipitate.  This was collected and washed with 3 8 mL H2O and a 
small amount of EtOH.  Yield: 37 mg (42%).  1H NMR (400 MHz, d3-
acetonitrile):  10.03 (1H, d, 3J 5.6, H6-bpy), 9.19 (1H, s, H3-bpy), 8.88 (1H, s, 
H3'-bpy), 8.61 (1H, d, 3J 4.0 Hz, H5-bpy), 8.23 (2H, d, 3J 7.6 Hz, H6-py) 7.82 (2H, 
t, 3J 7.6 Hz, H5-py), 7.64 (1H, d, 3J 6.4 Hz, H6'-bpy), 7.58 (2H, d, 3J 5.6 Hz, H3-
py), 7.52 (1H, d, 3J 6.4 Hz, H5'-bpy), 7.15 (1H, s, H2-xy), 7.03 (2H, t, 3J 6.8 Hz, 
H4-py), 2.87 (6H, s, Me).  MS (ES+): m/z 731 (M-PF6)
+. 
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Di-(O-ethyl-L-cysteinyl)-5-(N-dansylamino)isophthalamide 
 
N-dansyl-5-aminoisophthalic acid (96 mg, 0.23 mmol) was placed in 10 mL dry 
THF under nitrogen and cooled to 0 C.  EDCI (98 mg, 0.51 mmol) was added 
through a positive flow of nitrogen and the reaction was stirred for 15 min.  Ethyl 
cysteine hydrochloride (95 mg, 0.51 mmol) was then added and the reaction 
was warmed to RT then stirred for 16 h while maintained under a nitrogen 
atmosphere.  The resulting pale green solution was decanted from the residual 
white gum and the gum was washed with 2  5 mL THF.  The combined 
supernatant and washings were reduced to dryness under reduced pressure.  
An attempt to purify the product by flash column chromatography on alumina 
under nitrogen eluting with 5% MeOH in DCM ramped to 10% MeOH gave a 
small amount of product which was identified by 1H NMR and mass 
spectrometry, but not at an acceptable level of purity.  Yield (23 mg, 15%).  1H 
NMR (400 MHz, CDCl3):  8.49 (1H, d, 
3J 8.4 Hz, H-np), 8.39 (1H, d, 3J 7.6 Hz, 
H-np), 8.35 (1H, d, 3J 8.8 Hz), 7.88 (1H, s, H2-bn), 7.79 (2H, s, H4/6-bn), 7.51 
(1H, t, 3J 8.4 Hz, H-np), 7.47 (1H, t, 3J 8.4 Hz, H-np), 7.11 (1H, d, 3J 7.2 Hz, H-
np), 5.02 (2H, m, C*H), 4.26 (4H, q, 3J 7.2 Hz, OCH2CH3), 3.11 (4H, d, 
3J 
4.4 Hz, CH2SH), 2.83 (6H, s, NMe), 1.31 (6H, t, 
3J 7.2 Hz, OCH2CH3).  MS (ES-
): m/z 675 (M-H)-. 
 
S-(N-ethylaminocarbonyl)-cysteine ethyl ester hydrochloride 
 
Ethyl cysteine hydrochloride (1.85 g, 9.96 mmol) was dissolved in 15 mL DMF 
under argon gas and cooled to 0 C.  Ethyl isocyanate (800 µL, 718 mg, 
10.1 mmol) was added and the reaction was stirred for 72 h at RT under argon.  
The DMF solvent was removed using a Genevac leaving a white solid.  This 
solid was washed with diethyl ether and recrystallised from ethanol to give 
1.16 g (45%) white crystalline solid.  1H NMR (400 MHz, D2O):  4.42 (1H, t, 
3J 
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4.8 Hz, C*H), 4.29 (2H, q, 3J 7.2 Hz, OCH2CH3), 3.54 (1H, dd, 
2J 12.8 Hz, 3J 
4.8 Hz, SCHH), 3.48 (1H, dd, 2J 12.8 Hz, 3J 4.8 Hz, SCHH), 3.24 (2H, q, 3J 
7.6 Hz, NCH2CH3), 1.29 (3H, t, 
3J 7.2 Hz, OCH2CH3), 1.09 (3H, t, 
3J 7.6 Hz, 
NCH2CH3).  MS (ES+): m/z 221 (M-Cl)
+. 
 
Di(O-ethyl-S-(N-ethylaminocarbonyl)-cysteinyl)-5-(N-
dansylamino)isophthalamide 
 
N-dansyl-5-aminoiosphthalic acid (66 mg, 0.16 mmol) was dissolved in 7 mL dry 
THF under argon and the solution was cooled to 0 C.  EDCI (67 mmol, 
0.35 mmol) was added and the reaction was stirred for 30 min at 0 C before 
addition of triethylamine (50 µL, 36.3 mg, 0.36 mmol) and ethyl-S-(N-
ethylaminocarbonyl)-cysteine hydrochloride (103 mg, 0.40 mmol).  The reaction 
was then warmed to RT and stirred for 16 h.  The solution was decanted from 
the residual gum and the solvent removed under reduced pressure.  The crude 
product was columned on silica, eluting with 5% MeOH in DCM.  This yielded 
83 mg (64%) product (identified by mass spectrometry), however the purity was 
poor.  HRMS (ES+): m/z 819.24114; calculated for C36H47N6O10
32S3: 819.25103 
 
Bis(2-phenylpyridine)(O-ethyl-S-(N-ethylaminocarbonyl)-L-cysteinyl)-4'-
methyl-2,2'-bipyridine-4-carboxamide)iridium(III) hexafluorophosphate 
 
Bis(2-phenylpyridine)(4'-methyl-2,2'-bipyridine-4-carboxylic acid)iridium(III) 
hexafluorophosphate (100 mg, 0.116 mmol), was placed in 5 mL dry THF under 
argon and cooled to 0 C.  EDCI (25 mg, 0.13 mmol) was added and the 
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reaction was stirred for 30 min.  Triethylamine (18 µL, 13.1 mg, 0.13 mmol) and 
ethyl-S-(N-ethylaminocarbonyl)-cysteine hydrochloride (35 mg, 0.14 mmol) 
were added and the reaction was warmed to RT then stirred for 16 h.  The THF 
solution was decanted from the reaction vessel and the gummy residue was 
extracted with 2  5 mL THF.  The combined THF solutions were reduced to 
dryness on a rotary evaporator and the residue was dissolved in a minimum 
amount of acetonitrile.  This was added dropwise to a saturated solution of 
KPF6 (aq).  The resulting solid was collected and washed with H2O using a 
centrifuge then extracted into DCM.  Removal of the DCM under reduced 
pressure yielded the crude product.  Column chromatography on silica eluting 
with 5% MeOH in DCM gave 55 mg (45%) product, identified by mass 
spectrometry, however not at an acceptable level of purity.  MS(ES+): m/z 917 
(M-PF6)
+. 
 
 
The attempted thiol deprotection of bis(2-phenylpyridine)((S-(N-
ethylaminocarbonyl)-cysteine ethyl ester)-4'-methyl-2,2'-bipyridine-4-
carboxamide)iridium(III) hexafluorophosphate by the following method instead 
gave the dethiolated compound shown above, identified by mass spectrometry: 
The starting material was dissolved in 5 mL THF and degassed using the 
freeze-pump-thaw method.  5 mL 1 M NaOH(aq) was degassed separately then 
transferred to the reaction vessel via a cannula.  The reaction was then stirred 
at RT for 25 min.  The reaction was then quenched by addition of 5 mL 2 M HCl 
and 10 mL DCM was also added.  After stirring for 5 min the organic layer was 
separated and the solvent was removed under reduced pressure.  A saturated 
solution of NH4PF6 in methanol (2 mL) was added to the residue and stirred for 
5 min.  The methanol was removed under reduced pressure and the resulting 
solid was extracted with DCM.  The DCM solution was reduced to dryness 
yielding 12 mg red solid.  HRMS (ES+): m/z 810.21810; calculated for 
C39H33O3N5
191Ir: 810.21839. 
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S-(tert-butylmercapto)-L-cysteine methyl ester 
 
Acetyl chloride (1.0 mL, 1.10 g, 14.1 mmol) was added dropwise to 15 mL dry 
MeOH under nitrogen at -4 C.  S-(tert-butylmercapto)-L-cysteine (2.6 g, 
12.4 mmol) was added to the reaction which was then stirred at 0 C for 2 h, 
then for a further 16 h at RT.  The solvent was removed under reduced 
pressure and the residue was taken into 10 mL H2O and 20 mL 10% 
NaHCO3 (aq) was added producing a white precipitate.  30 mL Et2O was added 
to the suspension and the mixture was shaken vigorously.  Any remaining 
undissolved solid was removed by filtration (1.27 g starting material) then the 
organic phase was separated.  The aqueous phase was extracted with a further 
30 mL Et2O and the combined organics were dried over MgSO4 and the solvent 
was removed under reduced giving a clear, thin oil* (837 mg, 30%).  1H NMR 
(400 Hz, d4-methanol):  3.76 (1H, dd, 
3J 5.2 Hz, 6.8 Hz, C*H), 3.74 (3H, s, Me), 
3.08 (1H, dd, 2J 13.2 Hz, 3J 5.2 Hz, SCHH), 2.95 (1H, dd, 2J 13.2 Hz, 3J 6.8 Hz, 
SCHH), 1.34 (9H, s, tBu).  MS (ES+): m/z 224 (M+H)+. 
 
(O-methyl-S-tert-butylmercapto-L-cysteinyl)-4-(N-dansylamino)benzamide 
1b 
 
N-dansyl-5-amino benzoic acid (75 mg, 0.20 mmol) and methyl-S-(tert-
butylmercapto)-L-cysteine (67 mg, 0.30 mmol) were placed in a flask under 
nitrogen and dissolved in 5 mL dry THF.  The solution was cooled to 0 C and 
EDCI (45 mg, 0.23 mmol) was added through a flow of nitrogen.  The reaction 
was stirred for 15 min at 0 C then warmed to RT and stirred for a further 16 h.  
The solvent was removed under reduced pressure and the residue was 
                                            
*
 Avoid prolonged exposure to vacuum as this product is fairly volatile in the free-base form. 
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dissolved in 20 mL EtOAc.  This solution was washed with 20 mL each of 1 M 
HCl, 10% NaHCO3 (aq) and H2O, dried over MgSO4, fitered and the solvent was 
removed under reduced pressure.  The crude product was purified by column 
chromatography on silica with gradient elution from 70% to 90% Et2O in hexane 
(product Rf = 0.34 in 90% Et2O/hexane) yielding 56 mg (49%) green solid.  
1H 
NMR (400 MHz, CDCl3):  8.50 (1H, d, 
3J 8.8 Hz, H4-np), 8.33 (1H, d, 3J 8.8 Hz, 
H8-np), 8.25 (1H, d, 3J 7.6 Hz, H2-np), 7.59 (2H, d, 3J 8.8 Hz, H2/6 or 3/5-bn), 7.52 
(1H, t, 3J 8.0 Hz, H7-np), 7.45 (1H, t, 3J 8.0 Hz, H3-np), 7.15 (1H, d, 3J 7.6 Hz, 
H6-np), 7.04 (2H, d, 3J 8.8 Hz, H2/6 or 3/5-bn), 6.97 (1H, d, 3J 7.6 Hz, NH), 5.03 
(1H, m, C*H), 3.77 (3H, s, OMe), 3.25 (2H, m, SCH2C*), 2.85 (6H, s, NMe), 
1.28 (9H, s, tBu).  13C NMR* (100 MHz, CDCl3):  171.2 (C=O), 166.3 (C=O), 
140.3, 134.0, 131.2, 130.6, 129.6, 129.4, 128.8, 128.6, 123.4, 119.5, 118.7, 
115.6, 52.9, 52.7, 48.5, 42.1, 29.8 (C(CH3)3).  HRMS (ES+): m/z 576.16545; 
calculated for C27H34N3O5S3: 576.16551.  IR: (C=O) 1739, 1644 cm
-1.  C, H & 
N analysis: 53.56% C, 6.06% H, 6.83% N measured; 53.40% C, 6.06% H, 
6.92% N calculated for C27H33N3O5S3.{1.75(H2O)}. 
 
Di-(O-methyl-S-tert-butylmercapto-L-cysteinyl)-5-(N-
dansylamino)phthalamide 
2b 
 
N-dansyl-5-aminoiosphthalic acid (41 mg, .099 mmol) and O-methyl-S-(tert-
butylmercapto)-L-cysteine (78 mg, 0.35 mmol) were placed in 5 mL dry THF 
under nitrogen and cooled to 0 C.  EDCI (48 mg, 0.25 mmol) was added 
through a flow of nitrogen and the reaction was stirred for 30 min at 0 C then 
warmed to RT and stirred for a further 16 h.  The solvent was removed under 
reduced pressure and the residue was taken into 20 mL EtOAc and washed 
with 20 mL each of 1 M HCl(aq), 10% NaHCO3 (aq) and H2O.  The solution was 
then dried over MgSO4, filtered and the solvent was removed under reduced 
                                            
*
 Weak spectrum, 2 signals not resolved from noise. 
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pressure giving 57 mg (70%) green solid.  1H NMR (700 MHz, CDCl3):  8.48 
(1H, d, 3J 8.4 Hz, H4-np), 8.41 (1H, d, 3J 7.0 Hz, H2-np), 8.29 (1H, d, 3J 8.4 Hz, 
H8-np), 7.87 (1H, s, H4-bn), 7.80 (2H, s, H2/6-bn), 7.51 (1H, t, 3J 7.7 Hz, H3-np), 
7.41 (1H, t, 3J 8.4 Hz, H7-np), 7.31 (2H, d (broad), 3J 7.7 Hz, CONH), 7.08 (1H, 
d, 3J 7.7 Hz, H6-np), 5.14 (2H, m, C*H), 3.78 (6H, s, OMe), 3.32 (2H, dd, 2J 
14.0 Hz, 3J 4.9 Hz, SCHH), 3.27 (2H, dd, 2J 14.0 Hz, 3J 5.6 Hz, SCHH), 2.82 
(6H, s, NMe), 1.30 (18H, s, tBu).  13C NMR (175 MHz, CDCl3):  171.0 (OC=O), 
166.0, (NHC=O), 152.0 (C5-np), 138.7 (C3/5-bn), 135.0 (C1-bn), 133.8 (C1-np), 
131.3 (C4-np), 131.0 (C2-np), 130.0 (C4a-np), 129.6 (C8a-np), 128.7 (C7-np), 
123.4 (C3-np), 120.8 (C2/6-bn), 120.7 (C4-bn), 118.6 (C8-np), 115.4 (C6-np), 
52.9(2) and 52.9(1) (C* and OCH3), 48.4 (CMe3), 45.5 (NCH3), 41.9 (C*CH2S), 
29.9 (C(CH3)3).  HRMS (ES+): m/z 825.51492; calculated for C36H49N4O8S5: 
825.21485.  IR: (C=O) 1698, 1651 cm-1.  C, H & N analysis: 52.19% C, 6.02% 
H, 6.34% N measured; 52.40% C, 5.86% H, 6.79% N calculated for 
C36H48N4O8S5. 
 
Bis(2-phenylpyridine)(O-methyl-S-tert-butylmercapto-L-cysteinyl)-4'-
methyl-2,2'-bipyridine-4-carboxamide)iridium(III) hexafluorophosphate 
3b 
 
Bis(2-phenylpyridine)(4'-methyl-2,2'-bipyridine-4-carboxylic acid)iridium(III) 
hexafluorophosphate (138 mg, 0.16 mmol) and O-methyl-S-tert-butylmercapto-
L-cysteine (60 mg, 0.27 mmol) were placed in 5 mL 1:1 dry THF:dry DCM under 
nitrogen.  The solution was cooled to 0 C then EDCI (40 mg, 0.21 mmol) was 
added and the reaction stirred for 15 min.  The reaction was warmed to RT and 
stirred for a further 16 h.  The solvents were removed under reduced pressure 
and 20 mL sat. NH4Cl(aq) was added to the residue. The resulting solution was 
extracted with 2  15 mL DCM.  The combined organics were washed with 
20 mL sat. KPF6 (aq), dried over MgSO4, filtered and the solvent removed under 
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reduced pressure.  The crude product was purified by column chromatography 
on silica, eluting with 7.5% MeOH in DCM to yield 128 mg (74%) red solid.  
1H NMR (400 MHz, CDCl3):  10.59 (1H, s (broad), NH), 10.29 (1H, s, H
3 or 3'-
bpy), 9.67 (1H, s, H3 or 3'-bpy), 8.05 (1H, d, 3J 5.2 Hz), 7.97 (1H, d, 3J 5.6 Hz), 
7.91 (2H, d, 3J 8.0 Hz), 7.78-7.67 (5H, m), 7.48 (1H, d, 3J 6.0 Hz), 4.44 (1H, d, 
3J 6.0 Hz), 7.17 (1H, d, 3J 6.0 Hz), 7.06-6.88 (6H, m), 6.29 (2H, t, 3J 6.8 Hz), 
5.10 (1H, m, C*H), 3.73 (1H, m, SCHH), 3.73 (3H, d*, OMe), 3.37 (1H, mm 
SCHH), 2.61 (3H, s, bpy-Me), 1.33 (9H, d*, tBu).  HRMS (ES+): m/z 918.22533; 
calculated for C42H41
191IrN5O3S2: 918.22514.  IR: (C=O) 1720, 1666 cm
-1.  C, H 
& N analysis: 46.17% C, 4.53% H, 5.87% N measured; 46.04% C, 4.00% H, 
6.39% N calculated for C42H42IrN5O3S2PF6.{1.75(H2O)}. 
 
Bis(2-phenylpyridine)(Di-(O-methyl-S-tert-butylmercapto-L-cysteinyl)-2,2'-
bipyridine-4-4'-dicarboxamide)iridium(III) hexafluorophosphate 
4b 
 
Bis(2-phenylpyridine)(hydro-2,2'-bipyridine-4,4'-dicarboxylate)iridium(III) 
(117 mg, 0.157 mmol) and O-methyl-S-tert-butylmercapto-L-cysteine (106 mg, 
0.475 mmol) were placed under nitrogen and 5 mL MeCN was added.  2 M HCl 
was added dropwise until the iridium complex dissolved (~0.1 mL).  The 
solution was then cooled to 0 C and EDCI (70 mg, 0.355 mmol) was added 
through a flow of nitrogen.  The reaction was stirred for 15 min at 0 C, warmed 
to RT and stirred for a further 16 h.  The solvent was removed under reduced 
pressure and 20 mL DCM was added to the residue.  20 mL sat. NH4Cl(aq) was 
also added and the mixture shaken vigorously.  The organic phase was 
separated and washed with a further 20 mL sat. NH4Cl(aq) and then 2  10 mL 
sat. KPF6 (aq), dried over MgSO4, filtered and the solvent removed under 
                                            
*
 Methyl and tert-Butyl signals are both split into 2 equal integral signals.  Unlikely to be J 
coupling (~15 Hz for Me, ~7 Hz for 
t
Bu).  Possibly a result of diastereoisomers. 
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reduced pressure.  The product was purified by column chromatography on 
silica with gradient elution from 0% to 5% MeOH in DCM (Product Rf = 0.59 in 
5% MeOH) yielding 120 mg (59%) red solid.  1H NMR (400 MHz, CDCl3): 8.89 
(2H, s (broad), H3/3'-bpy), 8.07 (2H, d, 3J 6.0 Hz, H6/6'-bpy), 7.93 (2H, d, 3J 
8.0 Hz, H-ppy), 7.88 (2H, d, 3J 5.6 Hz, H5/5'-bpy), 7.78 (2H, t, 3J 8.0 Hz, H-ppy), 
7.70 (2H, d, 3J 8.0 Hz, H-ppy), 7.67 (2H, s (broad), NH), 7.48 (2H, d, 3J 5.6 Hz, 
H-ppy), 7.09-7.02 (4H, m, 2H-ppy), 6.94 (2H, t, 3J 7.2 Hz, H-ppy), 6.28 (2H, d, 
3J 7.6 Hz, H-ppy), 5.12, (2H, m, C*H), 3.80 (3H, s, Me), 3.78 (3H, s, Me), 3.35 
(2H, dd, 2J 13.6 Hz, 3J 4.8 Hz, SCHH), 3.20 (2H, dd, 2J 13.6 Hz, 3J 8.8 Hz, 
SCHH), 1.34 (9H, s, tBu), 1.33 (9H, s, tBu).  13C NMR (100 MHz, CDCl3):  
170.3, 167.6, 164.1, 156.0, 151.0, 149.4, 148.6, 144.6, 143.3, 138.4, 131.7, 
131.0, 127.3, 124.9, 123.6, 123.0, 122.5, 119.8, 53.5, 52.8, 48.2, 40.8, 29.9.  
HRMS (ES+): m/z 1153.26075; calculated for C50H54
191IrN6O6S4: 1153.25883.  
IR: (C=O) 1725, 1675 cm-1.  C, H & N analysis: 45.44% C, 4.20% H, 6.30% N 
measured; 45.43% C, 4.23% H, 6.36% N calculated for 
C50H53IrN6O6S4PF6.{1.25(H2O)}. 
 
General procedure for deprotection of S-tbutylmercapto cysteines 
Between 0.01 mmol and 0.04 mmol protected mimic was dissolved in 2 mL 
acetonitrile and degassed using the freeze-pump-thaw method.  In a separate 
flask, a solution of DTT in H2O (200 mM for singly functionalised mimics or 
400 mM for doubly functionalised) was degassed.  2 mL of the DTT solution 
was then transferred to the mimic solution via cannula and the reaction was 
heated at reflux for 1 h under nitrogen.  After cooling to RT, 6 mL organic 
solvent (EtOAc for Dansyl mimics and DCM for Iridium mimics) was added to 
the residue and then washed with 2  6 mL sat. Na2S2O3 (aq).  The organic 
phase was separated and dried over MgSO4, filtered and the solvent was 
removed under reduced pressure yielding the deprotected product.  
Deprotection was confirmed by mass spectrometry and by the loss of tBu 
signals in the 1H NMR spectrum. 
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